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Abstract 
 
Evaluation and Testing of Eye, Nose, and Mouth Protection for Biological 
Hazards to Support a Consensus Standard 
 
 
Jeremy R. Gouzd 
 
 
 
  Eye protection is one of the greatest personal protective equipment items 
that has ever been made readily available to workers. In almost every occupation there 
will be some hazard that requires the worker to wear eye protection. Nearly three out 
of five injured workers were not wearing eye protection at the time of the accident or 
were wearing the wrong kind of eye protection for the job. Eye injuries alone cost 
more than $300 million per year in lost production time, medical expenses and worker 
compensation (Matela, 2012). Eye protection should be integrated with other PPE to 
achieve head-to-toe protection. It should be fit to the individual worker or be 
adjustable so it can provide sufficient coverage. According to a BLS survey, 94 percent 
of the injuries to workers wearing eye protection resulted from objects or chemicals 
going around or under the protective device (Matela, 2012). When it comes to safety 
glasses, users need to know they’ve been rigorously tested, and held up to a set of 
industry standards. This knowledge allows wearers to be confident that their safety 
glasses will do their job, so workers can focus on the task at hand without worrying 
about whether their eyes are, in fact, protected. Whenever an employee or employer 
needs to reference standards on eye protection they generally are referred to ANSI 
Z87.1. Although this standard covers many occupational hazards there are still a few 
that are not addressed. These hazards are that of biological hazards such as blood borne 
pathogens. ANSI Z87.1 does not cover eye protectors for biological hazards. A 
committee was formed and concluded that a new standard ANSI Z87.62 standard will 
include a variety of testing procedures that mimic the different types of biological 
hazard exposures that can be experienced (spurt and spray). The most common 
occupations that are seen to have the highest incidence rate of these hazards projected 
at the workers eyes would be nurses, doctors performing procedures, dental healthcare 
workers, and laboratory workers in the health related research fields. A subcommittee 
has been formed to try and resolve this issue by creating a new standard, (ANSI 
Z87.62) to include a more detailed description of the proper eye and face protection 
that workers exposed to biological hazards should be using. A test apparatus, testing 
method, and standard for which eye and face protectors will be tested on, has been 
created in correlation to this standard to test that protectors are providing adequate 
worker protection. 
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CHAPTER 1 - INTRODUCTION 
 
1.1 Background 
 
The ANSI-ISEA Z87.1 American National Standard for Occupational and Educational 
Personal Eye and Face Protection Devices addresses many workplace hazards where 
eye and face protection is required. This standard is performance-based to allow for 
other designs and product types to be implemented to meet end user’s needs. The 
standard also focuses on helping the end user select PPE that is most appropriate for 
his/her specific work environment.  
 
ANSI Z87 committee has determined that a subcommittee needed to be formed to 
create a new standard. New test methods within the new ANSI Z87.62 standard will 
include a variety of testing procedures that mimic the different types of biohazard 
exposures that can be experienced (spurt and spray). ANSI has approved the ANSI 
Z87.62 subcommittee to look at “…criteria related to the general requirements, testing, 
permanent marking, selection, care and use of protectors to minimize or prevent 
exposure to the wearer's eyes and/or face caused by biological hazards including, but 
not limited to blood, body fluids or other potentially infectious materials (OPIMs) or 
microorganisms, viruses or toxins from a biological source that can affect human 
health.  This standard is NOT intended to address hazards related to transmission of an 
infectious agent by particles, dust, or droplet nuclei that are suspended in the air, and 
which may require other additional forms of protection”(ANSI Z87.62).   
 
Note that OSHA directs workers to see ANSI Z87.1 for appropriate eye and face 
2  
protection. In a vast majority of industry, workers are exposed to flying particles, 
liquid chemicals, gases or vapors, and blood borne pathogens. When a worker refers to 
ANSI Z87.1, it specifically states that blood borne pathogens are not covered in the 
standard.  
“Certain hazardous exposures are not covered in this standard. These include, but 
are not limited to: blood borne pathogens, X-rays, high-energy particulate 
radiation, microwave, radio-frequency radiation, lasers, masers, and sports and 
recreation” (ANSI Z87.1). 
 
 
1.2 Objectives 
 
 
Project Need  
This project is focusing on establishing minimum performance-oriented standard for a 
product that is widely used but for which no current standard exists for healthcare and 
related personnel, research facilities, or product manufacturers. Once minimum 
performance-oriented standards have been established, it will allow workers to be able 
to reference ANSI Z87.62 and have guidance for eye protectors for protection against 
biological hazards.  
 
Focus 
A subcommittee (ANSI Z87.62 Eye and Face Protection Used against Biological 
Hazards) has been formed to try and resolve this issue by creating a new standard, to 
include a more detailed description of the proper eye and face protection that workers 
exposed to biological hazards should be using. A testing method for eye and face 
protectors has been created to test that protectors are providing adequate worker 
3  
protection. 
In recent version and updates of the ANSI Z87.1 standards, protective eye wear are 
required to have efficient and easy-to-understand lens and frame markings. These 
markings help to make the selection process simpler and have increases in compliance 
(Eldridge 2017). All safety markings for ANSI Z87.1-2015 safety eyewear must be 
permanently and clearly marked on the frame or lens. This marking requirement 
includes goggles and face shields as well as safety glasses. A similar marking will be 
created to identify PPE that have been verified to protect against biological hazards.  
 
Some of the types of biological hazards to workers in these types of working 
environments are debris, blood, and other bodily fluids. Very infrequently, a worker 
may choose to wear a face shield, which offers improved protection for debris as well 
as blood and other bodily splashes. This method is hardly ever used due to higher costs 
and many other inconveniences and discomforts caused to the wearer (Arsenault, 
2016).  In the Z87.1 standard, guidance for splash could lead a user choose to wear a 
face shield as well as a secondary protector such as safety glasses. If the worker does 
not need impact protection, this combination suggested by the standard could be 
unnecessary extra protection. 
 
Dental care workers report routes of exposure most commonly in places where a user’s 
glasses meet their mask.  Front and side routes of entry are adequately blocked by a 
wearer’s safety glasses, however, bottom and top gaps remain completely exposed. 
This puts the wearer at increased risk of exposure to blood borne pathogens (Arsenault, 
2016). (See figure 1-1 and 1-2 below)  
4  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Benefits of the research 
 
After completion of this project, we will be able to implement a standard into Z87.1 to 
protect a user from representative biological hazards and a establish minimum 
performance-oriented standard for a product that is widely used for which a new and 
current standard will exist for healthcare and related personnel; research and healthcare 
facilities; product manufacturers. We will also be able to set forth criteria related to the 
general requirements, testing, permanent marking, selection, care and use of protectors 
to minimize or prevent exposure to the wearer's eyes and/or face caused by biological 
hazards including, but not limited to blood, body fluids or other potentially infectious 
materials (OPIMs) or microorganisms, viruses or toxins from a biological source that 
Figure 1-1: Bottom Gaps-Side View 
Figure 1-2: Bottom Gaps- Bottom View 
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can affect human health. This project’s main objective is to establish a standard testing 
apparatus that all tests will be performed on or of a similar and equivalent testing 
apparatus to ensure concise and consistent testing across the broad spectrum of safety 
manufacturers and end users. It is designed to simulate high risk occupations with 
biological hazards and where eye and face PPE are worn. After the completion of the 
test apparatus and results have been obtained, these methods and data will provide 
input to the ANSI Z87.62 standard.  
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CHAPTER 2 – REVIEW OF LITERATURE 
 
2.1 Blood Borne Pathogens; Not Covered In Standard – the problem 
 
 
2.1.1 Problem 
Blood poses high risk to health in a laboratory or clinical setting due to transmissions 
in the workplace when infected person's blood enters another person's bloodstream 
through an open wound or a mucous membrane. These risks are greatest among 
healthcare workers, including: nurses, surgeons, laboratory assistants, doctors, 
phlebotomists, and laboratory technicians. Some standard precautions when working in 
and around these occupational hazards are to use the universal precautions. Universal 
precautions is an approach to infection control to treat all human blood and certain 
human body fluids as if they were known to be infectious for HIV, HBV and other 
blood borne pathogens. One of the best ways to prevent and protect yourself from 
infected blood is to wear appropriate personal protective equipment: gloves, goggles, 
etc. as required.  
 
Many different job environments are covered in great detail in ANSI Z87.1 and end 
users are provided with ample amounts of information for selecting the correct eye and 
face protectors. However, within ANSI-ISEA Z87.1 there is no information on the use 
of protectors to aid against the risk of working with biological hazards such as blood 
borne pathogens.  
Inside the OSHA general requirements standard “1910.133,” it states;  
1910.133(a) 
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General requirements. 
1910.133(a) (1) 
The employer shall ensure that each affected employee uses appropriate eye or face 
protection when exposed to eye or face hazards from flying particles, molten metal, 
liquid chemicals, acids or caustic liquids, chemical gases or vapors, or potentially 
injurious light radiation. 
1910.133(a) (2) 
The employer shall ensure that each affected employee uses eye protection that 
provides side protection when there is a hazard from flying objects. Detachable side 
protectors (e.g. clip-on or slide-on side shields) meeting the pertinent requirements of 
this section are acceptable. 
1910.133(a) (3) 
The employer shall ensure that each affected employee who wears prescription lenses 
while engaged in operations that involve eye hazards wears eye protection that 
incorporates the prescription in its design, or wears eye protection that can be worn 
over the prescription lenses without disturbing the proper position of the prescription 
lenses or the protective lenses. 
1910.133(a) (4) 
Eye and face PPE shall be distinctly marked to facilitate identification of the 
manufacturer. 
1910.133(b) 
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Criteria for protective eye and face protection. 
1910.133(b) (1) 
Protective eye and face protection devices must comply with any of the following 
consensus standards: 
1910.133(b) (1)(i) 
ANSI/ISEA Z87.1-2010, Occupational and Educational Personal Eye and Face 
Protection Devices, incorporated by reference in § 1910.6; 
1910.133(b) (1) (ii) 
ANSI Z87.1-2003, Occupational and Educational Personal Eye and Face 
Protection Devices, incorporated by reference in § 1910.6; or 
1910.133(b) (1) (iii) 
ANSI Z87.1-1989 (R-1998), Practice for Occupational and Educational Eye and 
Face Protection, incorporated by reference in § 1910.6; 
1910.133(b) (2) 
Protective eye and face protection devices that the employer demonstrates are at least 
as effective as protective eye and face protection devices that are constructed in 
accordance with one of the above consensus standards will be deemed to be in 
compliance with the requirements of this section (UNITED STATES DEPARTMENT 
OF LABOR). 
When a worker goes to ANSI Z87.1, they will find a chart (as shown below-Table 1 
and Table 2) which covers most all things that could be found in a working 
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environment except for biological hazards. Within ANSI Z87.1, a worker would also 
find information on “Hazard Assessment” which gives a brief overview of how to 
correctly conduct an assessment. It also gives information on “Identifying Sources of 
Hazards” during a working conditions walk through. This summary of “Identifying 
Sources of Hazards,” even includes a section for “dust, sparks, spray, and mist,” but 
these are for non-biohazardous particles (Table 2-1 and Table 2-2; ANSI Z87.62, pg. 
46-52). 
 
 
 
Table 2- 1: Eye and Face Protector Selection Guide 1 
10  
 
Table 2-2: Eye and Face Protector Selection Guide 2 
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In the OSHA standard, it dictates that an employer must provide appropriate eye 
protection, which then leads the worker to ANSI for its descriptions of hazards and 
selections of different protectors. The selection guide for these protectors doesn’t 
include all possible routes of entry (front, side, bottom, and top) or biological hazards 
such as blood borne pathogens. Since the standard calls for the employer to supply the 
employee with the most appropriate eye protector, they then would need to provide an 
eye protector that encompasses all entry routes and hazards such as blood borne 
pathogens.  
 
2.2  Identifying and Categorizing Workplace Hazards 
 
 
2.2.1 Hazards  
 
Healthcare personnel are at risk for occupational exposure to blood borne pathogens. 
Blood borne pathogens are pathogenic microorganisms present in the human blood that 
can lead to diseases. The primary concerns of blood borne pathogens are hepatitis B 
virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). HBV 
causes serious liver disease (Hepatitis B), which can become a chronic condition that 
causes permanent scarring of liver, leading to liver failure or liver cancer; there are an 
estimated 2,000-4,000 deaths per year in U.S.(CDC, 2015). HBV is much more 
transmissible than HIV and 50% of infected people are unaware that they have HBV 
(CDC, 1997). Hepatitis C Virus (HCV) attacks the liver and leads to inflammation. 
Chronic infection develops in 75%-85% of patients with 70% developing active liver 
disease (CDC n.d.), and can result in long-term health problems, even death. Most 
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infected people have no symptoms and don’t know they are infected until decades later 
when liver damage shows up in routine tests. Human Immunodeficiency Virus (HIV) 
causes Acquired Immunodeficiency Syndrome (AIDS) and attacks the immune system 
cells which weakens and eventually destroys the immune system thus, leaving the body 
at higher risk of developing serious conditions such as pneumonia or cancer. It is 
estimated that close to 1 in 5 are unaware they are infected. Once a person is infected, 
the human body cannot get rid of the HIV completely. Some people experience flu-like 
symptoms (fever, chills, rash, night sweats, muscle aches, sore throat, fatigue, swollen 
lymph nodes, or mouth ulcers) 2-4 weeks after infection, while others may not feel sick 
and be unware of their infection (CDC, 2015). 
 
2.2.2 Transmission in the Workplace 
 
In most work situations, transmission is most likely to occur because of accidental 
puncture from contaminated needles, broken glass, or other sharps; contact between 
broken or damaged skin and infected body fluids; or contact between mucous 
membranes and infected body fluids. For example, if someone infected with HBV cut 
their finger on a piece of glass, and then you cut yourself on the now infected piece of 
glass, it is possible that you could contract the disease. Anytime there is blood-to-blood 
contact with infected blood or body fluids, there is a slight potential for transmission. 
Unbroken skin forms an impervious barrier against blood borne pathogens. However, 
infected blood can enter your system through: 
• Open sores 
• Cuts 
• Abrasions 
• Acne 
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• Any sort of damaged or broken skin such as sunburn or blisters 
Blood borne pathogens may also be transmitted through the mucous membranes of the 
eyes, nose and mouth. Important factors that influence the overall risk for occupational 
exposures to blood borne pathogens include the number of infected individuals in the 
patient population and the type and number of blood contacts. Most exposures do not 
result in infection. Following a specific exposure, the risk of infection may vary with 
factors such as these:  
• The pathogen involved  
• The type of exposure  
• The amount of blood involved in the exposure  
• The amount of virus in the patient's blood at the time of exposure 
Using appropriate barriers such as gloves, eye and face protection, or gowns when 
contact with blood is expected can prevent many exposures to the eyes, nose, mouth, or 
skin.  
Exposure to blood-borne pathogens poses a serious risk to health care workers 
(HCWs). Assessment of the risk of blood-borne pathogen transmission in the health 
care setting requires information derived from various sources, including surveillance 
data, studies of the frequency and preventability of blood contacts, seroprevalence 
studies among patients and HCWs, and prospective studies that assess the risk of 
seroconversion after an exposure to infected blood. Factors influencing the risk to an 
individual HCW over a lifetime career include the number and types of blood contact 
experienced by the worker, the prevalence of blood-borne pathogen infection among 
patients treated by the worker, and the risk of transmission of infection after a single 
blood contact.  
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There are many modes of blood-borne pathogen transmission in the health care setting; 
blood-borne pathogen transmission occurs predominantly by percutaneous or mucosal 
exposure of workers to the blood or body fluids of infected patients (American Red 
Cross, 2001). Occupational exposures that may result in HIV, HBV, or HCV 
transmission include needle stick and other sharps injuries; direct inoculation of virus 
into cutaneous scratches, skin lesions, abrasions, or burns; and inoculation of virus 
onto mucosal surfaces of the eyes, nose, or mouth through accidental splashes. HIV, 
HBV, and HCV do not spontaneously penetrate intact skin, and airborne transmission 
of these viruses does not occur. 
 
The mode of transmission that this study is most concerned and directed towards is 
transmission through the eye, nose or mouth. If the conjunctiva of the eye is 
compromised; bacteria, viruses, and fungi can easily penetrate into the eye, blood 
vessels, or vitreous / aqueous humor. These risks are exacerbated by abrasions, 
swelling, allergies, infection, inflammation, dryness, conjunctivitis, sty, recent surgery, 
and workers who wear contacts. Below is Figure 2-1 that outlines the eye and its 
anatomy. The possible routes of transmission for the eyes are highlighted.  
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Figure 2-1: Anatomy of Eye 
 
 
 
 
2.3 Occupations  
 
High Hazard occupations that use eye and face protection can be sorted and analyzed 
based on a risk assessment and the most common biological hazard that is seen with 
each situation. The broad range of hazards that are being compared are propelled 
droplets, splashes, sprays, and other potentials infectious materials. The most common 
occupations that are seen to have the highest incidence rate of these hazards projected 
at the workers eyes would be nurses, doctors performing procedures, dental healthcare 
Semi-Transparent Skin 
Covering: First Line of 
Defense 
 Capillaries 
Source: (Mitchell 2016)  
https://www.lhup.edu/~dsimanek/scenario/labman3/eye.htm 
Tear Duct 
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workers, and laboratory workers in the health related research fields (Mitchell 2016). 
Below is Table 2-3 which summarizes what specific occupational work environment 
gets the most exposure, subsequent infections, illnesses, and seroconversions.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-3: Reports in Occupational Work Environment 
Source: (Mitchell 2016) 
 
2.3.1 Surgeons / Physicians / Nurses (Involved in procedure)  
 
The risk of blood borne pathogen transmission through accidental exposure is low, it is 
still at 0.5% for needle stick injury with percutaneous needles and at 0.1% for mucous 
membrane exposure (Beltrami et al., 2000). This mucous membrane exposure can be 
transmitted through ocular contact. While most surgeons take precautions to avoid needle 
stick injuries, potential infection via fluid exposure to the eyes might not be as well recognized 
ICU Influenza, HIV 
ER / Isolation SARS 
Patient Room HBV 
Lab / Research Herpes B Virus 
Lab / Diagnostic HIV, HCV 
Lab Plague 
Ortho Surgery Hepatitis, HIV 
Dental HIV 
Security / Police HCV 
Veterinary Rabies 
Relief Workers Ebola 
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as a hazard. Non sharps (mucocutaneous) exposure poses a problem as well. Such 
exposure can arise from incidents ranging from accidental splashing of blood into the 
eyes or a skin cut when starting or removing an I.V. catheter to disposing of body 
fluids or dressing an open wound. A 2003 study found nurses had a higher 
mucocutaneous exposure rate than physicians and medical technologists. More than 
one-third (39%) of registered nurses and one-fourth (27%) of licensed practical nurses 
said they’d experienced one or more mucocutaneous blood exposures in the previous 3 
months—but few reported their exposures (Delisio, 2017). 
 
Looking at statistical data that categorizes the occupation of medical personal from the 
International Safety Center, one can see that the Doctors and Nurses are the highest 
exposed workers (Table 2-4).  
 
 
Table 2-4: Exposed Medical Workers 
Source: (Mitchell 2016) 
 
The data goes in depth to show where the exposure occurred. As seen, direct patient 
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care is the greatest cause of splashes. This is due to the fact that patients have a lot of 
fluid, i.e. these exposure are happening where the patients are. 75.6% are from direct 
patient contact (Table 2-5). Furthermore in Table 2-6, data shows that the eyes or 
conjunctiva is the most exposed part in the total records at 65.7%.  
 
 
Table 2-5: Exposure Setting 
Source: (Mitchell 2016) 
 
 
 
 
 
Table 2-6: Exposed Body Part 
Source: (Mitchell 2016) 
 
In a study that was done to quantify how frequently body fluids splash the mask and 
lens of protective glasses it was found that from a total of 384 operations, 174 (45%) 
showed blood or body fluid splash on the lens (Davies, 2007). A high incidence of 
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splashes was found in vascular surgical procedures (79%). All amputations showed 
splashes onto the protective lens of the eye protector. Also, the study showed that 50% 
of laparoscopic cases resulted in blood or body fluid splash on the protective lens 
(Davies, 2007). This study demonstrated that an overall 45% risk of blood and bodily 
fluid splash on protective spectacle lens during surgery. This agrees with previous 
studies where blood splash contamination recorded on spectacles and protective eye 
shields has varied from 25-51%. This study has shown significantly more incidents of 
blood and body fluid splash when undertaking vascular operations and amputations. 
Vascular surgery does expose a surgeon to blood splash frequently due to common use 
of bone cutters and power saws. Blood and bodily fluids are often sprayed into the 
operating room. Not only is the primary surgeon at risk but their assistants were shown 
to be equally at risk of blood and bodily fluid splash to their eyes. With the abundance 
of HIV and hepatitis, it seems prudent to protect oneself against possible routes of 
transmission. The prevalence of HIV and hepatitis is increasing; therefore, although the 
transmission risk of HIV and hepatitis is low, the overall risk cannot be ignored. In a 
prospective epidemiological study performed on patients undergoing invasive 
radiological procedures in France, 944 patients were screened for hepatitis C virus. 
Ninety-one patients (10%) tested positive for hepatitis C, of whom 82 (90%) had a 
positive viremia result demonstrating a high potential for contamination through blood 
contacts (Davies, 2007).  
 
Some surgeons and assistants will rely on their prescription spectacles as sole eye 
protection. With the majority of these spectacles being of a slim design, their 
effectiveness as an eye protector decreases. When looking at a survey done to asses 
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current operating theatre eye wear practices, out of 71 surgeons, 84.5% that used their 
prescription eyewear as their eye protector had experienced prior periorbital blood 
splashes to the facial region, of those 19 (26.8%) admitted to having been impacted in 
the eye (Chong, 2007).  Personal estimates of rates of facial blood splash varied 
widely, from 0 to 21.7 events per month, while twelve (16.9%) had previously 
intraoperatively un-gowned to clean themselves following a facial blood splash, and 6 
(8.5%) had sought infectious disease testing following conjunctival contamination 
(Chong, 2007). Two (2.8%) admitted to contracting an illness from palpebral fissure 
contamination, comprising 1 case of viral papilloma and 1 case of conjunctivitis 
(Chong, 2007).  
 
 
Table 2-7: Personal Experience with Facial Blood Splashes 
In an article written on the risks of blood splashes to the eye during surgery a study 
was approved and conducted by the Ethics Committee of the Faculty of Health 
Sciences of the University of Cape Town (Table 2-7). The study was undertaken to 
determine the incidence of blood splashes to the eyes during surgery. After the study 
concluded and results were analyzed it was found that the incidence of blood splashes 
(ocular) was 45%; the study also found that the risk of mucocutaneous exposure via 
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blood splashes to the eyes is either underestimated or not fully appreciated by health 
care workers (Silva, Mall, Panieri, Stupart, & Kahn, 2009). 
 
2.3.2 Dentist / Dental Care workers 
Dental practice presents opportunities for cross-contamination. The dentist's face is at 
high-risk of infection transmission. A large number of pathogens are localized in the 
oral cavity, which can be transmitted in different ways during dental procedures, 
usually by means of air/water syringe and high-speed instruments. Two basic ways for 
spreading pathogenic microorganisms in a dental practice are blood and saliva through 
droplets of infected patients. The greatest risks for the dentist are hepatitis B and C 
viruses, and HIV virus that spread through blood and cause life-threatening diseases. 
Eye injuries can vary from mild irritation to blindness. The use of eye protection, such 
as protective goggles and visors, reduces the risk of eye damage or complete loss of 
vision while working with dangerous and floating materials. Therefore, all precautions 
should be taken, even when performing common procedures for which the risk 
expectancy is relatively low. Porter et al. investigated occupational injuries reported in 
dental hospitals over a period of 9 years and found that eye injuries accounted for 10% 
of incidents (Porter, 1990). Similarly, Wazzen et al. examined the 1 month prevalence 
of ocular injuries and infections among dental personnel which consists of dental 
assistants, dentists and technicians for which he found the foreign body related injury 
prevalence of dental personal, the dentists and technicians was 42.3% (Wazzen, 2001). 
Research shows that approximately 48% of all dental providers suffer some sort of 
ocular trauma during their careers. It is worth noting that during one year, 27.6% of the 
dentists had contact with infectious material via damaged skin, and 28.1% of the 
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dentists reported trans-mucosal contact. Half (54.7%) of the dentists reported splashing 
infectious material on the conjunctiva of the eye (Garus-Pakowska, 2017). 
 
Other research has demonstrated the inadequacy of the present dental mask and 
regularly worn protective eye wear. Some dental workers wear dental masks and 
protective eye wear while performing their routine procedures. However, just a general 
off the shelf eye protector is not sufficient enough. These eye protectors generally 
conform to ANSI Z87.1 for their impact ratings but the standard has nothing to 
conform to on blood borne pathogens. Dr. Peter Arsenault conducted experiments and 
published a report showing the different entry routes for exposures to the user’s eyes. 
He states, “Also, the unavoidable generation of the bottom gaps renders the 
combination of regular protective eyewear and non-full face shield dental mask an 
unreasonably dangerous combination, since it is reasonably foreseeable that dental 
debris may reach the eyes of the dental practitioner through such open bottom gaps” 
(Arsenault, 2016).  
 
Dr. Arsenault goes on to report a firsthand account of a student with an eye injury. The 
report states: 
 
When I treated this patient I took all of the necessary precautions which 
include wearing a gown, gloves, face mask, and loupes with frames for eye 
protection. While cleaning the margins with a piece of floss some of the 
patient’s saliva splashed into my eye. The patient’s gingiva was bleeding 
and it was possible that some of his blood had splashed into my eye too. 
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When this occurred my facemask and loupes were fully tightened. I was 
confused how this happened, so I examined how my loupes sat on my face 
and noticed a slight opening between my face and the frames just lateral to 
the ridge of my nose. I noticed there was a space not protected by my loupe 
frame or facemask which left my eyes exposed at certain angles. Even 
though I followed all the mandatory safety guidelines, my eyes were still 
susceptible to flying debris and an infectious disease. Immediately after the 
incident I went to the emergency room to wash my eye and was prescribed 
prophylaxis medication” (Arsenault, 2016). 
 
The account goes on to talk about the medications he had to be on for treating an 
incident for infectious disease.  
 
“The medications I took had dramatic side effects that made doing simple 
things feel more difficult. Fortunately, I was able to recover without any 
major problem. However, I believe the situation could have been avoided 
with proper eye protection. The current standard for eye wear is 
unacceptable and requires improvements for the safety of all dentists” 
(Arsenault, 2016). 
 
2.3.3 Health Care / Laboratory Workers  
When it comes to occupational risks in the health care working environment, most 
people think of slips, trips, and falls right away. There are many other very 
hazardous risks that tend to get overlook. These come in the form of blood borne 
24  
pathogens exposures and infectious diseases. Most commonly, these hazardous risks 
are transmitted through sharps and bodily fluids (Splish Splash, 2003). These 
splashes, also known as mucocutaneous blood exposures can transfer pathogens 
through the eyes, nose, or mouth. Clinical lab work is at a very high risk because 
specimens that are in the lab are there because they are already suspected to have a 
contagion of some kind. Below Table 2-8 shows an outline of what the exposures 
are a result of. As one can see, the majority of the exposures in this type of setting is 
from specimen container leaks.  
 
 
 
 
 
 
 
Table 2-8: Health Care / Laboratory Exposure from Various Tasks  
Source: (Mitchell 2016) 
Other health care and laboratory work is performed with more than just human 
contact. Many clinical lab workers may help with research while worker on animals 
such as primates. In some cases there have been documented incidents where an 
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exposure has happened when working with animals. In 1997 a female worker at a 
primate center died from Cercopithecine herpesvirus (B virus) infection following a 
mucocutaneous exposure. This exposure happened after working with a rhesus 
macaque where biologic material splashed into her right eye. The worker was not 
wearing any eye protection due to the nature of task being deemed a “low risk.” 
After the exposure to the eye, the worker wiped it and then irrigate the eye with 
water about 45 minutes later. After many ongoing days of hospital visits and 
ophthalmologists consults, the worker died 42 days later from refractory respiratory 
failure (NIOSH, 1999).  
A study was done to simulate mucocutaneous exposures from a splash of infectious 
material onto the eye of a chimpanzee. This experiment was conducted involving 
direct eye inoculation of a chimpanzee with hepatitis B material that was known to 
be infectious. 50 micro liters of HLD-1 plasma (hepatitis B) was placed on the 
corneal surface of the eyes of the anesthetized chimpanzee (25 micro liters each 
eye). The Chimpanzee was refrained from rubbing its eyes for 10 minutes; 
afterward the eyes were gently blotted with absorbent tissue to remove excess fluid. 
After 9 weeks of observing the chimpanzee, it was found to be seropositive for 
hepatitis B surface antigen. After more observations over 25 weeks the chimpanzee 
was found to test positive for the last serological marker tested during the resolution 
of the disease. The results of this study directly confirm that eye inoculation of 
blood from hepatitis B patient may result in infection of a susceptible individual 
(Bond, Peterson, Favero, Ebert, & Maynard, 1982). It is certain for reasonable and 
prudent recommendations that workers use protective eyeglasses in and instance 
where direct or indirect splashing of bodily fluids from a hepatitis B patient is 
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possible (Bond, Peterson, Favero, Ebert, & Maynard, 1982).    
Nurses and health care workers provide relentless care to patients on a daily basis. 
Many tasks might be considered “not so hazardous.” However, when you consider 
that nurses and other health care workers empty cups and containers, wash dirty bed 
pans, clean urine bottles, and handle catheter bags; these tasks then start to become 
more concerning. According to a 2003 study, 39 percent of registered nurses and 27 
percent of licensed practical nurses experienced at least one mucocutaneous blood 
exposure (splash) in 3 months (Splish Splash, 2003). Many of these incidents go 
under reported. This is due to the inconvenience that it takes for the health care 
provider to report to employee health. It also can lead to a large list of tests to check 
for or treat for a transmissible disease. If anything is discovered that could result in 
infection, a round of prophylaxis is usually required for the health care provider. 
This medicine then leads to costly medical bills and a few weeks of feeling 
miserable. Occupational exposures such as splashes can lead to lost work days, 
financial burden, and physical impairment. They also can take an emotional toll on 
those exposed (Splish Splash, 2003).   
Another study led by Doebbeling et. al. at the Veterans Administration found that in 
the previous three months, roughly 38 percent of RNs had experienced some sort of 
mucocutaneous blood exposure (a splash containing blood that lands on a caregiver 
where it could transfer a pathogen such as the eyes, nose or mouth). They also 
found that only about 73 percent of these injuries were reported (Doebbeling, 2003). 
Gershon et al. surveyed many different types of healthcare workers found that about 
29 percent of respondents had some sort of exposure incident in the previous six 
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months, of which, only about 44 percent were reported. To create significant 
change, as stated in the study by Gershon, “There must be a culture of safety. Senior 
leadership must endorse measures that will lead to a safer environment. These 
include availability of PPE, design of the environment to decrease contamination 
and utilizing devices that are engineered to be safer” (Gershen, 2000). 
There are many studies being done to research and prove that splashes to the eye are 
a very prominent problem that isn’t being addressed enough to protect health care 
workers. In a study done of US Medical students in Botswana, they found this issue 
to be almost as prominent as incident with sharps. Students were asked to describe 
each individual exposure, and were asked about whether the exposure was reported 
when it occurred, the circumstances surrounding the exposure, and whether PEP 
(post-exposure prophylaxis) was taken. Of the 82 students who received the survey, 
67 responded. Seventeen of 67 (25.4%) reported having a blood or body fluid 
exposure; eight were needle sticks, and nine were splashes. All splashes were eye 
splashes (Merlin, et al., 2010). 
Many articles reviewed the use of face shields in the workplace. Most people still 
do not think that even a face shield is adequate protection against biological hazards 
(Roberge, 2016). From a journal review on face shields for infection control, 
Raymond Roberge discusses their uses and the additional need for research on 
infection control.  
 
Face shields are PPE that are commonly used as barrier protection for infection 
control purposes by numerous workers. There currently is no standard regarding 
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face/eye protection from biological hazards and this deficit needs to be remedied as 
quickly as possible. Due to the lack of a good facial seal peripherally that can allow 
for liquid penetration, face shields should not be used as solitary face/eye 
protection, but rather as adjunctive to other PPE (protective facemasks, goggles, 
etc.). Given the dearth of available data regarding the appropriate use of face shields 
for infection control, scientifically sound research needs to be conducted on the use 
of this form of PPE (Roberge, 2016). 
 
 
2.4 Risks  
The risk following a blood exposure to the eye, nose or mouth is unknown, but is 
believed to be very small; however, HCV infection from a blood splash to the eye 
has been reported.  For HIV, the average risk of HIV infection after a needle stick or 
cut exposure to HIV-infected blood is 0.3% (about 1 in 300).  The risk after an 
exposure of the eye, nose or mouth to HIV-infected blood is estimated to be on 
average, 0.1% (about 1 in 1000) (CDC, 2015). 
 
2.4.1 Risk Assessment 
Safety Professionals use a risk matrix to assess the various risks of hazards (and 
incidents) and other safety events. Severity is the amount of damage or harm a 
hazard could create and is ranked on a four point scale.  
• Catastrophic 4 - Operating conditions are such that human error, 
environment, design deficiencies, element, subsystem or component failure, 
or procedural deficiencies may commonly cause death or major system loss, 
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thereby requiring immediate cessation of the unsafe activity or operation. 
• Critical 3 - Operating conditions are such that human error, environment, 
design deficiencies, element, subsystem or component failure or procedural 
deficiencies may commonly cause severe injury or illness or major system 
damage thereby requiring immediate corrective action. 
• Marginal 2 - Operating conditions may commonly cause minor injury or 
illness or minor systems damage such that human error, environment, design 
deficiencies, subsystem or component failure or procedural deficiencies can 
be counteracted or controlled without severe injury, illness or major system 
damage. 
• Negligible 1 - Operating conditions are such that personnel error, 
environment, design deficiencies, subsystem or component failure or 
procedural deficiencies will result in no, or less than minor, illness, injury or 
system damage.  
(Risk Matrix Calculations) 
Probability is the likelihood of the hazard occurring and is ranked on a five point 
scale: 
• Frequent 5 - Likely to occur often in the life of an item 
• Probable 4 - Will occur several times in the life of an item 
• Occasional 3 - Likely to occur sometime in the life of an item. 
• Remote 2 - Unlikely but possible to occur in the life of an item. 
• Improbable 1 - So unlikely, it can be assumed occurrence may not be 
experienced 
Risk Assessment –The Risk Assessment Values are determined by multiplying the 
30  
scores for the Probability and Severity values together. The following Table 2-9 
displays the default risk assessment values (Risk Matrix Calculations). 
 
 
 
 
 
 
Table 2-9: Risk Assessment Table 
Source: (Risk Matrix Calculations) 
 
Given that the risk of infection after an exposure is relatively low (1 in 1000) due to 
exposure of the eye, nose, or mouth gives a notion that the risk should be in a moderate 
to low category. However, the probability of being exposed is relatively high within 
the occupation, given that statistics report it happening frequently and more than once 
a year and the severity of this risk is serious or disabling and life threatening, this puts 
the risk assessment matrix for these occupations for biological hazards of splashes to 
the eyes in a “High” category.  
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2.5 Summary 
According to the World Health Organization’s description of health, health is a state of 
complete physical, mental, and social well-being and not merely the absence of disease 
(WHO). Eye health is becoming an increasingly important subject both for the health 
care system and the society. Workers need to be more aware of the potential risks and 
dangers when working in and around biological hazards that have potentials for 
splashes and spurts to the facial region. Since transmissions of infections and injuries 
of the eye may go unnoticed; chronic eye injuries are possible. There are many 
protective measures which can help to provide good protection for eye health. Eye 
protectors can reduce the risk of eye damage or complete loss of vision while working 
in hazardous conditions. Though there are numerous technological and medical 
advances in eye protectors for health care workers; there are still many incidents and 
injuries that do occur. Most health care workers refer to ANSI Z87.1 for information of 
eye protectors and proper selection. ANSI Z87.1 is lacking in the biological hazards 
and blood borne pathogens category for selection of eye protectors. Many research 
articles prove that there is a problem that needs to be addressed for protection against 
splashes and spurts to the eyes of the health care worker. ANSI Z87.62 will allow 
workers to have a reference and have guidance for eye protectors for protection against 
biological hazards. This project gives a test apparatus and standard criteria that all eye 
and face protectors for biological hazards will be performed on. This will ensure 
concise and consistent testing across the broad spectrum of safety manufacturers and 
end users for eye and face protectors.  
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CHAPTER 3 –TEST APPARATUS / METHODS 
 
3.1 General test setup description 
 
 
This study evaluates the efficiency of manufacturer’s eye and face PPE for protection 
against biological hazards such as blood borne pathogens. The test apparatus is 
replicating the hazards that a worker would see in average working conditions. The 
majority of these hazards are coming from the human body such as sneezes/coughs, 
puncture wounds, saliva/mucous, or instances of low velocity splashes from 
containers in laboratory conditions. The test apparatus replicates these conditions to 
best match the patterns, velocities, and volumes that would be a biological hazard to 
the worker. Eye protectors will be selected and placed on the anthropometric head as 
if being worn for occupational hazards. The headform will be adjusted at the 
specified distance for the specific criteria being tested (spurt or spray). The test will 
be conducted at varying headform locations and angles. Immediately after each shot 
at each location, the eye, nose, and mouth of the headform will be evaluated for any 
droplets of fluid. If any fluid is found to be on the eye, nose or mouth, then the eye 
protector and coordinating ensemble (eye protector and face mask) fails the test. This 
angle and location will be noted and the testing will continue to evaluate other 
locations and angles. Once testing is concluded, if the protector has any failure spots, 
then that particular eye protector will fail the criteria to be labeled for protector 
against biological hazards under ANZI Z87.62. If the eye protector passes all the 
testing locations, then that particular eye protector passes and is allowed to be labeled 
for protection against biological hazards under ANZI Z87.62.  
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3.2 Test Parameters 
 
3.2.1 Spurt and Spray 
 
One criteria of a “shot” that will be used in evaluating eye protectors is the spurt test. 
The spurt is used to simulate a small arterial puncture or similar situation from a 
human at average blood pressure velocities. This speed of the simulated fluid for a 
“spurt” will be replicating the pressure from which an average human body could 
expel blood. These ranges will be from a low of 80 mmHg to a high of 160 mmHg. 
These two ranges are equivalent to 10.7 and 21.3 kPa. These two pressures will have 
stream velocities projected from the nozzle of 450 and 635 cm/s respectively. The 
proposed velocity for the test will be 635 cm/s to replicate a worst case scenario. Based 
on ASTM F1862 Standard Test Method for Resistance of Medical Face Masks to 
Penetration by Synthetic Blood test criteria of a max volume of 2 ml, the volume of 
fluid that will be expelled for this test apparatus will follow that of which will be 2 ml 
(ASTM F1862-Blood Spurt Tester). The spurt was tested at 30.48 cm. This is based off 
the average distances that health care workers operate from their patients (Neck Health 
2008). This is to test for the worst case scenario of being close to the patient. The 
nozzle for the spurt will be set at a horizontal distance of 30.48 cm for all spurt testing 
locations. The spurt criteria is achieved by using a detachable straight tubbed cannula 
fitted to the nozzle (Figure 3-1).  
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Figure 3-1: Spurt Cannula 
 
The apparatus will also be testing eye and face protetors for protection against “spray”. 
This spray is to replicate a human cough or sneeze. The speed of the fluid for a “spray” 
will be replicating the pressure from which an average human could expel a spray. The 
range of a sneeze and cough were conducted from a study by Hidekazu Nishimura. 
Nishimura concluded that the highest most common velocity is around 300 – 500 cm/s 
at a horizontal distance of 30-60 cm(11.8-23.6”) (Nishimura, Sakata et al. 2013).The 
concentration of particles, optimal spray pattern and coverage is what the spray 
category will be mostly concerned with. This spray is mostly around 30-35 cm 
horizontally. The nozzle for the spray will be set at a distance of 30.48 cm horizontal to 
the point of impact. Based on personal interviews of Dr. Arsenault, the volume of fluid 
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that will be sprayed at the headform will be that of at least 0.5 ml and no more than 1 
ml. (Arsenault). This spray criteria is achieved by using a detached spray tipped 
cannula fitted to the nozzle (Figure 3-2). 
 
Figure 3-2: Spray Cannula 
 
3.2.2  Headform Locations 
 
Both the Spurt and Spray categories will be using the same shot target locations on the 
headform at their specified horizontal distances. The protector device shall be placed 
on the headform in the designated wearing position. For the spurt and spray dispensing 
shots, the headform will be manipulated into 4 main locations. These locations will 
share a common reference point from which all locations will be measured. The exact 
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center between the eyes on the headform was used to aim all target locations. The first 
2 locations will be with the headform centered across the sagittal plane. The sagittal 
plane divides the body into left and right. On a person it would pass through the 
midline structures such as the spine and navel. The first centered sagittal plane shot 
will be with the headform tilted posteriorly 30 degrees off the coronal plane (Figure 3-
3). The nozzle should be aimed 1” below the center point of eyes on the bridge of the 
nose. The second sagittal plane shot will be with the headform titled anteriorly 30 
degrees off the coronal plane (Figure 3-4). The nozzle should be aimed 2” above the 
center point of the eyes on the forehead of the headform. The angle of which the 
headform will be tilted anteriorly and posteriorly is capturing the average angle at 
which a health care worker would angle their head to in relation to the patients head 
(Pirvu, 2014). The third and fourth shot will be to the left and right temple area of the 
headform. The headform will be centered across the sagittal and coronal plane in a 
vertical fashion. A coronal plane is any vertical plane that divides the body into ventral 
and dorsal sections (belly and back). On a person’s head, this would divide it into the 
front (facial portion) and back (back of the head). It then needs to be turned 55 degrees 
to the left and right for the third and fourth shot respectively, and not centered at the 
bridge (Figure 3-5, Figure 3-6) (Arsenault, 2016). The nozzle should be adjusted to the 
same height of the center point of the eyes for the targeted location. These 
manipulations will be referred to as Up, Down, Right, and Left; as they are shown in 
order below. The target locations above (2”) and below (1”) the center point of the 
eyes was chosen to get more varying locations for spurts and sprays. If every shot was 
placed at the center point of the eyes on the headform manipulations then the test 
would not be examining any other areas of protection from the eyewear but the center 
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point ( in between the eyes / bottom gap). By varying these locations 2” above, 1” 
below, 55 degree left and right, the test is examining more areas of protection of the 
eye wear and mask. (Top, Bottom, Left, Right) This in addition to the Range of 
Protection test which the target location is always at the center point of the eyes gives a 
large range of examination of the ensembles protection. 
 
 
Figure 3-3: Posteriorly Titled 30 Degrees         Figure 3-4: Anteriorly Tilted 30 Degrees 
30° 
30° 
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Figure 3-5: 55 Degrees Turned Right   Figure 3-6: 55 Degrees Turned Left  
 
 
 
 
 
 
3.2.3 Velocities 
 
The velocities that will be used for the speed of the spurt and spray are based off of 
averages of human bodily fluids that could be expelled naturally. The velocity of the 
stream that exits the test apparatus is deduced from the volume of the stream produced 
over a known period of time through a known area (1). Since the electronic dispensing 
unit can easily control the period of time and pressure at which the stream exits from, 
the flow velocity can be calculated. It is also easier and more accurate to measure the 
weight rather than the volume of the spurt and knowing the density of the fluid being 
used.  
 
 
55°
° 
 30° 
55° 
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v = Q/tA   (3-1) 
  
v = flow velocity 
Q = flow volume 
t = duration of the flow 
A = cross sectional area of the orifice 
 
ω = Qδ   (3-2) 
 
δ = density of the test fluid 
ω = weight of the spurt 
Q = volume of the spurt 
 
 
By using the difference in weight of streams shot in known times and using a derived 
equation, the steady state streams exit velocity can be estimated (3) 
 
(ω2- ω1) = v 
𝝅𝜹𝒅𝟐𝟒 (t2-t1) (3-3) 
 
This equation can also be represented as: 
 
(ω2- ω1) = 
𝒗(𝒕𝟐)𝒕𝟏)𝑪   (3-4) 
 
C= 𝟒𝝅𝜹𝒅𝟐   (3-5) 
 
The constant C (5) can be recalculated for fluids with other specific gravities that are 
less than 0.995 or greater than 1.015. It can also be recalculated when using different 
sized diameter cannulas on the nozzle. The equation for the value C can also be used to 
build tables of target velocities for limits and different spurt weights for varying test 
requests. Figure 3-16 shows tables built for easy calculation for target weights and 
velocities. This table has been rebuilt and manipulated for these tests from ASTM 
F1862. During experimentation with the different velocities and pressures, I was able 
to use a chronograph to validate the exit velocities with the estimated velocities using 
the Excel equations (Figure 3-7). A forecasted graph through Excel aids in getting a 
quick estimate of the pressure needed in the container for exit velocities (Figure 3-8). 
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Another useful forecasted graph to estimate exit velocities during tester setup is weight 
vs velocity (Figure 3-9). These forecasted graphs are making predictions about a value 
based on past and present data by using analysis of trends.  
 
Figure 3-7: Excel Velocity Calculations and Tables 
 
 
 
Figure 3-8: Predicted Velocity using Mass vs cm/s with Upper and Lower Limit Lines 
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Figure 3-9: Predicted Velocity using PSI vs cm/s 
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3.3 Test Equipment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-10: Overall Test Setup 
3-10.1 Anthropometric Headform 
3-10.2 Articulating Base 
3-10.3 Milling Table 
3-10.4 Dispensing Unit 
3-10.5 Pressurized Container 
3-10.6 Uni-Slide 
3-10.7 Nozzle 
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3.3.1 Anthropometric Headform  
 
The headform that will be used for this test will be the medium sized anthropometric 
European headform of the 50th percentile adult male due to its existing prevalence in 
ANSI Z87 (ANSI-ISEA Z87.1, 2015).  Unless otherwise specified by the 
manufacturer, the medium sized headform will be used. If the selected eye protector 
explicitly states that it is for a smaller head, then a smaller sized anthropometric 
headform (or equivalent) will be used for testing. Once the size of the headform is 
selected for the testing, all tests will be conducted with the same headform. Other 
headforms may be used if known or demonstrated to give equivalent results (Figure 3-
10.1, Figure 3-11, and Figure 3-12).  
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Table 3-1: European Anthropometric Headform Measurements 
Source: (ANSI-ISEA Z87.1, 2015) 
Figure 3-11: Headform Measurements 
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Figure 3-12: Anthropometric Headform 
 
 
3.3.2 Articulating Headform Base  
 
The headform for which the eye protectors will be placed on needs to be able to be 
manipulated in varying angles and rotations around a central point. This is possible by 
mounting the headform onto an articulating base. The base can be rotated 360 degrees 
and has the ability for the headform to be angled nearly 90 degrees downward in any 
direction. Having this ability to manipulate the headform into varying angles and 
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rotations allows the test to best replicate how a workers head would be angled during 
their working conditions (Figure 3-10.2, Figure 3-13).  
 
 
Figure 3-13 Articulating Base 
 
 
 
 
 
3.3.3 Milling Table  
 
To be able to compensate for varying distances and locations on the headform, the 
articulating base will be mounted onto a milling table. By having the headform 
mounted onto the milling table, it gives 12” of longitudinal travel and 7.5” of 
transverse travel. This will allow the headform great range of locations for testing. The 
milling table also offers precise adjustments for both lateral and transverse movement 
for easy replications of testing (Figure 3-10.3, Figure 3-14). 
 
47  
 
 
 
 
 
Figure 3-14: Milling table  
 
3.3.4 Dispensing Unit  
 
The fluid that will be used to assess penetration will be dispersed through an electronic 
digital dispenser. The DC 200 which will be used for testing offers a wide variety of 
dispensing applications. It has precise accuracy for dispensing specific volumes. It also 
has multi regulators for input air pressure which can be set to ensure consistent 
pressure all throughout the dispensing time. This controlling makes it easy to get 
Lateral 
 
Transverse 
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precise shots of fluid across all tests for consistency (Figure 3-10.4, Figure 3-15).  
 
 
 
 
Figure 3-15: Dispensing Unit  
 
3.3.5 Pressurized Container  
 
The pressurized container in the test apparatus contains the fluid which is air fed to the 
nozzle for delivery. On top of the container is an external air regulator which controls 
the exit velocity of the shot of fluid. The increase or decrease of air pressure in the tank 
is proportional to the increase or decrease of exit velocity (Figure 3-10.5, Figure 3-16).  
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Figure 3-16: Pressurized Container 
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3.3.6 Uni-slide  
 
A Uni- slide stand is set up in the middle of the apparatus and offers a large range of 
vertical travel for the nozzle. The Uni-slide stand has a horizontal mounting bracket 
with which the dispensing nozzle is attached. The vertical travel of the slide allows the 
test to place the shot upon the headform at any vertical distance wanted. It allows for a 
very wide range of test requested locations for future testing. The slide has a screw 
track driven hand crank which gives high precision to vertical adjustments (Figure 3-
10.6, Figure 3-17).  
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Figure 3-17: Uni-Slide 
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3.3.7 Dispensing Nozzle 
The dispensing valve chosen for this test apparatus is a multipurpose poppet-type 
pneumatic valve. It can dispense a wide range of liquids viscosity with precision 
making it ideal for the use of fluid / bodily fluids. This style of dispensing valve has its 
own shot volume control valve making it much more efficient at dialing in exact shot 
volumes for repeated testing. The valve also has a built in negative pressure control 
that eliminates the lumping at the end of the needle after dispensing shots. This 
negative pressure control feature aids in precise consistent shots (Figure 3-10.7, Figure 
3-18).  
 
Figure 3-18: Nozzle  
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3.3.8 Fluid 
The fluid that will be used in the dispensing of shots at specific locations on the 
headform will be a mixture of saline and a surfactant. This new recipe yields a fluid 
that has physical properties much more similar to the physical properties of blood. The 
main property that is most concerning is having the correct viscosity of the fluid to that 
of blood. The average viscosity of blood is 3-4 centipoise (cP). The surface tension 
range for blood and body fluids is approximately 42 – 60 dynes/cm (Harkins and 
Harkins). The lower end of the range of surface tension, the higher penetration it will 
have. By using the saline, it is simulating the typical bodily fluids that could be 
expelled or come in contact with another person. Using the Saline in addition to a fast-
acting surfactant will simulate a worst case scenario as well as bring the surface 
tension properties much closer to real blood properties (Portnoff).  In addition to the 
saline and a fast acting surfactant, we added fluorescein dye which is highly visible 
under blue light. This dye will aid in detection of any fluid on the eye of the headform 
and will yield in clear decisions of pass or fail results.  
 
 
 
3.4 Testing  
 
3.4.1 Hypothesis 
 
This test apparatus is designed to evaluate the efficacy of eye and face protection 
against biological hazards such as blood borne pathogens. The null hypothesis of this 
study is that current ANSI Z87.1 eye protectors will not pass the criteria from this test 
to be labeled for protection against biological hazards.  
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By using this test apparatus and testing procedure, typical eye and face protection was 
tested against the testing apparatus to see how effective they are with the apparatus’s 
replicated biohazardous conditions. These tests evaluate coverage protection from 
biohazards, however they will not evaluate the ability of PPE to be decontaminated from 
biohazards. With this testing apparatus we are looking for a test method to represent or 
mimic the biological hazards that are found in the workplace environments of clinical 
laboratories, surgical/nursing, and dentistry. When looking at these occupations the 
probability of being exposed is relatively high, given that statistics report it happening 
frequently and more than once a year. The severity of this risk is serious or disabling 
and life threatening which puts the risk assessment for these occupations for biological 
hazards of splashes to the eyes and face as a high risk. The testing apparatus will 
sufficiently produce repeatable testing criteria and standards across a range of eye and 
face protectors that are being used in the 3 occupational settings. We are using this 
testing apparatus and test method to develop a basis of testing of eye and face 
protectors that reduce exposures to the areas of concern for the hazardous occupations 
mentioned.  
 
3.4.2 Eye and Face Protectors 
Types, models, and combinations of eye and face protection vary from occupation to 
occupation, e.g. a surgeon will don different eye and face PPE than a dentist would, 
therefore a variety of samples will be collected from different manufacturers and 
occupational settings. The different types, styles, and combinations of currently used 
eye and face protectors will be from the main high hazard occupations that are being 
explored (Dental, Health Care, and Laboratory). To determine the most popular 
brands/models, a one question survey will be sent to health care professionals in the 
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various fields to ascertain their preference.  The top models will be evaluated using the 
criteria described below, regardless if they are stamped with ANSI Z87.1 or not. 
 
All tests being conducted will be randomized for the order in which they are conducted 
(Spurt positions 1-4 / Spray positions 1-4). The first initial spurt tests will all be 
conducted at a high velocity as well as high volume of fluid (2ml spurt / 1ml spray). If 
the PPE passes, then there will not be any subsequent tests done under the proven 
assumption that if the PPE passes at high velocity and high volume then it would also 
pass at a lower velocity or lower volume. If the PPE fails at the High velocity and High 
volume, then it will be considered for examination testing under lower velocities and 
lower volumes of fluid.  
A “high” exit velocity will be in the range of 600 cm/s. This is to mimic the varying 
velocities of fluids found within an occupational environment. A “high” volume of 
fluid will be 2 ml. A data sheet will be logged with the model and style of eye protector 
being tested prior to testing and then completed with the test results during testing. 
(Table 3-2).  
 
3.4.3 Test Criteria / Near Miss Ratings 
 
All PPE tests that are conducted will receive a Pass or Fail criteria. All tests that are 
given a Pass or Fail rating will also be measured for the distance that the fluid is in 
relation to the Pass or Fail. If the test passes then the fluid that is closest to the 
perimeter of the eyes, nose, or mouth will be measured and recorded. If the test fails 
then the fluid that is closest to the center of the area of concern (Eye, Nose, or Mouth), 
will be measured and recorded. The quadrant that the fluid which is measured is in will 
also be recorded. This quadrant is set up as a simple XY graph with corresponding 
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quadrants (Figure 3-19). 
 
Figure 3-19: Quadrants on Headform  
 
This test will be conducted 10 times for every ensemble that is being evaluated. A near 
miss rating could be given at a later date for more testing of products and helpful 
descriptions of how a product performs. This rating would be based off distances 
circling the perimeter such as fictitious concentric circles. Each region between the 
fictitious concentric rings will be what determines the ratings. These concentric circles 
will be 5mm each. If the fluid is within the concerned area then if would fail and the 
rating therefore would be a 4. If fluid is within 5mm of the perimeter or the eyes, nose, 
or mouth, then the rating would a 3; if fluid is within 10mm of the perimeter or the 
eyes, nose, or mouth, then the rating would a 2; if fluid is within 15mm of the 
perimeter or the eyes, nose, or mouth, then the rating would a 1; if the fluid is at a 
greater distance than 15mm from the perimeter of the eyes, nose, or mouth then it 
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would get a rating of 0. With each shot, the distance from the perimeter of the area of 
concern to the closest fluid would be record in the data sheet as well.  
 
Another criteria that was evaluated is the range of protection for every ensemble. For 
this range of protection evaluation, the headform’s ensemble will be tested on a 
horizontal plane and rotated about it. These degrees of rotation will be tested at 0, 30, 
60, and 90 degrees of rotation to the right, and then 30, 60, and 90 degrees to the left 
(degrees of rotation are oriented from the nozzle being the origin). The headform’s 
ensemble will then be tested on a vertical plane. These degrees of rotation will be 
tested at 0, 30, 60, and near 90 degrees of rotation to the up, and then 30, 60, and near 
90 degrees to the down (degrees of rotation are oriented from the nozzle being the 
origin) (Figure 3-20: Range of Protection Horizontal, Figure 3-21: Range of Protection 
Vertical, Table 3-3: Range of Protection Data Sheet).  
 
With this experimental design the outcomes are categorical and are dependent 
variables with two possible values (Pass or Fail) and all factors are categorical or 
indicator functions, the best model to use is a 2 x 4 logistic regression.  
By using a 2x4 table we can get a good look at unadjusted preliminary data from which 
we can draw estimates about the ensembles. Based on the time frame and limited 
resources (money and material) we decided upon a sample size of 10 replications. With 
this sample size it will give us 80 observations per ensemble with 800 total 
observations. This will provide a 2 x 4 x 10 model which can be looked at for 
interactions between ensemble and Spurt/Spray as well as interactions between 
ensemble and head positions.  
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Table 3-2: Eye Protector Data Sheet 
1 Brand Model  
 
Eyes   Nose   Mouth   
  
x 10 
  
 
Pass 
Fail 
Dist. to 
closest 
fluid 
(mm) 
Q
ua
dr
an
t 
Pass 
Fail 
Dist. to 
closest 
Fluid 
(mm) 
Q
ua
dr
an
t 
Pass 
Fail 
Dist. to 
closest 
Fluid 
(mm) 
Q
ua
dr
an
t 
1 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Up 
 
         
2 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Down
 
         
3 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Right
 
         
4 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Left
 
         
1 Spray 500 
cm/s 
1 ml Up 
 
         
2 Spray 500 
cm/s 
1 ml Down
 
         
3 Spray 500 
cm/s 
1 ml Right
 
         
4 Spray 500 
cm/s 
1 ml Left
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Figure 3-20: Range of Protection Horizontal 
 
Figure 3-21: Range of Protection Vertical 
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Repeat 
x 1 
    
Eyes 
 
 Nose   Mouth 
 
 
     Pass 
Fail 
Dist. 
To 
Closest 
Fluid 
mm Q
ua
dr
an
t 
Pass 
Fail 
Dist. 
To 
Closest 
Fluid 
mm Q
ua
dr
an
t 
Pass 
Fail 
Dist. 
To 
Closest 
Fluid 
mm Q
ua
dr
an
t 
90 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Horizontal 
plane 
  
 
  
 
  
 
60 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Horizontal 
plane 
  
 
  
 
  
 
30 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Horizontal 
plane 
  
 
  
 
  
 
0 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Horizontal 
plane 
  
 
  
 
  
 
30 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Horizontal 
plane 
  
 
  
 
  
 
60 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Horizontal 
plane 
  
 
  
 
  
 
90 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Horizontal 
plane 
  
 
  
 
  
 
       
 
  
 
  
 
90 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Vertical 
Plane 
  
 
  
 
  
 
60 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Vertical 
Plane 
  
 
  
 
  
 
30 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Vertical 
Plane 
  
 
  
 
  
 
0 Spurt High High Vertical 
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Table 3-3: Range of Protection Data Sheet 
Vel. 
635 
cm/s 
Volume 
2ml 
Plane 
30 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Vertical 
Plane 
  
 
  
 
  
 
60 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Vertical 
Plane 
  
 
  
 
  
 
90 Spurt High 
Vel. 
635 
cm/s 
High 
Volume 
2ml 
Vertical 
Plane 
  
 
  
 
  
 
       
 
  
 
  
 
90 Spray 500 
cm/s 
1 ml Horizontal 
plane 
  
 
  
 
  
 
60 Spray 500 
cm/s 
1 ml Horizontal 
plane 
  
 
  
 
  
 
30 Spray 500 
cm/s 
1 ml Horizontal 
plane 
  
 
  
 
  
 
0 Spray 500 
cm/s 
1 ml Horizontal 
plane 
  
 
  
 
  
 
30 Spray 500 
cm/s 
1 ml Horizontal 
plane 
  
 
  
 
  
 
60 Spray 500 
cm/s 
1 ml Horizontal 
plane 
  
 
  
 
  
 
90 Spray 500 
cm/s 
1 ml Horizontal 
plane 
  
 
  
 
  
 
       
 
  
 
  
 
90 Spray 500 
cm/s 
1 ml Vertical 
Plane 
  
 
  
 
  
 
60 Spray 500 
cm/s 
1 ml Vertical 
Plane 
  
 
  
 
  
 
30 Spray 500 
cm/s 
1 ml Vertical 
Plane 
  
 
  
 
  
 
0 Spray 500 
cm/s 
1 ml Vertical 
Plane 
  
 
  
 
  
 
30 Spray 500 
cm/s 
1 ml Vertical 
Plane 
  
 
  
 
  
 
60 Spray 500 
cm/s 
1 ml Vertical 
Plane 
  
 
  
 
  
 
90 Spray 500 
cm/s 
1 ml Vertical 
Plane 
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3.4.4 Blue light Detection 
A strong blue light is used to shine onto the headform for optimal visual inspection of a 
pass or fail rating of any fluid that may reach the headforms eyes. A light source of 494 
nm (light blue) will make a 512 nm color (bright green) of the fluid.   
 
3.4.5 Sight Laser 
The addition of a small battery operated cross haired laser will be mounted to the 
mounting bracket on the Uni-slide (Figure 3-22). This laser will project bright 
horizontal and vertical lines onto the anthropometric head for leveling and aligning it 
into its specified test manipulations quickly and efficiently (Figure 3-23). Although 
this sight laser is not a “must have” for this apparatus to function, it will highly aid in 
testing.  
 
 
 
 
 
 
 
 
 
 
Figure 3-22: Laser Mounting to Uni-Slide Bracket 
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Figure 3-23: Laser Projected onto Headform 
 
3.4.6 Pass / Fail criteria 
 
Once the eye wear and corresponding ensemble (e.g. eye protector and face mask) is 
mounted on the European 50th percentile or equivalent headform in a wearer’s normal 
position, the tester will then verify the target locations / distances to be accurate. The 
tester will then turn on the blue light used for visual indication of any fluid on the eyes, 
nose, or mouth of the headform and ensure that the lighting is suitable for inspection. 
The tester will administer a single shot of fluid to the targeted area, ensuring that the 
fluid hits the target area of the headform, the tester will then visually inspect the 
headforms eyes, nose, and mouth for any fluid within 5 sec of impact. If the tester 
suspects that there is fluid on the eye of the headform, they may use a cotton absorbent 
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swab or similar item to lightly daub the eye area. If there is no evidence of fluid on the 
headforms eyes, nose, or mouth, then the eye protector and corresponding ensemble 
passes that particular targeted location for the specified shot criteria. The eye protector 
and corresponding face mask must pass all spurt and spray target locations for it to 
pass the entire test. If there is evidence of fluid on the eyes of the headform then the 
eye protector fails that particular targeted location; if there is evidence of fluid on the 
nose or mouth of the headform then the face mask fails that particular targeted 
location. The tester will record what type of shot the eye protector or face mask failed 
on (spurt or spray) as well as the targeted location (Up, Down, Right, Left) (Table 3-1).  
 
Referencing Figures 3-24 through 3-30 below are some preliminary tests done to show 
the detection of the dye in a blue light with a spray and spurt test on the headform. The 
headform was not manipulated with any angles and was placed 30.48 cm away with a 
targeted location centered at the bridge of the nose. The headform was angled for the 
best light condition for a picture but was not angled for the duration of the test. The 
exit velocity was estimated to be around 435 cm/s. If this location and particular eye 
protector were to be placed in the testing criteria, they would have passed the spray test 
but would have failed the spurt test. Once the spray and spurt were administered, the 
headform was thoroughly wiped off and checked to make sure there was no residual 
fluid left behind (Figure 3-26). 
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Figure 3-24: Spray Test- Glasses On 
Figure 3-24 photo was immediately taken after the spray was conducted. The glasses 
will be removed carefully and a visual inspection of the eyes will take place next to 
determine if this is a “Pass” or “Fail.”  
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Figure 3-25: Eye Criteria Spray Test without Glasses- “Pass” 
 
After the glasses have been removed a detailed visual inspection was conducted on the 
eyes of the headform. Figure 3-25 shows that no fluid is on the eyes of the headform 
therefore classifying this particular section of the spray test as a “Pass” This example 
67  
test is solely looking at penetration to the eyes of the wearer. The nose and mouth are 
not part of this test shot. The wearer should be wearing other appropriate PPE to 
protect the nose and mouth area. When conducting a test on complete PPE attire on the 
headform, a pass or fail will also be assigned to the equipment being used to protect the 
nose and mouth. If any fluid or fluid residue is within the area of concern for the nose 
then a “Fail” is assigned. If any fluid or fluid residue is within the area of concern of 
the mouth then a “Fail” is assigned. If fluid outside of the perimeter of the area of 
concern of the nose or mouth then a “Pass” will be assigned.  
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Figure 3-26: Cleaned Headform 
Figure 3-26 shows that after a test has been conducted the headform can easily be wiped off 
and visually checked for any leftover fluid or fluid residue. The test apparatus was then 
changed over to next conduct a spurt test.  
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Figure 3-27: Spurt Test - Glasses On  
Figure 3-27 photo was taken immediately after the spurt test was conducted. The 
glasses will be removed carefully and a visual inspection of the eyes will take place 
next to determine if this is a “Pass” or “Fail.”  
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Figure 3-28: Spurt Test without Glasses – “Fail” 
After the glasses have been removed a detailed visual inspection was conducted on the 
eyes of the headform. Figure 3-28 shows that fluid is on the eyes of the headform 
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therefore classifying this particular section of the spurt test as a “Fail” 
 
As one can clearly see that for a pass or fail it is very easily distinguished whether or 
not the fluid has penetrated the glasses and is on the eye of the headform or not (Figure 
3-28). In the following figures (Figure 3-29 and 3-30), one can see the entire shot 
(spray and spurt) as it exits from the nozzle and impacts on the targeted location of the 
headform. From there one can see how the fluid dispersers depending on the different 
shot pattern. The spurt is much more penetrable to the headforms eyes than the spray 
is. Whereas the spray covers more facial area than the spurt. This test was conducted as 
an example to show how the fluid is used for verifying pass and fail criteria. When a 
real test is conducted the headform will be fully fitted with appropriate eye and face 
protection which covers the nose and mouth.  
 
 
Figure 3-29: Spray in Real Time  
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Figure 3-30: Spurt in Real Time 
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3.5 Defining Positions and Perimeters 
 
3.5.1 Eye 
 
The size of the human adult eye is approximately 24.2 mm (transverse) x 23.7mm 
(sagittal). The eyeball size may vary from about 21mm to 27mm in the transverse 
plane (Bekerman, 2014). When considering the human orbit, the height is usually 35 
mm whereas the typical width is approximately 40 mm (Turvey, 2012). The average 
aperture height of the eye is around 10-14mm while the eyelid covers about another 2-
3 mm of the eye itself. The average dimensions of the human eyelid are around 28-32 
mm wide and around 4-5 mm in height/thickness when the eye is opened (Eyeplastics). 
This total height of the eye and eyelids are around 23-25 mm from bottom to top. 
Through other studies done on the anatomy of the eye and orbit size, adults were found 
to have heights and widths slightly larger than that of 35 and 40mm. Other studies 
show that the thicknesses and widths of the eyelid vary a few millimeters as well. 
Therefore, it would be reasonable to want to protect at distances slightly greater than 
these parameters. Since the parameters stated previously are only averages of adults. 
There are some outliers that would need to have the parameters a little bigger. To 
accommodate the variety in sizes, an ellipse shape is used with height of 35mm and 
width of 50mm. The height should remain the same because this distance is based off 
the orbital bone. This distance will cover the height of the eye plus the eye lids when 
opened. The reason that the width needs to be lengthened is that the eye lid runs across 
the horizontal plane of the eye and leaves areas exposed such as the corners of the eye 
and the tear duct. This oversized parameter is to take in account for adults having 
larger sized eyes, varying sized tear ducts, and larger orbital sockets. By using an 
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oversized elliptical parameter the eye will then be completely encompassed (Figure 3-
32). Any fluid or fluid residue that is found within the perimeter of the ellipse will be 
considered a “fail” for the eye. The ellipse parameters will have its dimensions based 
off the center of the eye. From there a major and minor axis will be created of lengths 
of 35mm in height (minor) and 50mm in width (major). This ellipse shape will follow 
the orbital bone. The 45 degree diagonal measurements will be 42 mm in length 
(Figure 3-31).  
 
 
Figure 3-31: Graph of Ellipse 
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(Elsevier, 2008) 
Figure 3-32: Average Eye Measurements 
 
 
3.5.2 Nose 
 
Nose exposure will be evaluated using the 6 landmarks shown below. Connecting the 
points from 1-3-2-5-6-4-1 creates a perimeter along the bottom surface area of the 
nose. Any fluid or fluid residue that is found within this perimeter will be considered a 
“fail” for the nose.  
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(Etoz, 2011) 
 
Figure 3-33: Anthropometric Nose landmarks 
 
The nose perimeter measurements are defined in Figure 3-33 and Table 3-5 below for 
the European anthropometric headform.  
 
 
Table 3-4: Anthropometric Nose Landmarks 
 
1-2 Alare, the point where the nasal blade (ala nasi) extends farthest out.  
3 Subnasal, the midpoint of the columella base. 
4-5 The most convex point of lateral cruris of alar cartilage.  
6 Pronasal, the most prominent point on the nasal tip.  
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Figure 3-34: Nose measurement of most convex point- Points 4-5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-5: Nose Landmark Measurements 
 
 
 
 
 
1-3 27 mm 
3-2 27 mm 
1-4 18 mm 
2-5 18 mm 
4-6 20 mm 
5-6 20 mm 
4-5 25 mm 
3-6 22 mm 
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3.5.3 Mouth 
 
Figure 3-35 shows anthropometric landmarks that are widely used for the mouth. A 
perimeter formed by connecting the points (1-2-3-4-5-1) defines the mouth. Any fluid 
or fluid residue that falls within this perimeter will be considered a “fail” for the 
mouth.  
The perimeter will start at the left oral commissure or cheilion. This is where the lateral 
aspects of the vermilion of the upper and lower lips join. (Figure 3-35-point 1) From 
point 1, the perimeter will travel along the contour of the line formed by the vermilion 
border of the upper lip. In a frontal view, this line resembles an archer's bow, which 
curves medially and superiorly from the commissures to the paramedian peaks located 
at the bases of the pillars of the philtrum (crista philtrae) (Figure 3-35- points 2 and 3) 
with an inferior convexity lying between those peaks. The philtrum is the vertical 
groove in the midline of the upper lip bordered by these lateral pillars (ridges). From 
points 2-3, the perimeter will travel to point 4 which resides as the right oral 
commissure or cheilion (Figure 3-35-point 4). From point 4, the perimeter will travel 
along the contour of the line formed by the vermilion border of the lower lip until it 
reaches the lowest apex of the lower lip, which will be point 5. From point 5 the line 
will continue along the contour of the line formed by the vermillion border of the lower 
lip until it reconnects with point 1. 
 
79  
 
Source: (Raschke, et al., 2016) 
Figure 3-35: Anthropometric Mouth Landmarks 
 
 
The mouth perimeter measurements are defined in Figure 3-36 and Table 3-6 below for 
the European anthropometric headform.  
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Figure 3-36: Mouth measurement between left and right oral commissure-Points 1-4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-6: Mouth Landmark Measurements 
 
 
1-2 31 mm 
2-3 10 mm 
3-4 31 mm 
4-5 33.5 mm 
5-1 33.5 mm 
1-4 56.5 mm 
2-5 18 mm 
3-5 18 mm 
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CHAPTER 4 - Results 
 
4.1 Overview of Testing and Results 
This study evaluated the efficacy of protection of different ensembles that are currently 
used in occupational settings with high probability of biohazard exposure. This test 
apparatus is designed to mimic those hazards where PPE is needed for eye and face 
protection. Significant results and observations were found in a few areas within the 
make-up of each ensemble and between ensembles themselves. Each ensemble (10 
total) will be referred to as a corresponding letter (A-J). This is to refrain from 
mentioning any brands, makes, or models of PPE that were used in testing. Some 
description of the ensemble will be given. All ensembles (eye protector and face mask) 
were assembled based on the survey that was appointed to high hazards occupational 
settings in the surrounding areas. The specific names of these occupational work 
settings will also be omitted from the results.  
 
4.1.1 Statistical Analysis Overview  
When comparing two ensembles, a sample size of n=80 for each ensemble provides 
80% statistical power (at a type I rate [alpha] of 0.05) to detect a difference in the error 
rates of 21%. This study will have enough power to detect a difference if one ensemble 
has a pass rate of 50% and another ensemble has a pass rate of 71%.  Or if one 
ensemble has a pass rate of 50% and the other has a pass rate of 29%. The power to 
detect larger differences in the pass rates will be greater than 80%.  With smaller 
variances (pass rates larger or smaller than 50%), the study will have 80% power to 
detect smaller differences. The results will be further discussed in the following 
chapter.  
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4.2 Overview of Ensembles 
4.2.1 Pass Rate of Eyes 
Ensemble     Eyes             
     Up Down Left Right   PassRate 
A Spurt Pass 10 0 10 10 30 LCI 80% 
   Fail 0 10 0 0 10 UCI 95% 
  Spray Pass 10 10 10 10 40 70   
    Fail 0 0 0 0 0 10 88% 
B Spurt Pass 2 0 10 10 22 LCI 68% 
   Fail 8 10 0 0 18 UCI 87% 
  Spray Pass 10 10 10 10 40 62   
    Fail 0 0 0 0 0 18 78% 
C Spurt Pass 10 10 10 10 40 LCI NA 
   Fail 0 0 0 0 0 UCI NA 
  Spray Pass 10 10 10 10 40 80   
    Fail 0 0 0 0 0 0 100% 
D Spurt Pass 8 8 10 10 36 LCI 74% 
   Fail 2 2 0 0 4 UCI 91% 
  Spray Pass 0 10 10 10 30 66   
    Fail 10 0 0 0 10 14 83% 
E Spurt Pass 9 10 10 10 39 LCI 96% 
   Fail 1 0 0 0 1 UCI 10% 
  Spray Pass 10 10 10 10 40 79   
    Fail 0 0 0 0 0 1 99% 
F Spurt Pass 3 1 10 10 24 LCI 56% 
   Fail 7 9 0 0 16 UCI 77% 
  Spray Pass 5 4 10 10 29 53   
    Fail 5 6 0 0 11 27 66% 
G Spurt Pass 0 0 10 10 20 LCI 25% 
   Fail 10 10 0 0 20 UCI 45% 
  Spray Pass 0 7 1 0 8 28   
    Fail 10 3 9 10 32 52 35% 
H Spurt Pass 4 2 10 10 26 LCI 49% 
   Fail 6 8 0 0 14 UCI 71% 
  Spray Pass 2 10 10 0 22 48   
    Fail 8 0 0 10 18 32 60% 
I Spurt Pass 0 0 10 10 20 LCI 44% 
   Fail 10 10 0 0 20 UCI 66% 
  Spray Pass 0 10 7 7 24 44   
    Fail 10 0 3 3 16 36 55% 
J Spurt Pass 0 0 10 10 20 LCI 18% 
   Fail 10 10 0 0 20 UCI 37% 
  Spray Pass 0 0 2 0 2 22   
    Fail 10 10 8 10 38 58 28% 
Table 4-1: Ensemble Eyes Pass Rate 
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Figure 4-1: Eyes Pass Rate 
 
Looking at Table 4-1, one can see that Ensemble C (100%) and Ensemble E (99%) had 
the highest pass rates in the area of concern of the eyes. This is shown again 
graphically in Figure 4-1. The total pass rate of all ensembles for the eyes was 69%.  
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4.2.2 Pass Rate of Nose 
Ensemble     Nose             
     Up Down Left Right   PassRate 
A Spurt Pass 10 2 10 10 32 LCI 83% 
   Fail 0 8 0 0 8 UCI 97% 
  Spray Pass 10 10 10 10 40 72   
    Fail 0 0 0 0 0 8 90% 
B Spurt Pass 10 10 10 10 40 LCI NA 
   Fail 0 0 0 0 0 UCI NA 
  Spray Pass 10 10 10 10 40 80   
    Fail 0 0 0 0 0 0 100% 
C Spurt Pass 10 10 10 10 40 LCI NA 
   Fail 0 0 0 0 0 UCI NA 
  Spray Pass 10 10 10 10 40 80   
    Fail 0 0 0 0 0 0 100% 
D Spurt Pass 10 10 10 10 40 LCI NA 
   Fail 0 0 0 0 0 UCI NA 
  Spray Pass 10 10 10 10 40 80   
    Fail 0 0 0 0 0 0 100% 
E Spurt Pass 10 10 10 10 40 LCI NA 
   Fail 0 0 0 0 0 UCI NA 
  Spray Pass 10 10 10 10 40 80   
    Fail 0 0 0 0 0 0 100% 
F Spurt Pass 10 1 10 10 31 LCI 82% 
   Fail 0 9 0 0 9 UCI 96% 
  Spray Pass 10 10 10 10 40 71   
    Fail 0 0 0 0 0 9 89% 
G Spurt Pass 8 0 10 10 28 LCI 77% 
   Fail 2 10 0 0 12 UCI 93% 
  Spray Pass 10 10 10 10 40 68   
    Fail 0 0 0 0 0 12 85% 
H Spurt Pass 10 3 10 10 33 LCI 85% 
   Fail 0 7 0 0 7 UCI 97% 
  Spray Pass 10 10 10 10 40 73   
    Fail 0 0 0 0 0 7 91% 
I Spurt Pass 2 3 10 10 25 LCI 73% 
   Fail 8 7 0 0 15 UCI 90% 
  Spray Pass 10 10 10 10 40 65   
    Fail 0 0 0 0 0 15 81% 
J Spurt Pass 9 2 10 10 31 LCI 82% 
   Fail 1 8 0 0 9 UCI 96% 
  Spray Pass 10 10 10 10 40 71   
    Fail 0 0 0 0 0 9 89% 
Table 4-2: Ensemble Nose Pass Rate 
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Figure 4-2: Nose Pass Rate 
Looking at Table 4-2, one can see that Ensemble B, C, D, and E (100%) had the 
highest pass rates in the area of concern of the Nose. This is shown again graphically in 
Figure 4-2. The total pass rate of ensembles for the nose is 93%. The pass rate is 24% 
higher for the nose than the eyes.  
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4.2.3 Pass Rate of Mouth 
Ensemble     Mouth             
     Up Down Left Right   PassRate 
A Spurt Pass 10 4 10 10 34 LCI 87% 
   Fail 0 6 0 0 6 UCI 98% 
  Spray Pass 10 10 10 10 40 74   
    Fail 0 0 0 0 0 6 93% 
B Spurt Pass 10 4 10 10 34 LCI 87% 
   Fail 0 6 0 0 6 UCI 98% 
  Spray Pass 10 10 10 10 40 74   
    Fail 0 0 0 0 0 6 93% 
C Spurt Pass 10 10 10 10 40 LCI NA 
   Fail 0 0 0 0 0 UCI NA 
  Spray Pass 10 10 10 10 40 80   
    Fail 0 0 0 0 0 0 100% 
D Spurt Pass 10 9 10 10 39 LCI 96% 
   Fail 0 1 0 0 1 UCI 100% 
  Spray Pass 10 10 10 10 40 79   
    Fail 0 0 0 0 0 1 99% 
E Spurt Pass 10 10 10 10 40 LCI NA 
   Fail 0 0 0 0 0 UCI NA 
  Spray Pass 10 10 10 10 40 80   
    Fail 0 0 0 0 0 0 100% 
F Spurt Pass 10 0 10 10 30 LCI 80% 
   Fail 0 10 0 0 10 UCI 95% 
  Spray Pass 10 10 10 10 40 70   
    Fail 0 0 0 0 0 10 88% 
G Spurt Pass 8 7 10 10 35 LCI 88% 
   Fail 2 3 0 0 5 UCI 99% 
  Spray Pass 10 10 10 10 40 75   
    Fail 0 0 0 0 0 5 94% 
H Spurt Pass 10 3 10 10 33 LCI 85% 
   Fail 0 7 0 0 7 UCI 97% 
  Spray Pass 10 10 10 10 40 73   
    Fail 0 0 0 0 0 7 91% 
I Spurt Pass 1 3 10 10 24 LCI 71% 
   Fail 9 7 0 0 16 UCI 89% 
  Spray Pass 10 10 10 10 40 64   
    Fail 0 0 0 0 0 16 80% 
J Spurt Pass 6 1 10 10 27 LCI 76% 
   Fail 4 9 0 0 13 UCI 92% 
  Spray Pass 10 10 10 10 40 67   
    Fail 0 0 0 0 0 13 84% 
Table 4-3: Ensemble Mouth Pass Rate 
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Figure 4-3: Mouth Pass Rate 
Looking at Table 4-3, one can see that Ensemble C and E (100%) and Ensemble D 
(99%) had the highest pass rates in the area of concern of the Mouth. This is shown 
again graphically in Figure 4-3. The overall ensembles pass rate for the Mouth is 92%. 
The overall ensembles pass rate is 23% higher for the mouth than the eyes, and 1% 
lower than the overall ensembles pass rate for the nose.   
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4.2.4 Pass Rate of Total Ensemble 
Ensemble       Total Ensemble 
Pass Rate        
A Spurt Pass 96 LCI 86% 
   Fail 24 UCI 94% 
  Spray Pass 120 216   
    Fail 0 24 90% 
B Spurt Pass 96 LCI 86% 
   Fail 21 UCI 94% 
  Spray Pass 120 216   
    Fail 0 24 90% 
C Spurt Pass 120 LCI NA 
   Fail 0 UCI NA 
  Spray Pass 120 240   
    Fail 0 0 100% 
D Spurt Pass 115 LCI 91% 
   Fail 5 UCI 97% 
  Spray Pass 110 225   
    Fail 10 15 94% 
E Spurt Pass 119 LCI 99% 
   Fail 1 UCI 100% 
  Spray Pass 120 239   
    Fail 0 1 99.60% 
F Spurt Pass 85 LCI 76% 
   Fail 35 UCI 86% 
  Spray Pass 109 194   
    Fail 11 46 81% 
G Spurt Pass 83 LCI 66% 
   Fail 37 UCI 77% 
  Spray Pass 88 171   
    Fail 32 69 71% 
H Spurt Pass 92 LCI 76% 
   Fail 28 UCI 86% 
  Spray Pass 102 194   
    Fail 18 46 81% 
I Spurt Pass 69 LCI 66% 
   Fail 51 UCI 78% 
  Spray Pass 104 173   
    Fail 16 67 72% 
J Spurt Pass 78 LCI 61% 
   Fail 42 UCI 73% 
  Spray Pass 82 160   
    Fail 38 80 67% 
Table 4-4: Total Ensemble Pass Rate 
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Figure 4-4: Total Ensemble Pass Rate 
 
Figure 4-5: 95% Confidence Interval Plot of Ensembles Performance  
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Looking at Table 4-4, one can see that Ensemble C (100%) and Ensemble E (99.6%) 
had the highest total ensemble pass rate. This is shown again graphically in Figure 4-4. 
This comparison is also further confirmed with Figure 4-5 to show their performance 
and significance to each other’s performance.  
 
4.2.5 Left and Right Eye Failures 
  Left Eye       Right Eye   
         
Quadrant Total    Quadrant  Total   
L Q1 26 20%  R Q1 24 22% 
L Q2 28 22%  R Q2 17 15% 
L Q3 32 25%  R Q3 27 25% 
L Q4 41 32%  R Q4 42 38% 
L Total 127 54%  R Total 110 46% 
         
    Total Fail 237       
Table 4-5: Left and Right Eye Failures 
 
  LCI UCI   LCI UCI 
L Q1 13 27 R Q2 9 22 
L Q2 15 29 R Q1 14 30 
L Q3 18 33 R Q3 17 33 
L Q4 24 40 R Q4 29 47 
Table 4-6: Left and Right Quadrant CI 
 
 
 
91  
 
Figure 4-6: Left and Right Eye Failures 
 
 
  Left Eye       Right Eye   
         
127 237    110 237   
             
prop 0.535865 54%  prop 0.464135 46% 
SE 0.032395 0.032  SE 0.032395 0.032 
LCI 0.472371 47%  LCI 0.400641 40% 
UCI 0.599359 60%   UCI 0.527629 53% 
Table 4-7: Left and Right Eye Statistical Analysis 
When looking at Table 4-7, one can see that there is no significant difference between 
right or left eyes, or between quadrants within the eyes. This also proves to ensure that 
the test apparatus is consistent within its testing operations. 
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4.3 Pass Rate of Spurt vs Spray  
 
  Spray Spurt Spray Spurt 
A 40 30 100% 75% 
B 40 22 100% 55% 
C 40 40 100% 100% 
D 30 36 75% 90% 
E 40 39 100% 98% 
F 29 24 73% 60% 
G 8 20 20% 50% 
H 22 26 55% 65% 
I 24 20 60% 50% 
J 2 20 5% 50% 
Total 69% 69%     
Table 4-8: Pass Rate of Eyes – Spurt vs Spray 
 
 
Figure 4-7: Pass Rate of Eye Criteria – Spurt vs Spray 
 
 
 
 
100% 100% 100%
75%
100%
73%
20%
55% 60%
5%
75%
55%
100%
90% 98%
60%
50%
65%
50% 50%
0%
20%
40%
60%
80%
100%
A B C D E F G H I J
Pa
ss
 R
at
e
Ensemble
Pass Rate of Eyes
Spurt vs. Spray
Spray Spurt
93  
  Spurt Spray  Spurt Spray 
A 32 40 80% 100% 
B 40 40 100% 100% 
C 40 40 100% 100% 
D 40 40 100% 100% 
E 40 40 100% 100% 
F 31 40 78% 100% 
G 28 40 70% 100% 
H 33 40 83% 100% 
I 25 40 63% 100% 
J 31 40 78% 100% 
Total 85% 100%     
Table 4-9: Pass Rate of Nose – Spurt vs Spray 
 
 
Figure 4-8: Pass Rate of Nose Criteria – Spurt vs Spray 
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  Spurt Spray Spurt Spray 
A 34 40 85% 100% 
B 34 40 85% 100% 
C 40 40 100% 100% 
D 39 40 98% 100% 
E 40 40 100% 100% 
F 30 40 75% 100% 
G 35 40 88% 100% 
H 33 40 83% 100% 
I 24 40 60% 100% 
J 27 40 68% 100% 
Total 84% 100%     
Table 4-10: Pass Rate of Mouth – Spurt vs Spray 
 
 
Figure 4-9: Pass Rate of Mouth Criteria – Spurt vs Spray 
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Spurt  953 79% 
Spray 1075 90% 
Table 4-11: Overall Ensemble Pass Rate of Spurt vs Spray 
 
 
Figure 4-10: Overall Ensemble Pass Rate of Spurt vs Spray 
 
 
 
  LCI UCI 
Spurt  77 82 
Spray 88 91 
 
Table 4-12: CI of Overall Pass Rate of Spurt vs Spray 
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Figure 4-11: CI of Overall Pass Rate of Spurt vs Spray 
 
Analysis of Maximum Likelihood Estimates 
Parameter   DF Estimate Standard 
Error 
Wald 
Chi-Square 
Pr > ChiSq 
type1 Spray-E 1 0.0627 0.1120 0.3130 0.5758 
type1 Spray-N 1 8.0958 56.8641 0.0203 0.9581 
type1 Spray-M 1 7.9343 60.3654 0.0173 0.8954 
Table 4-13: Statistical Analysis of Spurt vs Spray  
Table 4-13 above is looking at the significance of spurt vs spray between the 3 areas of 
concern (Eyes, Nose, and Mouth). It is found that there is no significant difference 
between spurt and spray by the SAS data output.  
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4.4 Pass Rate per Position 
 
  Up Down Left Right 
Spurt Pass 46% 31% 100% 100% 
Spray Pass 47% 81% 80% 67% 
Eyes Total 47% 56% 90% 84% 
Table 4-14: Eyes Pass Rate per Position 
 
Figure 4-12: Eyes Pass Criteria per Position 
 
Contrast Test Results 
Contrast DF Wald 
Chi-Square 
Pr > ChiSq 
1 v 2 1 8.8573 0.0029 
1 v 3 1 94.6000 <.0001 
1 v 4 1 90.3394 <.0001 
2 v 3 1 64.7605 <.0001 
2 v 4 1 60.2873 <.0001 
3 v 4 1 0.3214 0.5707 
Table 4-15: Eye Positions Contrasts 
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In Table 4-15, we comparing the significance between positions 1, 2, 3, and 4 when 
looking at the results from the eyes. One can see that the only 2 positions that are not 
significantly different. Therefore we can conclude that there are differences in between 
positions 1 and 3, 1 and 4, 2 and 3, and 2 and 4 (1-Up, 2-Down, 3-Left, and 4-Right).  
 
 
  Up Down Left Right 
Spurt  Pass 89% 51% 100% 100% 
Spray Pass 100% 100% 100% 100% 
Nose Total 95% 76% 100% 100% 
Table 4-16: Nose Pass Rate per Position 
 
Figure 4-13: Nose Pass Criteria per Position 
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Contrast Test Results 
Contrast DF Wald 
Chi-Square 
Pr > ChiSq 
1 v 2 1 36.6124 <.0001 
1 v 3 1 0.0053 0.9420 
1 v 4 1 0.0053 0.9420 
2 v 3 1 0.0088 0.9254 
2 v 4 1 0.0088 0.9254 
3 v 4 1 0.0000 1.0000 
Table 4-17: Nose Positions Contrasts 
In Table 4-17, we are comparing the significance between positions 1, 2, 3, and 4 when 
looking at the results from the nose. Therefore we can conclude that there are 
differences in between positions 1 and 2. (1-Up, 2-Down, 3-Left, and 4-Right). Due to 
many of the nose positions having high passing rates the contrasts between positions 
are limited in their detection level.  
 
 
  Up Down Left Right 
Spurt  Pass 85% 51% 100% 100% 
Spray Pass 100% 100% 100% 100% 
Mouth Total 93% 76% 100% 100% 
Table 4-18: Mouth Pass Rate per Position 
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Figure 4-14: Mouth Pass Criteria per Position 
 
Contrast Test Results 
Contrast DF Wald 
Chi-Square 
Pr > ChiSq 
1 v 2 1 26.2149 <.0001 
1 v 3 1 0.0055 0.9408 
1 v 4 1 0.0055 0.9408 
2 v 3 1 0.0081 0.9283 
2 v 4 1 0.0081 0.9283 
3 v 4 1 0.0000 1.0000 
Table 4-19: Mouth Positions Contrasts  
In Table 4-19, we are comparing the significance between positions 1, 2, 3, and 4 when 
looking at the results from the mouth. Therefore we can conclude that there are 
differences in between positions 1 and 2 (1-Up, 2-Down, 3-Left, and 4-Right). Due to 
many of the mouth positions having high passing rates the contrasts between positions 
are limited in their detection level. 
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Figure 4-15: Total Pass Rate per Position per Area of Concern 
 
Figure 4-16: Overall Total Pass Rate per Position 
Figure 4-15 shows the total pass rate for each position per area of concern. While 
Figure 4-16 shows the overall total pass rate per position when combining the pass rate 
of all three of the areas of concern (Eyes, Nose, and Mouth).  
 
Other very useful results that were gathered from the testing apparatus is Table 4-20 
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(below) which depicts the mean, standard deviation, variance, and an upper and lower 
95% confidence interval of the distance of passes for each ensemble for spurt and 
spray. Table 4-20 for the eye criteria is useful to reflect the reliability of the estimates 
based on the observed data. These confidence intervals are intended to offer assurance 
that all data obtained in the future with this apparatus and procedure should include the 
true value of the data with a given level of confidence. Any future group mean can be 
compared to these and declared "the same" or "different.” 
 
Obs Ensemble position2 type1 mean standdev variance low95 up95 
1 A Down Spray 16.6750 0.9278 0.861 16.011 17.339 
2 A Left Spray 19.0750 3.0092 9.055 16.922 21.228 
3 A Left Spurt 20.2540 1.7025 2.898 19.036 21.472 
4 A Right Spray 17.9860 2.3538 5.540 16.302 19.670 
5 A Right Spurt 17.8100 3.4714 12.050 15.327 20.293 
6 A Up Spray 24.4920 1.4595 2.130 23.448 25.536 
7 A Up Spurt 19.3350 6.7772 45.931 14.487 24.183 
8 B Down Spray 40.8980 11.7074 137.064 32.523 49.273 
9 B Down Spurt 55.5500 . . . . 
10 B Left Spray 42.8860 9.2647 85.834 36.258 49.514 
11 B Left Spurt 33.6970 15.1501 229.525 22.859 44.535 
12 B Right Spray 44.6010 8.1343 66.167 38.782 50.420 
13 B Right Spurt 41.2080 25.3405 642.143 23.080 59.336 
14 B Up Spray 59.4590 5.1856 26.890 55.749 63.169 
15 B Up Spurt 18.5150 23.5679 555.444 -193.234 230.264 
16 C Down Spray 34.4650 1.9207 3.689 33.091 35.839 
17 C Down Spurt 34.0290 9.8360 96.746 26.993 41.065 
18 C Left Spray 40.8160 5.8184 33.854 36.654 44.978 
19 C Left Spurt 51.1580 5.0464 25.466 47.548 54.768 
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Obs Ensemble position2 type1 mean standdev variance low95 up95 
20 C Right Spray 42.8390 7.2155 52.064 37.677 48.001 
21 C Right Spurt 53.5110 2.7375 7.494 51.553 55.469 
22 C Up Spray 51.2840 4.7379 22.448 47.895 54.673 
23 C Up Spurt 37.4980 2.8049 7.867 35.492 39.504 
24 D Down Spray 20.5730 11.4871 131.954 12.356 28.790 
25 D Left Spray 13.1800 2.5994 6.757 11.321 15.039 
26 D Left Spurt 20.9470 3.3058 10.928 18.582 23.312 
27 D Right Spray 11.8240 3.3774 11.407 9.408 14.240 
28 D Right Spurt 18.8220 5.7901 33.526 14.680 22.964 
29 D Up Spurt 7.9050 10.4336 108.861 -0.818 16.628 
30 E Down Spray 29.4540 8.2486 68.040 23.553 35.355 
31 E Down Spurt 43.5033 3.7424 14.005 34.207 52.800 
32 E Left Spray 48.9350 10.2740 105.556 41.585 56.285 
33 E Left Spurt 47.3380 6.7367 45.383 42.519 52.157 
34 E Right Spray 47.3250 8.0792 65.274 41.545 53.105 
35 E Right Spurt 42.8280 5.0567 25.571 39.211 46.445 
36 E Up Spray 52.7410 17.8736 319.466 39.955 65.527 
37 E Up Spurt 26.6233 23.0622 531.864 8.896 44.350 
38 F Down Spray 5.0850 2.6481 7.013 0.871 9.299 
39 F Down Spurt . . . . . 
40 F Left Spray 10.6120 1.9871 3.948 9.191 12.033 
41 F Left Spurt 16.2080 4.9092 24.101 12.696 19.720 
42 F Right Spray 10.9920 4.6364 21.497 7.675 14.309 
43 F Right Spurt 15.2190 2.8195 7.950 13.202 17.236 
44 F Up Spray 16.1360 4.1840 17.506 10.941 21.331 
45 F Up Spurt 3.4433 1.9358 3.747 -1.366 8.252 
46 G Down Spray 3.2086 0.8650 0.748 2.409 4.009 
47 G Left Spurt 17.1930 5.8286 33.973 13.023 21.363 
48 G Right Spray 0.0810 . . . . 
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Obs Ensemble position2 type1 mean standdev variance low95 up95 
49 G Right Spurt 12.9430 2.4144 5.829 11.216 14.670 
50 H Down Spray 6.3850 1.3051 1.703 5.451 7.319 
51 H Down Spurt 1.4100 0.7071 0.500 -4.943 7.763 
52 H Left Spray 8.0910 2.6350 6.943 6.206 9.976 
53 H Left Spurt 13.1900 5.2152 27.199 9.459 16.921 
54 H Right Spray 11.3610 2.8547 8.149 9.319 13.403 
55 H Right Spurt 12.3670 4.0398 16.320 9.477 15.257 
56 H Up Spray 6.3700 . . . . 
57 H Up Spurt 8.8950 3.4778 12.095 3.361 14.429 
58 I Down Spray 2.7100 1.2866 1.655 1.790 3.630 
59 I Left Spray 2.4957 0.5940 0.353 1.946 3.045 
60 I Left Spurt 17.2420 3.3224 11.038 14.865 19.619 
61 I Right Spray 3.6800 1.9467 3.790 1.880 5.480 
62 I Right Spurt 15.4920 3.8213 14.602 12.758 18.226 
63 J Left Spurt 21.2210 4.7275 22.350 17.839 24.603 
64 J Right Spray 3.8650 0.6576 0.432 -2.043 9.773 
65 J Right Spurt 19.2300 4.1360 17.106 16.271 22.189 
Table 4-20: Overall 95% CI of Pass Distance per Ensembles for Eye Criteria 
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Spurt    Spray   
Type Order Random  Type Order Random 
1 4 0.110105  1 3 0.771812 
1 1 0.866044  1 4 0.899898 
1 3 0.575045  1 2 0.620639 
1 2 0.209213  1 1 0.253192 
2 4 0.100062  2 3 0.434974 
2 3 0.64155  2 1 0.67247 
2 1 0.271539  2 4 0.107855 
2 2 0.639137  2 2 0.48079 
3 2 0.308732  3 4 0.485787 
3 1 0.035325  3 1 0.034049 
3 3 0.61792  3 2 0.626298 
3 4 0.644714  3 3 0.065569 
4 4 0.454954  4 3 0.972744 
4 3 0.515109  4 1 0.755114 
4 2 0.146152  4 4 0.509375 
4 1 0.279676  4 2 0.007701 
5 2 0.247228  5 2 0.677996 
5 1 0.272828  5 4 0.473996 
5 4 0.896784  5 3 0.672279 
5 3 0.342129  5 1 0.391638 
6 1 0.241775  6 2 0.416609 
6 2 0.127472  6 4 0.599407 
6 4 0.706046  6 3 0.503911 
6 3 0.821264  6 1 0.584669 
7 4 0.490619  7 4 0.495893 
7 1 0.477712  7 2 0.321757 
7 3 0.095565  7 1 0.630011 
7 2 0.049422  7 3 0.623625 
8 4 0.871248  8 1 0.21115 
8 1 0.330814  8 2 0.595587 
8 2 0.8773  8 3 0.781672 
8 3 0.359281  8 4 0.607079 
9 1 0.389863  9 2 0.149353 
9 4 0.103653  9 4 0.000394 
9 3 0.722085  9 3 0.890708 
9 2 0.3049  9 1 0.194994 
10 3 0.206174  10 4 0.577079 
10 1 0.781835  10 3 0.717418 
10 4 0.415395  10 2 0.18312 
10 2 0.740884  10 1 0.994418 
Table 4-21: Random Number Generator for Testing Order 
In Table 4-21 one will see how the order of testing was randomized. This table was 
created in Excel where the type and order was assigned to the random number that was 
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generated. The “order” was then sorted by “type” making each series of position (1-4) 
randomized for the 10 replications of each spurt and spray categories.  
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CHAPTER 5 - Discussion 
 
5.1 Overview of Findings 
During the initial start of this project the original hypothesis was stated that current 
ANSI Z87.1 eye protectors will not pass the criteria from this test to be labeled for 
protection against biological hazards. The test matrix was set up to include 10 
ensembles (e.g eye protector and face mask) that were currently being used in high 
hazard occupations for biological protection. Out of the 10 ensembles that were tested 
on the apparatus for spurt and spray protection, only 1 ensemble passed the testing 
criteria fully (Ensemble C). This particular ensemble did not have any failures on any 
of the head manipulations in any of the areas of concern. The other 9 ensembles failed 
in 1 or more of the head manipulations. Within this general result, 90% of the eye and 
face protection currently used for biological hazard protection would not pass proposed 
Z87.62 testing criteria.  
 
5.2 Overview of Ensembles 
5.2.1 Total Pass Rate of Areas of Concern 
When looking at the particular areas of concern (Eyes, Nose, and Mouth) we can see 
that the Nose and the Mouth were more effectively protected than the eyes for this 
testing procedure. The Nose and the Mouth had a total pass rate of 93% and 92% 
respectively. While the total pass rate for the Eyes was 69%. This can be expected as 
the Nose and the Mouth are more adequately covered by most face masks and leave 
fewer and smaller gaps than eye protectors tend to do. The face mask tend to press 
tightly against the face which seals most areas. Most face masks also have a built in 
wire strip at the top which a wearer is instructed to conform to the curvature of the 
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nose and upper cheeks. This also aids in closing the gaps for added protection to the 
Nose and Mouth. Eye protectors that were testing did not have these features. Some sit 
at the face closer than others which aided in protection to the Eyes, but most still had 
large gaps. The eye protectors that performed best were built in an effort to close these 
gaps (top gap, bottom gap and side gaps). Most eye protectors do provide some sort of 
side protection but few had adequate protection for the top and bottom gaps.  
 
5.2.2 Comparing Pass Rate of Areas of Concern 
When looking at individual ensembles pass rates for the Eyes, we can see that 
Ensemble C (100%) and E (99%) proved to provide the best protection. The next 
highest total pass rate for the eyes was Ensemble A (88%). Looking at the overall pass 
rate for the Nose we can see that there are multiple ensembles that offered a high level 
of protection. Ensemble B, C, D, and E, all had a pass rate of 100%. The next highest 
was Ensemble A at 90%. The Overall pass rate for the Nose was again 24% higher 
than that of the eyes. Comparing the pass rates now with that of the Mouth we again 
can see higher levels of protection for passing rates. Ensembles C and E both had a 
passing rate of 100%, while the next highest are Ensemble D (99%) and Ensemble G 
(94%). The overall ensembles pass rate is 23% higher for the mouth than the eyes, and 
1% lower than the overall ensembles pass rate for the nose. Looking at the Total 
Ensemble pass rate, we can see that Ensemble C was the only one to have zero failures, 
therefore having a pass rate of 100%. However, Ensemble E did complete the testing 
procedure with an end Total Ensemble Pass Rate of 99.6% making it a very close 2nd 
for best protective Ensemble. When comparing the Ensembles to each other based on 
their performance, we can look into a histogram plot using the ensembles upper and 
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lower confidence intervals to analyze significance between them (Figure 4-5). Since 
Ensemble C had a passing rate of 100% it cannot have true confidence intervals, 
however I included it on the analysis to represent a perfect score (Figure 4-4). 
Ensemble C and E have significantly better protective performance than the other 8 
ensembles. From this plot, a conclusion can also be drawn that Ensemble D has 
significantly better protective performance than Ensembles F, G, H, I, and J, but cannot 
determine a difference between Ensemble A and B.  
 
5.3 Left and Right Eye Comparison 
When looking at Table 4-5 and Table 4-7, we can conclude that testing between the 
Left and the Right eye were consistently even. This helps to see how much variance is 
within the test procedure and apparatus itself. The ideal perfect test would have the 
same amount of failures in the Left eye as the Right eye but due to testing error, fluid 
being unpredictable, and human error this might not happen. However, the statistical 
analysis of the data between the left and the right eye showed that the left nor the right 
eye had significant differences in failures between them. Further, we can look at Table 
4-6 and see that there is no significant difference between any quadrants in the Left eye 
to its corresponding quadrant in the Right eye. This demonstrates that the test 
apparatus and method are consistent within its testing operations.  
 
5.4 Pass Rate of Spurt vs Spray 
5.4.1 Pass Rate of Spurt vs Spray - Eyes 
Looking at the specific area of concern of the Eyes in regards to the pass rate of Spurt 
vs Spray we can see that in Table 4-8 and Figure 4-7 that the Spray looks graphically 
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to be much more consistent at passing. When this data is broken down in the table by 
percentages of all the ensembles it actually comes out to be 69% for both Spurt and 
Spray pass rates. When looking at the overall total passes for the eyes of spurt and 
spray there was no statistical significant difference between the 2 tests. This is further 
conveyed by looking at the SAS data output in Table 4-13 for the Eyes section.   
 
5.4.2 Pass Rate of Spurt vs Spray – Nose 
Looking at the specific area of concern of the Nose in regards to the pass rate of Spurt 
vs Spray we can see that in Table 4-9 and Figure 4-8, we can see that there was a much 
higher rate of Passing than in the Eyes as shown in other areas previously. When 
looking at the table we can see that the Spray had a 100% pass rate while the Spurt had 
an 85% pass rate. When looking at the SAS data output in Table 4-13 for the Nose 
section, it reports that there is no statistical difference between Spurt and Spray. 
However, the large amount of 10/10 or 100% pass rates causes the power of the test to 
decrease quickly because of the decrease in variance as the rate gets closer to 100%. 
This causes the test to lose power of being able to detect small differences within the 
data set. Hence, the data output to report no significant difference between spurt and 
spray for the Nose. This is why we must also look to the data table to see the actual 
percent passing rate and draw conclusions from it.  
5.4.3 Pass Rate of Spurt vs Spray – Mouth 
Looking at the specific area of concern of the Mouth in regards to the pass rate of Spurt 
vs Spray we can see that in Table 4-10 and Figure 4-9, we can see that there was a 
much higher rate of Passing than in the Eyes as shown in other areas previously. When 
looking at the table we can see that the Spray had a 100% pass rate while the Spurt had 
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an 84% pass rate. When looking at the SAS data output in Table 4-13 for the Mouth 
section, it reports that there is no statistical difference between Spurt and Spray. 
However, the large amount of 10/10 or 100% pass rates causes the power of the test to 
decrease quickly because of the decrease in variance as the rates get closer to 100%. 
This causes the test to lose power of being able to detect small differences within the 
data set. Hence, the data output to report no significant difference between spurt and 
spray for the Mouth. This is why we must also look to the data table to see the actual 
percent passing rate and draw conclusions from it. Both the Nose and the Mouth show 
to have more failures in Spurt than in Spray. This conclusion is also supported by 
Table 4-12, which does show that there is a significant difference in Spurt vs Spray. 
This is due to the volume and concentration of this volume delivered to a more specific 
target location. The Spurt delivers 2ml of fluid to a very small area, where as the spray 
delivers 1ml of fluid to a very spread out area. Most all of the failures that were to the 
Nose and Mouth were due to a “Run Through” of fluid. This was caused by the fluid 
not actually penetrating through the mask but from running through the seal from top 
to bottom. The “Run Through” would leave a small trail of fluid from where it initially 
impacted down the nose and mouth. Occasionally the fluid would stop at the nose and 
not make it to the mouth or bypass the nose and hit the mouth due to the larger surface 
area of the mouth.  
 
5.5 Pass Rate per Position 
5.5.1 Pass Rate per Position –Eyes 
When looking at Table 4-14, we can see that the majority of the passes in the Eyes 
were in the Left or Right (90% and 84%) head manipulation position. The majority of 
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the failures were in the Up position (pass rate- 47%). Looking at Table 4-15, the 
contrasts of the positions, we can conclude that there is no significant difference 
between position 3 and 4 (Left and Right). We can conclude that all other interactions 
between positions are significantly different when compared in the eye area. This is 
supported by Table 4-14.  
5.5.2 Pass Rate per Position –Nose 
When looking at Table 4-16, we can see that the majority of the passes in the Nose 
were in the Left or Right (100% and 100%) head manipulation position. This was 
closely followed by the Up position with a pass rate of 95%. The majority of the 
failures were in the Down position (pass rate- 76%). Looking at Table 4-17, we can 
conclude that there is a significant difference between positions 1 and 2 (Up and 
Down). All other interactions between positions show no significant difference. This is 
supported by Table 4-16.  
5.5.3 Pass Rate per Position –Mouth 
When looking at Table 4-18, we can see that the majority of the passes in the Mouth 
were in the Left or Right (100% and 100%) head manipulation position. This was 
closely followed by the Up position with a pass rate of 93%. The majority of the 
failures were in the Down position (pass rate- 76%). Looking at Table 4-19, we can 
conclude that there is a significant difference between positions 1 and 2 (Up and 
Down). All other interactions between positions show no significant difference. This is 
supported by Table 4-18.  
5.5.4 Total Pass Rate per Position per Area of Concern 
When looking at Figure 4-15, we can see that Left and the Right positions have the 
highest passing rate for the Eyes, Nose, and Mouth; closely followed by the Up 
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positions. The Down position as a whole appears to present itself with the lowest 
passing rate. Going even further by looking at Figure 4-16, we can see that the Down 
position has the lowest pass rate overall with 17%. The second lowest is the Up 
position with 19% and the highest pass rates are Left and Right positions with 24% 
each.  
5.6 Range of Protection Tests 
A pilot test was also conducted for a “Range of Protection Test.” This test only had 1 
replication of each position for each ensemble due to time and material constraints. 
This was a means to measure how far each Ensemble would offer protection on a 
horizontal and vertical plane. This test did prove to have some interested findings that 
could be further investigated. Some of the generalized findings of all ensembles are 
seen in Tables 5-1.   
 
Position Eyes Nose Mouth 
  Pass Rate 
90 R 85% 100% 100% 
60 R 90% 100% 100% 
30 R 75% 100% 100% 
0 50% 80% 85% 
30 L 75% 100% 100% 
60 L 90% 100% 100% 
90 L 85% 100% 100% 
90 U 45% 95% 100% 
60 U 40% 95% 95% 
30 U 30% 95% 95% 
30 D 50% 95% 100% 
60 D 75% 90% 100% 
90 D 80% 85% 95% 
Table 5-1: Pass Rates of Range of Protection Tests 
From Table 5-1, we can see that in the areas of concern of the Nose and Mouth that the 
0 degree target location is the position with the lowest pass rate. This is a straight on 
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target location to the bridge of the nose centered across the eyes. The lowest Pass rate 
for the area of concern for the Eyes was 30 degree up. We can see that the majority of 
the failures were in the looking “Up” position. This pilot Range of Protection Test was 
to do a quick investigation of other areas of protection with ensembles.  
 
5.7 Summary of Tests 
By looking at all the data as a whole and by running the tests first hand, I can conclude 
that the test apparatus does operate efficiently and is very repeatable with little 
variance. I also conclude that it ensures concise and consistent testing across the broad 
spectrum of safety manufacturers and end users. This provides an important first step 
to simulate high risk biological hazardous occupations where eye and face PPE are 
worn.  
 
 
5.7.1 Limitations of Experiment 
During the Range of Protection Tests, one limitation of the testing apparatus is that it 
cannot have a target location of a complete 90 degree posterior or anterior head tilt. 
This is due to how the head is attached to the articulating base and milling table. It is 
also due to the range of travel that which the nozzle is mounted to. If the range of 
travel was longer and the articulating base gave more clearance, then it would be able 
to test a true 90 degree posterior or anterior head tilt.  
 
Experimental data must always be evaluated with due consideration to the accuracy of 
measurement equipment used and human error of running the test operations. Many 
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measurements were taken to have the error reduced to a minimal amount. The addition 
of the cross haired laser made a huge impact on the consistency of leveling the head 
during its different manipulations. A standalone self-leveling laser was also used to 
reduce the error in head positioning. This self-leveling laser was used to ensure the 
cross hair lasers degree of level was correct. A spirit level was also used to triple check 
the degree of level during testing operations.  
 
This study addresses the regulatory aspects of Eye and Face Protection and not 
Respiratory protection. The researcher recognizes that 1 head form does not include 
race or other head sizes outside of the 50th percentile. Future research will include more 
heads and more anthropometric characteristics. It can also include testing on human 
subjects with no hazardous fluid. The researcher recognizes such real-life conditions 
such as sweating and skin conductivity may affect results. Future research may address 
this.  
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CHAPTER 6 - Conclusions and Recommendations  
 
6.1 Conclusions 
When looking back at the individual data reports of all the ensembles, we can draw 
some conclusions about how each ensemble performed and why. As stated earlier the 2 
ensembles that had the best protective performance were Ensemble C and E. Ensemble 
C had an overall protective performance pass rate of 100%, while Ensemble E had an 
overall pass rate of 99.6%. These 2 ensembles both utilized the effectiveness of a “face 
shield.” Ensemble C was a full face shield that was sealed at the forehead and hung 
downward. Because of this it passed all tests in the 4 head manipulations and all tests 
in the Range of Protection Test. Ensemble E also used the same idea of a face shield 
but was built within the mask and protruded upwards. Ensemble E only failed in one 
position of the 4 manipulations and another in the Range of Protection Tests. In these 
particular positions it presented a small gap between the face shield and the mask that 
was not adequately sealed in the Up position. Because of this slight gap, it caused 
failures. If this gap was closed by either sealing it or extended the face shield 
downward more, then I believe this Ensemble E would pass completely. The eye and 
face protectors that incorporate a “shield” into their design perform best for protection 
against biological hazards.  
 
When taking the eyes only into consideration, the bottom gap is the position in which 
the most amount of failures occur. The “Up” position was designed to investigate this 
area. This bottom gap is hard to seal solely with eye protectors unless they are built 
specifically to seal this gap. This is why a face shield design protects best in this area. 
Of the ensembles tested 2 were of a “full face shield” type and 1 was a mask built for 
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bottom gap protection in addition to separate eye protectors. All 3 of these ensembles 
protected the best against this bottom gap from spurts and sprays.  
 
The other position that is hard to protect against penetration around is the top gap or 
the “Down” position. This position is hard to protect because of the gap that is left 
between the eye protector and the forehead. The ensembles that did the best in this 
area, tended to sit very close to the forehead to minimize fluid penetration. The best 
way to protect against spurts and sprays in this position is to seal this gap. Ensemble C 
that completely passed this test used a foam pad that made that seal possibly. This 
allow for no fluid to get through. Even if the ensemble did not have an actual “seal,” 
ones that did contour to the forehead performed better.  
 
Other conclusions that can be made about ensembles are that the eye protectors that 
have more of a side shield to accommodate for the side gaps do tend to protect better. 
Some of the eye protectors, though sleek in appearance, did not protect as well as 
others that had a larger surface area to the sides. The classic “lab safety glasses” design 
of eye protectors that were tested performed best at protection against spurts and sprays 
from the sides.  
 
When looking at the SAS data output, it gives a skewed outlook on significant 
differences with Spurt vs Spray in some areas. This is why the data has been analyzed 
in multiple ways to draw the best conclusions. After analyzing the data in several 
areas, it can be concluded that Spurt and Spray are significantly different (Table 4-12). 
For this reason it is crucial to keep both elements within the test procedure. By using 
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both aspects of Spurt and Spray, the test is able to investigate PPE’s protective 
performance at a much broader spectrum.  
 
6.2 Recommendations for Future Work 
Some recommendations for future work would be to gather more data and have a 
larger sample size. It’s good to have large data sets because the larger the data set, the 
more we can extract insights that we trust from that data set. This is especially true 
when looking at the Range of Protection Test. I think that for future work this test 
would be beneficial to further investigate using more replications. In this study, time 
and material constraints only allowed for 1 replication per ensemble. I would 
recommend going as far as 10 replications or more depending on time and material. 
  
Another aspect of this test that could be further investigated is to decrease the degrees 
for when the Range of Protection Test tested at. In this study, we looked at positions 
separated every 30 degrees. By increasing the positions tested, or decrease the gap 
between degrees, the test would give more specific data for each ensemble and a more 
precise “Range of Protection”. I would recommend to test at every 10 degrees. 
Another alteration to the test apparatus that could be made for the betterment of testing 
would be to increase the travel distance on the Uni-Slide stand. By increasing this 
travel distance the nozzle would be able to have more target locations at a lower angle. 
This would give the head manipulation a true 90 degree posterior or anterior tilt. 
Another aspect that could be positively altered is to give the articulating base more 
clearance when moving the headform at extreme degrees. With these two changes it 
would give the test apparatus an even greater variety of testing options.  
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1. PURPOSE 
 
This establishes the procedure to evaluate the protective performance of eye and face 
protection from a small velocity stream (spurt and spray) of synthetic blood Eye and 
Face PPE Tester.  
 
2.  SCOPE 
 
This procedure applies to the operation of the instrument when used to test the 
protective performance eye and face protection in simulation of high hazard 
occupations where biological hazards from spurts and sprays are present.  
 
      3.   SUMMARY OF TEST METHOD 
 
 3.1.   OPERATION    
 
 3.1.1. A volume of synthetic blood is disbursed at an ensemble by a pneumatically  
       controlled valve from a set distance to simulate the spurt or spray of blood or 
  other body fluid onto the ensemble.  Any evidence of synthetic blood  
  penetration on the areas of concern constitutes a failure.   
 
 3.1.2.  Results are reported in the test matrix as pass/fail, the distance from failure or to 
 passing, and the quadrant of a failure for each area of concern. 
 
 3.2.   EVALUATION 
  
            3.2.1. Ensembles are evaluated at velocities of 635 cm/s for spurt and estimated of 
  300-500 cm/s for spray.  These velocities correspond to the velocity exiting a 
  small arterial at human blood pressure of 160 mm/Hg as well as the max  
  average velocity of human sneeze/cough with sufficient spray pattern at the 
  specified average distance of  30.48 cm.  
 
                              
     4.   MATERIALS AND SET-UP 
 
4.1.  MATERIALS REQUIRED 
 
4.1.1. Test ensembles (eye protector and face mask or complete unit) and synthetic 
 blood solution.  
4.1.2. Lab coat, safety glasses, gloves, *not necessary but helpful*-laser level, spirit 
 level, cross hair laser mounted to nozzle platform.   
  
     4.2.  PREPARATION OF TEST APPARATUS AND CALIBRATION 
 
 4.2.1.  Install a clean spurt cannula on the front of the nozzle valve.  The cannula  
  attaches to the exit of the valve.  The standard size for this method is a 1.27 cm 
 (0.5 in.) long 18 gauge stainless steel cannula with an internal diameter of 0.084 
 cm (0.033 in.) Deviations from the standard cannula must be noted in the test 
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 report. 
4.2.2.  Fill the reservoir with fresh synthetic blood (approximately 1 liter) (see Fluid 
Preparation SOP at end). 
 
4.2.3.  Adjust the reservoir pressure to deliver the desired steady-state fluid velocity 
 (~6.5 psi) a target velocity of 635 cm/s)  
 
4.2.4. Set the valve timer to 0.5 seconds. Collect and weigh the amount of liquid 
 delivered over a 0.5 second spurt.  
 
4.2.5. Set the valve timer to 1.5 seconds. Collect and weigh the amount of liquid 
 delivered over a 1.5 second spurt. 
 
4.2.6. Calculate the difference in weight of the two spurts. 
 
4.2.7. Adjust the reservoir pressure and repeat steps 4.2.3 to 4.2.6. until the weight 
 difference is within the target range shown in Table 1 below.  Record this 
 weight. 
                      
 Weight Difference (g) for a 1 Second Difference in Spurt Duration. 
Target Velocity (cm/s)                     Minimum (g)      Target (g)       Maximum (g)  
 635                 3.466                 3.537      3.607 
 550                 3.002                 3.063      3.124 
 450                 2.456                 2.506      2.556  
  
 Table 1.   Target difference in weights plus lower and upper limits for a velocity range 
 within 2% of the target.                          
       
            4.2.8.  Record the pressure in the reservoir and use this as the initial reservoir  
  pressure in subsequent testing to expedite set-up. 
  
 4.2.9. Once the reservoir pressure has been set (per target velocity), maintain  
  the same pressure in tank throughout testing. 
 
           4.3.  POSITIONING OF THE CANNULA NOZZLE 
 
 4.3.1. Aim the nozzle so that the stream makes contact where the center of the  
  cross hair lasers is pointing on the headform (assuming the laser has  
  been installed and leveled). 
 
 
    
  *Example Test Order of Positions will be Up-1, Down-2, Left-3, Right-4*  
 
 4.3.2. Set the valve time to ~0.44 sec. for Spurt and ~.60 sec. for Spray. Squirt  
  the fluid into a graduated cylinder to ensure that 2ml-spurt or 1ml spray  
  is being delivered. Adjust the valve time accordingly to achieve 2ml or  
  1ml.  
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 4.3.3.  Place the headform in the desired head manipulation for the testing  
  order.  
  
(Up-1) The headform must be centered and anteriorly titled 30 degrees. The 
headform must be 30.48 cm away from the tip of the cannula to the target 
locations. The target location for this position is 2” above the center point of the 
midline from the left and right eye on the forehead. Adjust the uni-slide mount 
so the sighted in cross hair laser is at this point 
  
(Down-2) The headform must be centered and posteriorly titled 30 degrees. The 
headform must be 30.48 cm away from the tip of the cannula to the target 
locations. The  target location for this position is 1” below the center point of the 
midline from the left and right eye on the bridge of the nose. Adjust the uni-
slide mount so the sighted in  cross hair laser is at this point 
  
(Left-3) The headform must be centered across the coronal and sagittal plane in 
a vertical fashion. Adjust the uni-slide mount so the sighted in cross hair laser is 
aimed at the center point between the eyes across the midline from the left and 
right eye. Rotate the headform clockwise 55 degrees. This is the target location 
(temple area). The headform must be 30.48 cm away from the tip of the cannula 
to the target location. 
 
(Right-4) The headform must be centered across the coronal and sagittal plane 
in a vertical fashion. Adjust the uni-slide mount so the sighted in cross hair laser 
is aimed at the center point between the eyes across the midline from the left 
and right eye. Rotate the headform counter-clockwise 55 degrees. This is the 
target location (temple area). The headform must be 30.48 cm away from the tip 
of the cannula to the target location.  
 
 4.3.4. Once the headform is adjust into the position specified by the testing  
  order and aimed to the target location corresponding to the head   
  manipulation, Don the PPE for this test. Check to make sure the target  
  location is still accurate with the nozzle, press the pedal to shoot the  
  fluid onto the headform.  
 
4.3.5.   Within 5 sec. of shooting the fluid onto the headform, carefully remove the PPE 
and check for any fluid within the areas of concentration. Measure record the 
data into the test matrix with a caliper. If the fluid is within an area of concern it 
is deemed a failure. Measure from the center of area of concern to the closest 
fluid droplet and record this data. Record the quadrant that the fluid is in. If the 
fluid is outside the area of concern, measure from the perimeter of this area of 
concern to the closest fluid droplet and record this data. 
 
 
 4.3.6.   After the completion of a set of “spurts” or “sprays”, ensure that the test  
  apparatus is delivering 2 ml or 1ml of test liquid by collecting and   
  weighing the output passing through the targeting hole.  If the delivered  
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  output has shifted more than (2%), repeat the calibration procedure in  
  Sections 4.2.4. 
 
                          
             4.4.    CLEANING 
                     
 4.4.1.  If the cannula is left for 1 hour or more without use after passing   
  synthetic blood during testing, replace with a clean cannula and clean  
  the used cannula by immersing in isopropyl alcohol for 24 hours and  
  rinsing with distilled water. 
 
 4.4.2.   Following testing, clean system lines and the reservoir with distilled  
  water.  Do not use isopropyl alcohol or other solvents on the valve or  
  system lines, they could damage the valve.     
  
 
 
   5.    TEST PROCEDURE AND QUALITATIVE EVALUATION 
 
5.1. TEST PROCEDURE AND EVALUATION 
 
           5.1.1. Once the headform is adjust into the position specified by the testing  
  order and aimed to the target location corresponding to the head   
  manipulation, Don the PPE for this test. Check to make sure the target  
  location is still accurate with the nozzle, press the pedal to shoot the  
  fluid onto the headform.  
 
 5.1.2.   Within 5 sec. of shooting the fluid onto the headform, carefully remove  
  the PPE and inspect for any fluid within the areas of concentration. The  
  use of the blue light makes inspection much more effective. Measure  
  and record the data into the test matrix with a caliper. If the fluid is  
  within an area of concern it is deemed a failure. Measure from the center  
  of area of concern to the closest fluid droplet and record this data.   
  Record the quadrant that the fluid is in. If the area of concern passes,  
  measure from the perimeter of this area of concern to the closest fluid  
  droplet and record this data.  
 
 5.1.3.   After the completion of a set of “spurts” or “sprays”, ensure that the test  
  apparatus is delivering 2 ml or 1ml of test liquid by collecting and   
  weighing the fluid.  If the delivered output has shifted more than (2%),  
  repeat the calibration procedure in Sections 4.2.4. 
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     6. REPORTS  
   *See Test Matrix* 
 
    
  
x 10 
  
 
Pass 
Fail 
Dist. to 
closest 
fluid 
(mm) 
Q
ua
dr
an
t 
Pass 
Fail 
Dist. to 
closest 
Fluid 
(mm) 
Q
ua
dr
an
t 
Pass 
Fail 
Dist. to 
closest 
Fluid 
(mm) 
Q
ua
dr
an
t 
1 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Up 
 
         
2 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Down
 
         
3 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Right
 
         
4 Spurt High 
Vel. 
635 
cm/s 
High 
Vol. 
(2 ml) 
Left
 
         
1 Spray 500 
cm/s 
1 ml Up 
 
         
2 Spray 500 
cm/s 
1 ml Down
 
         
3 Spray 500 
cm/s 
1 ml Right
 
         
4 Spray 500 
cm/s 
1 ml Left
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7. SETTING UP LANDMARKS 
 
7.1 Eyes 
 
The ellipse parameters will have its dimensions based off the center of the eye. From 
there a major and minor axis will be created of lengths of 35mm in height (minor) and 
50mm in width (major). This ellipse shape will follow the orbital bone. The 45 degree 
diagonal measurements will be 42 mm in length (Figure 6-1: Graph of Ellipse).  
 
 
Figure 7-1: Graph of Ellipse 
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(Elsevier, 2008) 
Figure 7-2: Average Eye Measurements 
 
 
7.2 Nose 
 
Nose exposure will be evaluated using the 6 landmarks shown below. Connecting the 
points from 1-3-2-5-6-4-1 creates a perimeter along the bottom surface area of the 
nose. Any fluid or fluid residue that is found within this perimeter will be considered 
a “fail” for the nose.  
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(Etoz, 2011) 
 
Figure7-3: Anthropometric Nose landmarks 
 
The nose perimeter measurements are defined in Figure 6-2 and Table 6-2 below for 
the European anthropometric headform.  
 
 
 
 
 
 
Table 7-1: Anthropometric Nose Landmarks 
 
1-2 Alare, the point where the nasal blade (ala nasi) extends farthest out.  
3 Subnasal, the midpoint of the columella base. 
4-5 The most convex point of lateral cruris of alar cartilage.  
6 Pronasal, the most prominent point on the nasal tip.  
132  
 
 
Figure 7-4: Nose measurement of most convex point- Points 4-5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7-2: Nose Landmark Measurements 
 
 
 
1-3 27 mm 
3-2 27 mm 
1-4 18 mm 
2-5 18 mm 
4-6 20 mm 
5-6 20 mm 
4-5 25 mm 
3-6 22 mm 
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7.3 Mouth 
 
Figure 4-5 shows anthropometric landmarks that are widely used for the mouth. A 
perimeter formed by connecting the points (1-2-3-4-5-1) defines the mouth. Any fluid 
or fluid residue that falls within this perimeter will be considered a “fail” for the 
mouth.  
The perimeter will start at the left oral commissure or cheilion. This is where the 
lateral aspects of the vermilion of the upper and lower lips join. (Figure 6-5-point 1) 
From point 1, the perimeter will travel along the contour of the line formed by the 
vermilion border of the upper lip. In a frontal view, this line resembles an archer's 
bow, which curves medially and superiorly from the commissures to the paramedian 
peaks located at the bases of the pillars of the philtrum (crista philtrae) (Figure 6-5- 
points 2 and 3) with an inferior convexity lying between those peaks. The philtrum is 
the vertical groove in the midline of the upper lip bordered by these lateral pillars 
(ridges). From points 2-3, the perimeter will travel to point 4 which resides as the 
right oral commissure or cheilion (Figure 6-5-point 4). From point 4, the perimeter 
will travel along the contour of the line formed by the vermilion border of the lower 
lip until it reaches the lowest apex of the lower lip, which will be point 5. From point 
5 the line will continue along the contour of the line formed by the vermillion border 
of the lower lip until it reconnects with point 1. 
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Source: (Raschke, et al., 2016) 
Figure 7-5: Anthropometric Mouth Landmarks 
 
 
The mouth perimeter measurements are defined in Figure 6-6 and Table 6-4 below for 
the European anthropometric headform.  
 
135  
 
Figure 7-6: Mouth measurement between left and right oral commissure-Points 1-4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7-3: Mouth Landmark Measurements 
 
 
1-2 31 mm 
2-3 10 mm 
3-4 31 mm 
4-5 33.5 mm 
5-1 33.5 mm 
1-4 56.5 mm 
2-5 18 mm 
3-5 18 mm 
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8. PICTURES 
 
 
 
Figure 8-1. Pressure control gauge/reducer and Reservoir 
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Figure 8-2. Cannula on the front of the pneumatic-controlled valve 
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Figure 8-3. Anthropometric headform and grid with quadran 
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Figure 8-4. Cross Hair Laser on Platform 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8-5. Spurt cannula 
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Figure 8-6. Spray cannula 
 
 
Figure 8-7: Posterior and Anterior head Manipulations 
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Figure 8-8: Left and Right head Manipulations 
 
 
 
 
 
 
 
 
 
 
Figure 8-9. Overall Setup 
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9. Fluid Preparation SOP 
 
 
 
Fluid Preparation SOP 
 
(saline + fluorescein + surfactant): 
0.9 % saline 
0.002 M fluorescein 
0.1 % surfynol 104H 
 
For 1 Liter: 
9 g NaCl 
0.752 g fluorescein 
1.0 mL surfynol 104H 
diH2O to 1 L 
 
a. Place magnetic stir bar in 1 L Erlenmeyer flask and weigh both with triple beam 
balance to determine tare weight.   
b. Add 1000 g auxiliary weight to opposite end of balance beam 
c. Weigh NaCl on a scientific balance and add to flask, rinsing with diH2O as needed 
d. Weigh fluorescein on a scientific balance and add to flask, rinsing with diH2O as 
needed 
e. Add remaining volume of diH2O until indicator at the end of balance beam is level 
with the zero indicator on the balance base.   
f. Transfer flask to magnetic stirrer and create a strong vortex. 
g. Using an Eppendorf micropipettor device and disposable tip, carefully pipet the 
surfynol 104H into the solution, rinsing tip several times. 
h. Allow solution to mix with a strong vortex for 30 minute. 
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APPENDIX B: APPARATUS BUILDING INSTRUCTIONS 
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All materials listed below are what is recommended for building materials. These materials or 
materials of equivalence are to be used when constructing this apparatus.   
 
The apparatus is to be mounted on a solid sheet of material rigid enough to hold each part in a 
stable and sturdy position. This was done by using a 24” x 48” x ½” sheet of LDPE as shown 
below (Figure 1).  
 
0  
Figure 1: Top View of Apparatus 
 
The next step is to mount the milling table to the LDPE sheet. The milling table used in this 
apparatus is a Grizzly 6” x 18.5” compound table (Figure 2). To mount the table it is necessary 
to raise the milling table 1.5” above the LDPE sheet. This was done by use two 1.5x1.5” 80/20 
stock bar that was cut into two 11” long pieces. The 2 pieces then have a ½ hole drilled through 
the center of the 80/20 stock bar. Each hole is drilled at 1.5” in from each end. Next, the 
milling tables anchor points are to be aligned with the holes in the 80/20 stock bar and fitted to 
be squared with the corner of the LDPE sheet. The milling table is held down through the 
80/20 stock bar and the LDPE sheet by four 3/8”-2” hex bolts along 1-1/4” washers and 
corresponding nuts (Figure 3 and Figure 4). To be able to bolt the milling table down, the 
LDPE must have 4 aligned holes drilled at ½”. These 4 holes must also have a counter sunk 
hole to allow for the hex head of the bolt to sit beneath the bottom of the LDPE sheet (Figure 
5). This counter sunk hole should be around 7/8” wide.  
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Figure 2: Milling Table 
 
 
 
 
Figure 3: Inside View of Milling Table Anchored to LDPE Sheet 
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Figure 4: Outside View of Milling Table Anchored to LDPE Sheet 
 
 
 
 
Figure 5: Counter Sunk Hole with Through Bolt  
 
 
 
After getting the milling table attached to the LDPA platform sheet, the next step is to attach 
the headform to the articulating base. The articulating base is made from ThorLabs and is 
shown in the CAD file below (Figure 6).  
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Figure 6: Articulating Base Layout 
 
The UK Anthropometric headform is attached to the articulating base by using two 2” dry wall 
screws. Both of the headforms center ear holes must be aligned directly to the center of the 
articulating base. The wood screws can then be inserted in any appropriated hole of the 
articulating base and into the base of the neck of the headform.  The optimal screw pattern 
would be 1 screw on either side of the pedestal (Figure 7).  
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Figure 7: Articulating Base Screw Pattern  
 
After attached the anthropometric head to the articulating base, the base then needs to be 
attached to the milling table. This is done using two 3/16” -1-1/4” fully threaded bolts, 
corresponding nuts, and   ½” washers (Figure 8, Figure 9, and Figure 10).  
 
 
 
 
Figure 8: Top View of Articulating Base Attachment 
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Figure 9: Side View of Articulating Base Attachment 
 
Figure 10: Close Up of Bolt on Articulating Base Attachment 
 
 
The next piece of the apparatus that needs to be anchored to the LDPE sheet platform is the 
uni-slide stand. Given that the milling table is 6 ½” tall, the uni-slide stand then needs to be 
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raised on a platform itself to have matching heights for adequate nozzle projection (Figure 11). 
This platform can be built into a simple rectangular 4”x4” box by using LDPE, polycarbonate, 
PTFE, or equivalent materials. This rectangular box can also be bought; either method is 
sufficient as long as the stand can remain stable and is raised at least 6 ½”. The box used to 
raise the uni-slide in this apparatus was built out of PTFE sheets. Two pieces were cut into 3”x 
6 ½” and two more 4”x 6 ½”. These four pieces were screwed together using ¾” plastic screws 
(Figure 12). The box ends remain open. The uni slide will then sit atop the box and is screwed 
down into the top of the fabricated box through the uni slides pre drilled holes using four ¾” 
plastic screws (Figure 13). 
 
 
Figure 11: Uni-Slide Attached to Fabricated Box 
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Figure 12: Fabricated Box 
 
 
Figure 13: Uni-Slide Screwed to Box 
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After securing the uni-slide stand to the fabricated box, the next step is to attach the nozzle to 
the uni-slides mounting bracket. The nozzle is secured to the mounting bracket by one 3/16”-
1/2” fully threaded hex head bolt. The nozzle is held by using the M5 mounting hole (Figure 
14). A locking washer is also needed between the bolt head and the bottom of the mounting 
bracket for tension purposes (Figure 15 and Figure 16).  
 
 
 
Figure 14: Nozzle Diagram 
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Figure 15: Mounted Nozzle on Bracket 
 
 
Figure 16: Bottom View of Mounting Bracket 
 
 
After getting the nozzle mounted to the uni-slides mounting bracket, it is important to get the 
nozzle as square and in the center as possible on the bracket before completely tightening it 
down (Figure 17).  
 
 
Figure 17: Top View of Nozzle Mounted 
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The next step is securing the fabricated box to the LDPE sheet platform. (At this point the 
nozzle should already be attached to the uni-slide mount and the uni-slide should be attached to 
the fabricated box)  The nozzle needs to the place in a manner so that when it is shot the fluid 
would pass directly through the center of the milling table or to the center of the 
anthropometric head (Figure 18). The edge of the fabricated box should also run parallel with 
the edge of the LDPE sheet platform (Figure 18).  
 
 
Figure 18: Orientation of Nozzle and Uni-Slide 
 
After getting the orientation of the nozzle stand to that of the milling table and anthropometric 
head, it will then need to be anchored down. This can be achieved by the same method as the 
milling table. By using four 1-1/4” plastic screws that are drilled and countersunk from the 
bottom of the LDPE sheet platform (Figure 19 and Figure 20).  
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Figure 19: Fabricated Box Secured to LDPE Sheet 
 
 
 
Figure 20: Countersunk Hole for Uni-Slide Box 
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The next step is to connect air pressure to the pressurized container and dispensing unit with an 
airline capable of supply consistent pressure of at least 70 psi. These two air inlets are fed by a 
¼” push connection (Figure 21 and Figure 22). After running the airline to the container and 
dispensing unit, another ¼” airline needs to be connected from the dispensing unit to the nozzle 
(Figure 23 and Figure 24). After connecting all of airlines to the container, dispenser, and 
nozzle; the next step is to connect the pressurized container reservoir to the nozzle (Figure 25 
and Figure 26).  
 
 
Figure 21: Supply Air Line Connection into Container 
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Figure 22: Supply Air Line Connection into Dispenser 
 
 
Figure 23: Air Line from Dispenser to Nozzle-Dispenser Output 
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Figure 24: Air Line from Dispenser to Nozzle-Nozzle Input 
 
Figure 25: Fluid line from Pressurized Container Reservoir to Nozzle 
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Figure 26: Fluid line Into Nozzle from Pressurized Container Reservoir to Nozzle 
After the airlines and fluid line is connected, the power cord and foot pedal must be connected 
to the dispensing unit. Both of these connections are made at the back of the dispensing unit 
(Figure 27 and Figure 28).  
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Figure 27: Connections at Back of Dispenser 
 
 
Figure 28: Foot Pedal and Connections for Dispenser 
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Parts List 
 
McMaster-Carr  
(1) LDPE Sheet 24”x48”x1/2” Part# 8657K616 
 
(1) 80/20 1”x1”-24” 47065T101 
 
(4) Hex bolt 3/8”-2” 91309A632 
 
(4) Hex nuts 3/8”-16 95462A031  
 
(4) 1-1/4” flat washer 90107A040 
 
(2) Dry wall screws 90093A400 
 
(2) 3/16 Hex bolts 91309A626 
 
(2) 3/16 Hex nuts  
 
(3) 1.125” washers 91525A268 
 
(1) LDPE sheet 24”x24” 8657K416 
 
(24) No.4 - ¾”Screws 90380A120 
 
(4) No. 8 1-1/4” Screws 92325A319 
 
(1) 0-30 PSI Pressure Gauge 4089K61 
 
 
Grizzly  
(1) 6” x 18.5” compound Table - G8750 
 
 
ThorLabs  
(1) Articulation base – SL20 
 
Velmex  
(1) UniSlide Elevating Table-T=9.5” - B2912W1 
 
Ellsworth 
(1) Poppet Valve - VP300 
 
(1) Pressure Tank Stainless Steel Special - IJ2601N-SS-SP 
 
(1) Digital Dispenser-Valve Controlled - DC200 
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Fluid Preparation SOP 
 
(saline + fluorescein + surfactant): 
0.9 % saline 
0.002 M fluorescein 
0.1 % surfynol 104H 
 
For 1 Liter: 
9 g NaCl 
0.752 g fluorescein 
1.0 mL surfynol 104H 
diH2O to 1 L 
 
i. Place magnetic stir bar in 1 L Erlenmeyer flask and weigh both with triple beam 
balance to determine tare weight.   
j. Add 1000 g auxiliary weight to opposite end of balance beam 
k. Weigh NaCl on a scientific balance and add to flask, rinsing with diH2O as needed 
l. Weigh fluorescein on a scientific balance and add to flask, rinsing with diH2O as 
needed 
m. Add remaining volume of diH2O until indicator at the end of balance beam is level 
with the zero indicator on the balance base.   
n. Transfer flask to magnetic stirrer and create a strong vortex. 
o. Using an Eppendorf micropipettor device and disposable tip, carefully pipet the 
surfynol 104H into the solution, rinsing tip several times. 
p. Allow solution to mix with a strong vortex for 30 minute. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
163  
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position1 type1 type2 type3 position2 passfaileyes distance quad1 passfailnose distance2 quad2 passfailmout distance3 quad3 Ensemble 
1 Spurt 635 cm/s 2ml Up Pass 22.32 - Pass 5.69 - Pass 33.61 - A 
2 Spurt 635 cm/s 2ml Down Fail 1.26 L Q2 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 A 
3 Spurt 635 cm/s 2ml Right Pass 17.91 - Pass 50.4 - Pass 50.79 - A 
4 Spurt 635 cm/s 2ml Left Pass 20.49 - Pass 50.14 - Pass 36.14 - A 
1 Spray 500 cm/s 1ml Up Pass 26.32 - Pass 74.45 - Pass 78.26 - A 
2 Spray 500 cm/s 1ml Down Pass 17.19 - Pass 71.22 - Pass 93.4 - A 
3 Spray 500 cm/s 1ml Right Pass 13.29 - Pass 48.26 - Pass 37.58 - A 
4 Spray 500 cm/s 1ml Left Pass 15.13 - Pass 41.94 - Pass 33.5 - A 
1 Spurt 635 cm/s 2ml Up Pass 22.42 - Pass 3.36 - Pass 35.87 - A 
2 Spurt 635 cm/s 2ml Down Fail 18.42 L Q3 Fail Ran Thru Q4 Fail Ran Thru Q2/Q4 A 
3 Spurt 635 cm/s 2ml Right Pass 19.25 - Pass 56.08 - Pass 39.09 - A 
4 Spurt 635 cm/s 2ml Left Pass 18.28 - Pass 38.59 - Pass 34.9 - A 
1 Spray 500 cm/s 1ml Up Pass 22.52 - Pass 70.68 - Pass 77.54 - A 
2 Spray 500 cm/s 1ml Down Pass 17.63 - Pass 67.83 - Pass 92.19 - A 
3 Spray 500 cm/s 1ml Right Pass 17.37 - Pass 43.96 - Pass 32.53 - A 
4 Spray 500 cm/s 1ml Left Pass 23.04 - Pass 43.2 - Pass 38.16 - A 
1 Spurt 635 cm/s 2ml Up Pass 23.01 - Pass 72.4 - Pass 77.85 - A 
2 Spurt 635 cm/s 2ml Down Fail 17.35 R Q4 Fail Ran Thru Q2/Q3 Pass 5.84 - A 
3 Spurt 635 cm/s 2ml Right Pass 17.49 - Pass 56.52 - Pass 46.2 - A 
4 Spurt 635 cm/s 2ml Left Pass 21.89 - Pass 50.84 - Pass 48.19 - A 
1 Spray 500 cm/s 1ml Up Pass 26.57 - Pass 76.23 - Pass 78.35 - A 
2 Spray 500 cm/s 1ml Down Pass 16.87 - Pass 68.08 - Pass 92.44 - A 
3 Spray 500 cm/s 1ml Right Pass 19.95 - Pass 46.05 - Pass 36.8 - A 
4 Spray 500 cm/s 1ml Left Pass 23.96 - Pass 41.56 - Pass 33.65 - A 
1 Spurt 635 cm/s 2ml Up Pass 4.91 - Pass 45.72 - Pass 81.97 - A 
2 Spurt 635 cm/s 2ml Down Fail 21.6 L Q2 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 A 
3 Spurt 635 cm/s 2ml Right Pass 16.28 - Pass 54.66 - Pass 30.24 - A 
4 Spurt 635 cm/s 2ml Left Pass 20.46 - Pass 62.82 - Pass 43.66 - A 
1 Spray 500 cm/s 1ml Up Pass 23.4 - Pass 73.51 - Pass 74.55 - A 
2 Spray 500 cm/s 1ml Down Pass 15.75 - Pass 71.99 - Pass 97.16 - A 
3 Spray 500 cm/s 1ml Right Pass 18.23 - Pass 45.84 - Pass 37.59 - A 
4 Spray 500 cm/s 1ml Left Pass 16.84 - Pass 44.11 - Pass 36.48 - A 
1 Spurt 635 cm/s 2ml Up Pass 8.59 - Pass 2.75 - Pass 30.55 - A 
2 Spurt 635 cm/s 2ml Down Fail 11.5 L Q3 Fail Ran Thru Q3/Q4 Fail Ran Thru Q1/Q4 A 
3 Spurt 635 cm/s 2ml Right Pass 18.14 - Pass 46.22 - Pass 45.95 - A 
4 Spurt 635 cm/s 2ml Left Pass 18.11 - Pass 49.46 - Pass 52.76 - A 
1 Spray 500 cm/s 1ml Up Pass 23.37 - Pass 74.6 - Pass 76.1 - A 
2 Spray 500 cm/s 1ml Down Pass 18.16 - Pass 68.29 - Pass 97.22 - A 
3 Spray 500 cm/s 1ml Right Pass 19.03 - Pass 44.56 - Pass 37.52 - A 
4 Spray 500 cm/s 1ml Left Pass 15.21 - Pass 41.46 - Pass 39.12 - A 
1 Spurt 635 cm/s 2ml Up Pass 21.94 - Pass 74.79 - Pass 82.14 - A 
2 Spurt 635 cm/s 2ml Down Fail 22.43 R Q1 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 A 
3 Spurt 635 cm/s 2ml Right Pass 20.62 - Pass 31.47 - Pass 34.26 - A 
4 Spurt 635 cm/s 2ml Left Pass 22.14 - Pass 52.44 - Pass 45.33 - A 
1 Spray 500 cm/s 1ml Up Pass 25.79 - Pass 75.05 - Pass 75.93 - A 
2 Spray 500 cm/s 1ml Down Pass 16.51 - Pass 71.97 - Pass 92.85 - A 
3 Spray 500 cm/s 1ml Right Pass 14.68 - Pass 43.07 - Pass 29.09 - A 
4 Spray 500 cm/s 1ml Left Pass 19.71 - Pass 44.55 - Pass 31.82 - A 
1 Spurt 635 cm/s 2ml Up Pass 23.76 - Pass 3.56 - Pass 338.68 - A 
2 Spurt 635 cm/s 2ml Down Fail 17.24 L Q3 Pass 1.82 - Pass 2.54 - A 
3 Spurt 635 cm/s 2ml Right Pass 19.33 - Pass 47.34 - Pass 51.98 
 
A 
4 Spurt 635 cm/s 2ml Left Pass 18.04 - Pass 56.91 - Pass 52.42 
 
A 
1 Spray 500 cm/s 1ml Up Pass 24.35 - Pass 74.52 - Pass 74.71 - A 
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2 Spray 500 cm/s 1ml Down Pass 15.12 - Pass 70.67 - Pass 96.91 - A 
3 Spray 500 cm/s 1ml Right Pass 21.03 - Pass 40.79 - Pass 34.5 - A 
4 Spray 500 cm/s 1ml Left Pass 20.81 - Pass 51.61 - Pass 33.21 - A 
1 Spurt 635 cm/s 2ml Up Pass 23.19 - Pass 75.45 - Pass 77.36 - A 
2 Spurt 635 cm/s 2ml Down Fail 16.25 R Q1 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 A 
3 Spurt 635 cm/s 2ml Right Pass 8.86 - Pass 34.93 - Pass 53.02 - A 
4 Spurt 635 cm/s 2ml Left Pass 21.16 - Pass 50.55 - Pass 52.5 - A 
1 Spray 500 cm/s 1ml Up Pass 25.58 - Pass 73.83 - Pass 80.39 - A 
2 Spray 500 cm/s 1ml Down Pass 17.21 - Pass 70.16 - Pass 93.54 - A 
3 Spray 500 cm/s 1ml Right Pass 18.3 - Pass 42.84 - Pass 38.54 - A 
4 Spray 500 cm/s 1ml Left Pass 18.94 - Pass 43.61 - Pass 37.62 - A 
1 Spurt 635 cm/s 2ml Up Pass 23.39 - Pass 76.25 - Pass 88.6 - A 
2 Spurt 635 cm/s 2ml Down Fail 18.19 R Q4 Fail Ran Thru Q3 Pass 4.86 - A 
3 Spurt 635 cm/s 2ml Right Pass 18.9 - Pass 49.4 - Pass 51.97 - A 
4 Spurt 635 cm/s 2ml Left Pass 19.49 - Pass 48.41 - Pass 35.14 - A 
1 Spray 500 cm/s 1ml Up Pass 23.93 - Pass 74.95 - Pass 79.12 - A 
2 Spray 500 cm/s 1ml Down Pass 15.84 - Pass 71.56 - Pass 94.63 - A 
3 Spray 500 cm/s 1ml Right Pass 19.23 - Pass 44.51 - Pass 35.26 - A 
4 Spray 500 cm/s 1ml Left Pass 19.66 - Pass 49.26 - Pass 34.12 - A 
1 Spurt 635 cm/s 2ml Up Pass 19.82 - Pass 6.99 - Pass 32.54 - A 
2 Spurt 635 cm/s 2ml Down Fail 19.23 L Q2 Pass 3.12 - Pass 2.45 - A 
3 Spurt 635 cm/s 2ml Right Pass 21.32 - Pass 55.25 - Pass 44.62 - A 
4 Spurt 635 cm/s 2ml Left Pass 22.48 - Pass 51.28 - Pass 47.81 - A 
1 Spray 500 cm/s 1ml Up Pass 23.09 - Pass 74.44 - Pass 75.32 - A 
2 Spray 500 cm/s 1ml Down Pass 16.47 - Pass 72.95 - Pass 93.11 - A 
3 Spray 500 cm/s 1ml Right Pass 18.75 - Pass 44.65 - Pass 37.72 - A 
4 Spray 500 cm/s 1ml Left Pass 17.45 - Pass 41.36 - Pass 39.24 - A 
1 Spurt 635 cm/s 2ml Up Pass 1.85 - Pass 58.38 - Pass 76.92 - B 
2 Spurt 635 cm/s 2ml Down Pass 55.55 - Pass 105.58 - Pass 125.68 - B 
3 Spurt 635 cm/s 2ml Right Pass 68.72 - Pass 73.78 - Pass 61.23 - B 
4 Spurt 635 cm/s 2ml Left Pass 49.42 - Pass 67.71 - Pass 62.45 - B 
1 Spray 500 cm/s 1ml Up Pass 68.46 - Pass 115.63 - Pass 134.9 - B 
2 Spray 500 cm/s 1ml Down Pass 30.8 - Pass 81.68 - Pass 100.62 - B 
3 Spray 500 cm/s 1ml Right Pass 39.95 - Pass 70.72 - Pass 45.65 - B 
4 Spray 500 cm/s 1ml Left Pass 39.41 - Pass 39.76 - Pass 33 - B 
1 Spurt 635 cm/s 2ml Up Fail 0.75 L Q1 Pass 37.64 - Pass 57.14 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 54.47 - Pass 67.47 - Pass 53.96 - B 
4 Spurt 635 cm/s 2ml Left Pass 56.54 - Pass 72.23 - Pass 61.46 - B 
1 Spray 500 cm/s 1ml Up Pass 48.42 - Pass 65.66 - Pass 59.87 - B 
2 Spray 500 cm/s 1ml Down Pass 70.21 - Pass 120.23 - Pass 110.15 - B 
3 Spray 500 cm/s 1ml Right Pass 29.23 - Pass 79.73 - Pass 102.3 - B 
4 Spray 500 cm/s 1ml Left Pass 37.55 - Pass 68.26 - Pass 41.39 - B 
1 Spurt 635 cm/s 2ml Up Fail 8.49 L Q1 Pass 45.68 - Pass 70.37 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 49.92 - Pass 63.95 - Pass 51.2 - B 
4 Spurt 635 cm/s 2ml Left Pass 37.46 - Pass 47.01 - Pass 41.54 - B 
1 Spray 500 cm/s 1ml Up Pass 59.78 - Pass 97.79 - Pass 123.16 - B 
2 Spray 500 cm/s 1ml Down Pass 38.99 - Pass 87.95 - Pass 113.45 - B 
3 Spray 500 cm/s 1ml Right Pass 47.63 - Pass 52.27 - Pass 37.12 - B 
4 Spray 500 cm/s 1ml Left Pass 47.47 - Pass 55.62 - Pass 33.67 - B 
1 Spurt 635 cm/s 2ml Up Fail 2.67 R Q2 Pass 18.26 - Pass 44.38 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 69.83 - Pass 87.4 - Pass 73.9 - B 
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4 Spurt 635 cm/s 2ml Left Pass 47.1 - Pass 68.5 - Pass 64.19 - B 
1 Spray 500 cm/s 1ml Up Pass 60.23 - Pass 89.32 - Pass 115.18 - B 
2 Spray 500 cm/s 1ml Down Pass 30.21 - Pass 94.51 - Pass 112.32 - B 
3 Spray 500 cm/s 1ml Right Pass 45.83 - Pass 47.25 - Pass 35.02 - B 
4 Spray 500 cm/s 1ml Left Pass 44.32 - Pass 51.22 - Pass 31.64 - B 
1 Spurt 635 cm/s 2ml Up Fail 5.05 L Q2 Pass 36.08 - Pass 55.98 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 25.63 - Pass 75.98 - Pass 63.27 - B 
4 Spurt 635 cm/s 2ml Left Pass 42.61 - Pass 69.09 - Pass 49.97 - B 
1 Spray 500 cm/s 1ml Up Pass 58.55 - Pass 98.73 - Pass 123.16 - B 
2 Spray 500 cm/s 1ml Down Pass 44.24 - Pass 104.99 - Pass 115.34 - B 
3 Spray 500 cm/s 1ml Right Pass 53.77 - Pass 62.17 - Pass 47.81 - B 
4 Spray 500 cm/s 1ml Left Pass 50.54 - Pass 59.4 - Pass 25.76 - B 
1 Spurt 635 cm/s 2ml Up Fail 5.97 R Q2 Pass 4.8 - Pass 32.18 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 12.28 - Pass 66.57 - Pass 50.4 - B 
4 Spurt 635 cm/s 2ml Left Pass 13.66 - Pass 70.25 - Pass 56.62 - B 
1 Spray 500 cm/s 1ml Up Pass 55.75 - Pass 95.73 - Pass 110.11 - B 
2 Spray 500 cm/s 1ml Down Pass 43.44 - Pass 102.84 - Pass 120.05 - B 
3 Spray 500 cm/s 1ml Right Pass 51.53 - Pass 55.48 - Pass 45.58 - B 
4 Spray 500 cm/s 1ml Left Pass 48.45 - Pass 53.34 - Pass 21.23 - B 
1 Spurt 635 cm/s 2ml Up Pass 35.18 - Pass 83.58 - Pass 85.75 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 74.89 - Pass 79.11 - Pass 60.56 - B 
4 Spurt 635 cm/s 2ml Left Pass 29.45 - Pass 51.74 - Pass 49.67 - B 
1 Spray 500 cm/s 1ml Up Pass 59.62 - Pass 115.07 - Pass 134.58 - B 
2 Spray 500 cm/s 1ml Down Pass 40.26 - Pass 99.97 - Pass 124.12 - B 
3 Spray 500 cm/s 1ml Right Pass 38.84 - Pass 68.34 - Pass 47.59 - B 
4 Spray 500 cm/s 1ml Left Pass 29.16 - Pass 58.62 - Pass 38.45 - B 
1 Spurt 635 cm/s 2ml Up Fail 2.51 L Q4 Pass 30.69 - Pass 55.81 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 17.71 - Pass 55.96 - Pass 45.45 - B 
4 Spurt 635 cm/s 2ml Left Pass 20.31 - Pass 49.17 - Pass 45.09 - B 
1 Spray 500 cm/s 1ml Up Pass 61.23 - Pass 109.57 - Pass 105.22 - B 
2 Spray 500 cm/s 1ml Down Pass 38.76 - Pass 102.2 - Pass 112.69 - B 
3 Spray 500 cm/s 1ml Right Pass 36.45 - Pass 62.32 - Pass 45.23 - B 
4 Spray 500 cm/s 1ml Left Pass 27.16 - Pass 55.36 - Pass 39.68 - B 
1 Spurt 635 cm/s 2ml Up Fail 0 L Q1 Pass 20.27 - Pass 50.12 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 8.67 - Pass 36.16 - Pass 49.77 - B 
4 Spurt 635 cm/s 2ml Left Pass 14.69 - Pass 53.83 - Pass 49.14 - B 
1 Spray 500 cm/s 1ml Up Pass 63.93 - Pass 109.61 - Pass 92.52 - B 
2 Spray 500 cm/s 1ml Down Pass 29.53 - Pass 79.66 - Pass 101.67 - B 
3 Spray 500 cm/s 1ml Right Pass 52.62 - Pass 54.27 - Pass 42.65 - B 
4 Spray 500 cm/s 1ml Left Pass 53.54 - Pass 52.47 - Pass 30.74 - B 
1 Spurt 635 cm/s 2ml Up Fail 9.36 R Q1 Pass 35.05 - Pass 61.59 - B 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - B 
3 Spurt 635 cm/s 2ml Right Pass 29.96 - Pass 76.09 - Pass 58.34 - B 
4 Spurt 635 cm/s 2ml Left Pass 25.73 - Pass 67.69 - Pass 59.12 - B 
1 Spray 500 cm/s 1ml Up Pass 58.62 - Pass 97.78 - Pass 119.27 - B 
2 Spray 500 cm/s 1ml Down Pass 42.54 - Pass 105.23 - Pass 101.2 - B 
3 Spray 500 cm/s 1ml Right Pass 50.16 - Pass 51.73 - Pass 44.34 - B 
4 Spray 500 cm/s 1ml Left Pass 51.26 - Pass 53.64 - Pass 31.73 - B 
1 Spurt 635 cm/s 2ml Up Pass 42.07 - Pass 95.7 - Pass 89.12 - C 
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2 Spurt 635 cm/s 2ml Down Pass 9.58 - Pass 67.78 - Pass 93.61 - C 
3 Spurt 635 cm/s 2ml Right Pass 51.13 - Pass 64.38 - Pass 77.87 - C 
4 Spurt 635 cm/s 2ml Left Pass 41.91 - Pass 67.14 - Pass 81.29 - C 
1 Spray 500 cm/s 1ml Up Pass 51.62 - Pass 104.57 - Pass 81.98 - C 
2 Spray 500 cm/s 1ml Down Pass 38.24 - Pass 89.49 - Pass 113.94 - C 
3 Spray 500 cm/s 1ml Right Pass 45.49 - Pass 81.28 - Pass 82.68 - C 
4 Spray 500 cm/s 1ml Left Pass 43.94 - Pass 74.16 - Pass 78.07 - C 
1 Spurt 635 cm/s 2ml Up Pass 39.25 - Pass 91.25 - Pass 87.01 - C 
2 Spurt 635 cm/s 2ml Down Pass 34.57 - Pass 79.27 - Pass 102.31 - C 
3 Spurt 635 cm/s 2ml Right Pass 53.19 - Pass 67.68 - Pass 51.04 - C 
4 Spurt 635 cm/s 2ml Left Pass 47.02 - Pass 59.05 - Pass 56.22 - C 
1 Spray 500 cm/s 1ml Up Pass 59.35 - Pass 103.79 - Pass 85.18 - C 
2 Spray 500 cm/s 1ml Down Pass 35.17 - Pass 82.93 - Pass 110.7 - C 
3 Spray 500 cm/s 1ml Right Pass 35.2 - Pass 78.17 - Pass 72.09 - C 
4 Spray 500 cm/s 1ml Left Pass 37.15 - Pass 74.76 Pass 69.13 - C 
1 Spurt 635 cm/s 2ml Up Pass 35.79 - Pass 87.04 - Pass 90.7 - C 
2 Spurt 635 cm/s 2ml Down Pass 40.21 - Pass 88.31 - Pass 109.42 - C 
3 Spurt 635 cm/s 2ml Right Pass 52.13 - Pass 66.45 - Pass 58.91 - C 
4 Spurt 635 cm/s 2ml Left Pass 45.86 - Pass 58.12 - Pass 57.42 - C 
1 Spray 500 cm/s 1ml Up Pass 44.02 - Pass 93.27 - Pass 81.51 - C 
2 Spray 500 cm/s 1ml Down Pass 34.57 - Pass 84.85 - Pass 111.31 - C 
3 Spray 500 cm/s 1ml Right Pass 42.45 - Pass 60.36 - Pass 62.65 - C 
4 Spray 500 cm/s 1ml Left Pass 39.09 - Pass 67.69 - Pass 56.5 - C 
1 Spurt 635 cm/s 2ml Up Pass 39.81 - Pass 85.12 - Pass 89.53 - C 
2 Spurt 635 cm/s 2ml Down Pass 30.82 - Pass 79.5 - Pass 103.63 - C 
3 Spurt 635 cm/s 2ml Right Pass 53.14 - Pass 78.27 - Pass 70.57 - C 
4 Spurt 635 cm/s 2ml Left Pass 55.92 - Pass 75.13 - Pass 73.69 - C 
1 Spray 500 cm/s 1ml Up Pass 46.05 - Pass 99.24 - Pass 72.65 - C 
2 Spray 500 cm/s 1ml Down Pass 31.93 - Pass 87.75 - Pass 109.27 - C 
3 Spray 500 cm/s 1ml Right Pass 42.85 - Pass 81.06 - Pass 61.68 - C 
4 Spray 500 cm/s 1ml Left Pass 40.93 - Pass 80.27 - Pass 58.36 - C 
1 Spurt 635 cm/s 2ml Up Pass 38.14 - Pass 88.56 - Pass 88.78 - C 
2 Spurt 635 cm/s 2ml Down Pass 31.26 - Pass 80.54 - Pass 105.46 - C 
3 Spurt 635 cm/s 2ml Right Pass 56.81 - Pass 77.43 - Pass 72.56 - C 
4 Spurt 635 cm/s 2ml Left Pass 54.62 - Pass 81.23 - Pass 70.45 - C 
1 Spray 500 cm/s 1ml Up Pass 56.78 - Pass 103.92 - Pass 80.06 - C 
2 Spray 500 cm/s 1ml Down Pass 35.04 - Pass 87.38 - Pass 111.25 - C 
3 Spray 500 cm/s 1ml Right Pass 35.83 - Pass 74.43 - Pass 70.49 - C 
4 Spray 500 cm/s 1ml Left Pass 36.02 - Pass 81.52 - Pass 73.01 - C 
1 Spurt 635 cm/s 2ml Up Pass 31.89 - Pass 84.12 - Pass 81.26 - C 
2 Spurt 635 cm/s 2ml Down Pass 29.89 - Pass 78.92 - Pass 101.61 - C 
3 Spurt 635 cm/s 2ml Right Pass 51.12 - Pass 70.14 - Pass 68.42 - C 
4 Spurt 635 cm/s 2ml Left Pass 55.69 - Pass 73.26 - Pass 69.87 - C 
1 Spray 500 cm/s 1ml Up Pass 52.96 - Pass 101.8 - Pass 77.68 - C 
2 Spray 500 cm/s 1ml Down Pass 33.16 - Pass 85.62 - Pass 112.43 - C 
3 Spray 500 cm/s 1ml Right Pass 43.45 - Pass 31.36 - Pass 62.34 - C 
4 Spray 500 cm/s 1ml Left Pass 38.11 - Pass 67.26 - Pass 56.25 - C 
1 Spurt 635 cm/s 2ml Up Pass 37.51 - Pass 85.49 - Pass 85.83 - C 
2 Spurt 635 cm/s 2ml Down Pass 42.81 - Pass 91.25 - Pass 113.44 - C 
3 Spurt 635 cm/s 2ml Right Pass 50.58 - Pass 75.54 - Pass 65.04 - C 
4 Spurt 635 cm/s 2ml Left Pass 48.26 - Pass 80.81 - Pass 69.35 - C 
1 Spray 500 cm/s 1ml Up Pass 53.84 - Pass 102.31 - Pass 79.15 - C 
2 Spray 500 cm/s 1ml Down Pass 34.65 - Pass 84.16 - Pass 110.38 - C 
3 Spray 500 cm/s 1ml Right Pass 43.45 - Pass 61.63 - Pass 63.24 - C 
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4 Spray 500 cm/s 1ml Left Pass 38.98 - Pass 68.69 - Pass 55.12 - C 
1 Spurt 635 cm/s 2ml Up Pass 35.13 - Pass 86.21 - Pass 84.19 - C 
2 Spurt 635 cm/s 2ml Down Pass 40.23 - Pass 85.12 - Pass 110.26 - C 
3 Spurt 635 cm/s 2ml Right Pass 52.32 - Pass 76.01 - Pass 68.92 - C 
4 Spurt 635 cm/s 2ml Left Pass 51.69 - Pass 75.48 - Pass 66.13 - C 
1 Spray 500 cm/s 1ml Up Pass 48.62 - Pass 105.78 - Pass 83.47 - C 
2 Spray 500 cm/s 1ml Down Pass 36.33 - Pass 87.19 - Pass 113.41 - C 
3 Spray 500 cm/s 1ml Right Pass 43.58 - Pass 80.06 - Pass 62.86 - C 
4 Spray 500 cm/s 1ml Left Pass 41.91 - Pass 79.89 - Pass 59.36 - C 
1 Spurt 635 cm/s 2ml Up Pass 36.98 - Pass 84.56 - Pass 88.23 - C 
2 Spurt 635 cm/s 2ml Down Pass 39.72 - Pass 84.95 - Pass 102.68 - C 
3 Spurt 635 cm/s 2ml Right Pass 56 - Pass 80.63 - Pass 65.38 - C 
4 Spurt 635 cm/s 2ml Left Pass 54.99 - Pass 76.32 - Pass 62.91 - C 
1 Spray 500 cm/s 1ml Up Pass 51.48 - Pass 101.69 - Pass 77.14 - C 
2 Spray 500 cm/s 1ml Down Pass 32.15 - Pass 83.46 - Pass 110.9 - C 
3 Spray 500 cm/s 1ml Right Pass 35.83 - Pass 75.34 - Pass 70.33 - C 
4 Spray 500 cm/s 1ml Left Pass 36.28 - Pass 82.51 - Pass 72.94 - C 
1 Spurt 635 cm/s 2ml Up Pass 38.41 - Pass 81.2 - Pass 90.21 - C 
2 Spurt 635 cm/s 2ml Down Pass 41.2 - Pass 82.56 - Pass 105.36 - C 
3 Spurt 635 cm/s 2ml Right Pass 58.69 - Pass 83.11 - Pass 69.51 - C 
4 Spurt 635 cm/s 2ml Left Pass 55.62 - Pass 84.22 - Pass 71.21 - C 
1 Spray 500 cm/s 1ml Up Pass 48.12 - Pass 106.23 - Pass 76.35 - C 
2 Spray 500 cm/s 1ml Down Pass 33.41 - Pass 86.53 - Pass 112.57 - C 
3 Spray 500 cm/s 1ml Right Pass 60.26 - Pass 71.75 - Pass 62.11 - C 
4 Spray 500 cm/s 1ml Left Pass 55.75 - Pass 67.82 - Pass 65.89 - C 
1 Spurt 635 cm/s 2ml Up Pass 3.68 - Pass 20.2 - Pass 40.35 - D 
2 Spurt 635 cm/s 2ml Down Fail 11.6 L Q3 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3/Q4 D 
3 Spurt 635 cm/s 2ml Right Pass 20.62 - Pass 31.47 - Pass 34.26 - D 
4 Spurt 635 cm/s 2ml Left Pass 22.14 - Pass 62.44 - Pass 50.3 - D 
1 Spray 500 cm/s 1ml Up Fail 3.96 R Q1 Pass 37.69 - Pass 48.63 - D 
2 Spray 500 cm/s 1ml Down Pass 1.44 - Pass 40.62 - Pass 61.4 - D 
3 Spray 500 cm/s 1ml Right Pass 13.43 - Pass 33.11 - Pass 26.06 - D 
4 Spray 500 cm/s 1ml Left Pass 15.25 - Pass 36.05 - Pass 34.18 - D 
1 Spurt 635 cm/s 2ml Up Pass 6.61 - Pass 46.61 - Pass 66.13 - D 
2 Spurt 635 cm/s 2ml Down Fail 17.84 R Q4 Pass 2.05 - Pass 2.1 - D 
3 Spurt 635 cm/s 2ml Right Pass 22.13 - Pass 40.18 - Pass 48.21 - D 
4 Spurt 635 cm/s 2ml Left Pass 20.7 - Pass 54.6 - Pass 43.04 - D 
1 Spray 500 cm/s 1ml Up Fail 9.11 L Q4 Pass 28.92 - Pass 44.82 - D 
2 Spray 500 cm/s 1ml Down Pass 19.7 - Pass 75.15 - Pass 97.43 - D 
3 Spray 500 cm/s 1ml Right Pass 12.65 - Pass 38.29 - Pass 34.06 - D 
4 Spray 500 cm/s 1ml Left Pass 8.82 - Pass 34.21 - Pass 33.07 - D 
1 Spurt 635 cm/s 2ml Up Pass 7.16 - Pass 46.59 - Pass 62.12 - D 
2 Spurt 635 cm/s 2ml Down Fail 19.19 R Q4 Pass 29.34 - Pass 52.36 - D 
3 Spurt 635 cm/s 2ml Right Pass 19.33 - Pass 47.34 - Pass 51.98 - D 
4 Spurt 635 cm/s 2ml Left Pass 18.04 - Pass 56.91 - Pass 52.42 - D 
1 Spray 500 cm/s 1ml Up Fail 1.45 R Q1 Pass 32.22 - Pass 43.01 - D 
2 Spray 500 cm/s 1ml Down Pass 1.36 - Pass 25.81 - Pass 49.92 - D 
3 Spray 500 cm/s 1ml Right Pass 5.61 - Pass 34.51 - Pass 31.28 - D 
4 Spray 500 cm/s 1ml Left Pass 10.38 - Pass 32.84 - Pass 32.97 - D 
1 Spurt 635 cm/s 2ml Up Pass 1.59 - Pass 45.03 - Pass 65.79 - D 
2 Spurt 635 cm/s 2ml Down Fail 18.6 R Q4 Pass 24.21 - Pass 47.55 - D 
3 Spurt 635 cm/s 2ml Right Pass 20.52 - Pass 50.07 - Pass 49.41 - D 
4 Spurt 635 cm/s 2ml Left Pass 22.39 - Pass 51.09 - Pass 57.01 - D 
1 Spray 500 cm/s 1ml Up Fail 7.25 L Q4 Pass 38.71 - Pass 52.98 - D 
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2 Spray 500 cm/s 1ml Down Pass 12.58 - Pass 61.61 - Pass 85.46 - D 
3 Spray 500 cm/s 1ml Right Pass 11.11 - Pass 36.79 - Pass 33.06 - D 
4 Spray 500 cm/s 1ml Left Pass 14.1 - Pass 36.02 - Pass 32.32 - D 
1 Spurt 635 cm/s 2ml Up Pass 2.96 - Pass 45.7 - Pass 68.31 - D 
2 Spurt 635 cm/s 2ml Down Fail 11.63 L Q3 Pass 38.27 - Pass 53.54 - D 
3 Spurt 635 cm/s 2ml Right Pass 8.86 - Pass 34.93 - Pass 53.02 - D 
4 Spurt 635 cm/s 2ml Left Pass 21.16 - Pass 50.55 - Pass 52.5 - D 
1 Spray 500 cm/s 1ml Up Fail 10.06 R Q3 Pass 25.9 - Pass 50.53 - D 
2 Spray 500 cm/s 1ml Down Pass 29.55 - Pass 74.81 - Pass 96.87 - D 
3 Spray 500 cm/s 1ml Right Pass 9.33 - Pass 36.29 - Pass 37.07 - D 
4 Spray 500 cm/s 1ml Left Pass 15.65 - Pass 37.64 - Pass 35.06 - D 
1 Spurt 635 cm/s 2ml Up Fail 14.16 R Q1 Pass 44.95 - Pass 65.94 - D 
2 Spurt 635 cm/s 2ml Down Fail 23.29 R Q1 Pass 47.29 - Pass 67.1 - D 
3 Spurt 635 cm/s 2ml Right Pass 27.34 - Pass 45.11 - Pass 55.2 - D 
4 Spurt 635 cm/s 2ml Left Pass 22.49 - Pass 55.84 - Pass 62.62 - D 
1 Spray 500 cm/s 1ml Up Fail 6.67 L Q4 Pass 33.06 - Pass 48.02 - D 
2 Spray 500 cm/s 1ml Down Pass 25.76 - Pass 75.49 - Pass 94.97 - D 
3 Spray 500 cm/s 1ml Right Pass 13.21 - Pass 34.71 - Pass 31.63 - D 
4 Spray 500 cm/s 1ml Left Pass 12.77 - Pass 36.31 - Pass 32.85 - D 
1 Spurt 635 cm/s 2ml Up Pass 5.62 - Pass 43.03 - Pass 71.44 - D 
2 Spurt 635 cm/s 2ml Down Fail 16.77 R Q1 Pass 2.95 - Pass 26.82 - D 
3 Spurt 635 cm/s 2ml Right Pass 25.21 - Pass 45.86 - Pass 31.85 - D 
4 Spurt 635 cm/s 2ml Left Pass 19.19 - Pass 44.92 - Pass 35.4 - D 
1 Spray 500 cm/s 1ml Up Fail 21.21 L Q1 Pass 39.31 - Pass 50.19 - D 
2 Spray 500 cm/s 1ml Down Pass 29.01 - Pass 76.93 - Pass 101.91 - D 
3 Spray 500 cm/s 1ml Right Pass 14.82 - Pass 40.26 - Pass 30.41 - D 
4 Spray 500 cm/s 1ml Left Pass 16.79 - Pass 41.22 - Pass 34.74 - D 
1 Spurt 635 cm/s 2ml Up Fail 21.45 R Q1 Pass 2.91 - Pass 29.22 - D 
2 Spurt 635 cm/s 2ml Down Fail 17.22 R Q4 Pass 38.33 - Pass 59.73 - D 
3 Spurt 635 cm/s 2ml Right Pass 18.21 - Pass 53.04 - Pass 56.84 - D 
4 Spurt 635 cm/s 2ml Left Pass 14.2 - Pass 54.09 - Pass 42.51 - D 
1 Spray 500 cm/s 1ml Up Fail 11.99 L Q1 Pass 53.55 - Pass 43.01 - D 
2 Spray 500 cm/s 1ml Down Pass 30.91 - Pass 76.93 - Pass 98.54 - D 
3 Spray 500 cm/s 1ml Right Pass 12.32 - Pass 41.61 - Pass 38.57 - D 
4 Spray 500 cm/s 1ml Left Pass 10.29 - Pass 32.9 - Pass 30.21 - D 
1 Spurt 635 cm/s 2ml Up Pass 2.38 - Pass 46.34 - Pass 67.27 - D 
2 Spurt 635 cm/s 2ml Down Fail 13.05 13.05 Pass 13.82 - Pass 34.57 - D 
3 Spurt 635 cm/s 2ml Right Pass 14.35 - Pass 54.8 - Pass 40.17 - D 
4 Spurt 635 cm/s 2ml Left Pass 22.47 - Pass 60.66 - Pass 47.84 - D 
1 Spray 500 cm/s 1ml Up Fail 16.06 L Q4 Pass 34.64 - Pass 48.02 - D 
2 Spray 500 cm/s 1ml Down Pass 27.31 - Pass 77.88 - Pass 97.48 - D 
3 Spray 500 cm/s 1ml Right Pass 17.39 - Pass 35.11 - Pass 33.64 - D 
4 Spray 500 cm/s 1ml Left Pass 13.55 - Pass 37.6 - Pass 35.23 - D 
1 Spurt 635 cm/s 2ml Up Pass 33.24 - Pass 81.94 - Pass 103.51 - D 
2 Spurt 635 cm/s 2ml Down Fail 23.03 L Q3 Fail Ran Thru Q3/Q4 Fail Ran Thru Q1/Q4 D 
3 Spurt 635 cm/s 2ml Right Pass 11.65 - Pass 52.64 - Pass 59.83 - D 
4 Spurt 635 cm/s 2ml Left Pass 26.69 - Pass 60.15 - Pass 60.21 - D 
1 Spray 500 cm/s 1ml Up Fail 5.29 R Q4 Pass 39.83 - Pass 54.78 - D 
2 Spray 500 cm/s 1ml Down Pass 28.11 - Pass 70.83 - Pass 93.19 - D 
3 Spray 500 cm/s 1ml Right Pass 8.37 - Pass 35.05 - Pass 30.06 - D 
4 Spray 500 cm/s 1ml Left Pass 14.2 - Pass 34.98 - Pass 36.93 - D 
1 Spurt 635 cm/s 2ml Up Pass 67.26 - Pass 122.22 - Pass 94.8 - E 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - E 
3 Spurt 635 cm/s 2ml Right Pass 47.15 - Pass 65.2 - Pass 46.98 - E 
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4 Spurt 635 cm/s 2ml Left Pass 52.47 - Pass 58.92 - Pass 37.6 - E 
1 Spray 500 cm/s 1ml Up Pass 64.61 - Pass 110.68 - Pass 75.5 - E 
2 Spray 500 cm/s 1ml Down Pass 45.27 - Pass 99.04 - Pass 117.96 - E 
3 Spray 500 cm/s 1ml Right Pass 55.82 - Pass 54.21 - Pass 36.44 - E 
4 Spray 500 cm/s 1ml Left Pass 55.32 - Pass 51.95 - Pass 37.38 - E 
1 Spurt 635 cm/s 2ml Up Fail 5.69 R Q2 Pass 1.45 - Pass 32.36 - E 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - E 
3 Spurt 635 cm/s 2ml Right Pass 49.2 - Pass 64.89 - Pass 48.15 - E 
4 Spurt 635 cm/s 2ml Left Pass 50.86 - Pass 57.45 - Pass 39.54 - E 
1 Spray 500 cm/s 1ml Up Pass 65.51 - Pass 114.19 - Pass 84.45 - E 
2 Spray 500 cm/s 1ml Down Pass 32.03 - Pass 85.29 - Pass 108.24 - E 
3 Spray 500 cm/s 1ml Right Pass 32.09 - Pass 62.05 - Pass 43.8 - E 
4 Spray 500 cm/s 1ml Left Pass 30.41 - Pass 52.83 - Pass 47.83 - E 
1 Spurt 635 cm/s 2ml Up Pass 1.64 - Pass 4.18 - Pass 33.28 - E 
2 Spurt 635 cm/s 2ml Down Pass 47.32 - Pass 94.82 - Pass 116.5 - E 
3 Spurt 635 cm/s 2ml Right Pass 45.87 - Pass 67.45 - Pass 38.1 - E 
4 Spurt 635 cm/s 2ml Left Pass 50.31 - Pass 60.29 - Pass 41.85 - E 
1 Spray 500 cm/s 1ml Up Pass 6.68 - Pass 41.26 - Pass 57.69 - E 
2 Spray 500 cm/s 1ml Down Pass 38.05 - Pass 93.83 - Pass 115.13 - E 
3 Spray 500 cm/s 1ml Right Pass 40.31 - Pass 64.15 - Pass 42.75 - E 
4 Spray 500 cm/s 1ml Left Pass 46.59 - Pass 62.51 - Pass 49.65 - E 
1 Spurt 635 cm/s 2ml Up Pass 28.41 - Pass 5.02 - Pass 35.35 - E 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - E 
3 Spurt 635 cm/s 2ml Right Pass 48.17 - Pass 66.32 - Pass 36.51 - E 
4 Spurt 635 cm/s 2ml Left Pass 53.47 - Pass 59.93 - Pass 33.21 - E 
1 Spray 500 cm/s 1ml Up Pass 48.05 - Pass 91.13 - Pass 110.23 - E 
2 Spray 500 cm/s 1ml Down Pass 33.63 - Pass 87.57 - Pass 108.86 - E 
3 Spray 500 cm/s 1ml Right Pass 49.07 - Pass 53.28 - Pass 37.47 - E 
4 Spray 500 cm/s 1ml Left Pass 52.27 - Pass 51.76 - Pass 32.46 - E 
1 Spurt 635 cm/s 2ml Up Pass 51.86 - Pass 98.1 - Pass 74.85 - E 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - E 
3 Spurt 635 cm/s 2ml Right Pass 45.12 - Pass 60.21 - Pass 48.56 - E 
4 Spurt 635 cm/s 2ml Left Pass 46.56 - Pass 54.98 - Pass 39.62 - E 
1 Spray 500 cm/s 1ml Up Pass 49.04 - Pass 79.72 - Pass 80.06 - E 
2 Spray 500 cm/s 1ml Down Pass 19.54 - Pass 75.79 - Pass 92.75 - E 
3 Spray 500 cm/s 1ml Right Pass 53.64 - Pass 56.21 - Pass 39.07 - E 
4 Spray 500 cm/s 1ml Left Pass 58.96 - Pass 59.77 - Pass 41.91 - E 
1 Spurt 635 cm/s 2ml Up Pass 4.37 - Pass 33.23 - Pass 55.23 - E 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - E 
3 Spurt 635 cm/s 2ml Right Pass 40.45 - Pass 64.74 - Pass 46.2 - E 
4 Spurt 635 cm/s 2ml Left Pass 58.39 - Pass 64.79 Pass 51.38 - E 
1 Spray 500 cm/s 1ml Up Pass 65.78 - Pass 114.02 - Pass 84.52 - E 
2 Spray 500 cm/s 1ml Down Pass 20.75 - Pass 74.46 - Pass 94.5 - E 
3 Spray 500 cm/s 1ml Right Pass 38.29 - Pass 61.17 - Pass 40.86 - E 
4 Spray 500 cm/s 1ml Left Pass 63.56 - Pass 72.06 - Pass 54.67 - E 
1 Spurt 635 cm/s 2ml Up Pass 4.99 - Pass 44.6 - Pass 69.15 - E 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - E 
3 Spurt 635 cm/s 2ml Right Pass 41.54 - Pass 65.74 - Pass 45.61 - E 
4 Spurt 635 cm/s 2ml Left Pass 41.39 - Pass 63.73 Pass 49.32 - E 
1 Spray 500 cm/s 1ml Up Pass 68.19 - Pass 104.78 - Pass 83.24 - E 
2 Spray 500 cm/s 1ml Down Pass 24.56 - Pass 75.68 - Pass 103.13 - E 
3 Spray 500 cm/s 1ml Right Pass 53.25 - Pass 59.86 - Pass 40.63 - E 
4 Spray 500 cm/s 1ml Left Pass 36.3 - Pass 52.76 - Pass 37.53 - E 
1 Spurt 635 cm/s 2ml Up Pass 40.93 - Pass 83.26 - Pass 104.8 - E 
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2 Spurt 635 cm/s 2ml Down Pass 39.84 - Pass 88.35 - Pass 109.8 - E 
3 Spurt 635 cm/s 2ml Right Pass 40.04 - Pass 64.74 - Pass 46.2 - E 
4 Spurt 635 cm/s 2ml Left Pass 39.56 - Pass 69.79 
 
Pass 51.83 - E 
1 Spray 500 cm/s 1ml Up Pass 51.66 - Pass 103.24 - Pass 83.04 - E 
2 Spray 500 cm/s 1ml Down Pass 32.16 - Pass 84.81 - Pass 106.97 - E 
3 Spray 500 cm/s 1ml Right Pass 53.63 - Pass 58.36 - Pass 37.6 - E 
4 Spray 500 cm/s 1ml Left Pass 55.14 - Pass 68.15 - Pass 52.28 - E 
1 Spurt 635 cm/s 2ml Up Pass 26.62 - Pass 75.59 - Pass 40.31 - E 
2 Spurt 635 cm/s 2ml Down Pass - - Pass NA - Pass NA - E 
3 Spurt 635 cm/s 2ml Right Pass 34.51 - Pass 55.23 - Pass 40.13 - E 
4 Spurt 635 cm/s 2ml Left Pass 39.11 - Pass 57.43 
 
Pass 52.21 - E 
1 Spray 500 cm/s 1ml Up Pass 54.72 - Pass 100.82 - Pass 82.61 - E 
2 Spray 500 cm/s 1ml Down Pass 22.65 - Pass 76.58 - Pass 98.73 - E 
3 Spray 500 cm/s 1ml Right Pass 44.61 - Pass 62.18 - Pass 42.13 - E 
4 Spray 500 cm/s 1ml Left Pass 42.96 - Pass 57.54 - Pass 37.84 - E 
1 Spurt 635 cm/s 2ml Up Pass 13.53 - Pass 47.91 - Pass 75.32 - E 
2 Spurt 635 cm/s 2ml Down Pass 43.35 - Pass 96.45 - Pass 114.15 - E 
3 Spurt 635 cm/s 2ml Right Pass 36.23 - Pass 49.23 - Pass 37.54 - E 
4 Spurt 635 cm/s 2ml Left Pass 41.26 - Pass 50.87 
 
Pass 38.92 - E 
1 Spray 500 cm/s 1ml Up Pass 53.17 - Pass 105.44 - Pass 76.91 - E 
2 Spray 500 cm/s 1ml Down Pass 25.9 - Pass 82.53 - Pass 102.4 - E 
3 Spray 500 cm/s 1ml Right Pass 52.54 - Pass 59.89 - Pass 45.82 - E 
4 Spray 500 cm/s 1ml Left Pass 47.84 - Pass 60.39 - Pass 46.09 - E 
1 Spurt 635 cm/s 2ml Up Pass 1.26 - Pass 44.83 - Pass 69.43 - F 
2 Spurt 635 cm/s 2ml Down Pass 0.01 L Q2 Fail Ran Thru Q3/Q4 Fail Ran Thru Q1,Q2,Q3,Q4 F 
3 Spurt 635 cm/s 2ml Right Pass 15.93 - Pass 40.77 - Pass 41.39 - F 
4 Spurt 635 cm/s 2ml Left Pass 15.3 - Pass 38.13 - Pass 24.49 - F 
1 Spray 500 cm/s 1ml Up Pass 12.61 - Pass 37.07 - Pass 46.77 - F 
2 Spray 500 cm/s 1ml Down Pass 6.76 - Pass 58.7 - Pass 71.9 - F 
3 Spray 500 cm/s 1ml Right Pass 4.23 - Pass 34.38 - Pass 36.35 - F 
4 Spray 500 cm/s 1ml Left Pass 9.56 - Pass 38.45 - Pass 33.21 - F 
1 Spurt 635 cm/s 2ml Up Fail 17.63 L Q3 Pass 30.25 - Pass 53.86 - F 
2 Spurt 635 cm/s 2ml Down Fail 11.82 L Q4 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 F 
3 Spurt 635 cm/s 2ml Right Pass 7.76 - Pass 38.54 - Pass 37.26 - F 
4 Spurt 635 cm/s 2ml Left Pass 22.34 - Pass 43.88 - Pass 37.5 - F 
1 Spray 500 cm/s 1ml Up Fail 6.2 R Q4 Pass 36.09 - Pass 40.81 - F 
2 Spray 500 cm/s 1ml Down Fail 5.33 L Q1 Pass 25.64 - Pass 45.86 - F 
3 Spray 500 cm/s 1ml Right Pass 12.57 - Pass 37.18 - Pass 41.04 - F 
4 Spray 500 cm/s 1ml Left Pass 10.11 - Pass 35.13 - Pass 40.21 - F 
1 Spurt 635 cm/s 2ml Up Fail 7.72 R Q1 Pass 40.72 - Pass 38.12 - F 
2 Spurt 635 cm/s 2ml Down Fail 5.556 L Q2 Fail Ran Thru Q3/Q4 Fail Ran Thru Q1,Q2,Q3,Q4 F 
3 Spurt 635 cm/s 2ml Right Pass 15.24 - Pass 42.88 - Pass 36.09 - F 
4 Spurt 635 cm/s 2ml Left Pass 18.13 - Pass 39.55 - Pass 30.38 - F 
1 Spray 500 cm/s 1ml Up Fail 6.62 R Q4 Pass 35.84 - Pass 38.45 - F 
2 Spray 500 cm/s 1ml Down Pass 1.17 - Pass 46.36 - Pass 70.52 - F 
3 Spray 500 cm/s 1ml Right Pass 12.43 - Pass 31.46 - Pass 36.19 - F 
4 Spray 500 cm/s 1ml Left Pass 13.87 - Pass 30.23 - Pass 38.69 - F 
1 Spurt 635 cm/s 2ml Up Fail 8.09 L Q3 Pass 32.49 - Pass 36.84 - F 
2 Spurt 635 cm/s 2ml Down Fail 9.87 L Q3 Pass On Line Q3 Fail Ran Thru Q2/Q3 F 
3 Spurt 635 cm/s 2ml Right Pass 18.31 - Pass 49.85 - Pass 44.58 - F 
4 Spurt 635 cm/s 2ml Left Pass 15.86 - Pass 38.31 - Pass 38.02 - F 
1 Spray 500 cm/s 1ml Up Pass 20.27 - Pass 34.4 - Pass 46.91 - F 
2 Spray 500 cm/s 1ml Down Pass 6.65 - Pass 59.76 - Pass 84.39 - F 
3 Spray 500 cm/s 1ml Right Pass 9.89 - Pass 35.37 - Pass 40.41 - F 
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4 Spray 500 cm/s 1ml Left Pass 7.47 - Pass 35.23 - Pass 45.89 - F 
1 Spurt 635 cm/s 2ml Up Pass 4.12 - Pass 45.41 - Pass 46.81 - F 
2 Spurt 635 cm/s 2ml Down Fail 23.71 R Q4 Fail Ran Thru Q3/Q4 Fail Ran Thru Q1,Q2,Q3,Q4 F 
3 Spurt 635 cm/s 2ml Right Pass 16.07 - Pass 33.95 - Pass 27.8 - F 
4 Spurt 635 cm/s 2ml Left Pass 9.84 - Pass 47.89 - Pass 44.61 - F 
1 Spray 500 cm/s 1ml Up Pass 19.54 - Pass 36.28 - Pass 42.97 - F 
2 Spray 500 cm/s 1ml Down Fail 20.11 L Q4 Pass 50.98 - Pass 64.69 - F 
3 Spray 500 cm/s 1ml Right Pass 7.28 - Pass 32.96 - Pass 39.58 - F 
4 Spray 500 cm/s 1ml Left Pass 9.25 - Pass 30.26 - Pass 41.54 - F 
1 Spurt 635 cm/s 2ml Up Fail 11.24 R Q2 Pass 44.15 - Pass 43.15 - F 
2 Spurt 635 cm/s 2ml Down Fail 24.12 R Q1 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 F 
3 Spurt 635 cm/s 2ml Right Pass 15.73 - Pass 42.74 - Pass 37.9 - F 
4 Spurt 635 cm/s 2ml Left Pass 23.56 - Pass 41.94 - Pass 36.49 - F 
1 Spray 500 cm/s 1ml Up Pass 17.36 - Pass 36.41 - Pass 47.48 - F 
2 Spray 500 cm/s 1ml Down Fail 23.86 L Q1 Pass 50.05 - Pass 61.06 - F 
3 Spray 500 cm/s 1ml Right Pass 5.21 - Pass 31.69 - Pass 33.95 - F 
4 Spray 500 cm/s 1ml Left Pass 8.63 - Pass 29.51 - Pass 34.12 - F 
1 Spurt 635 cm/s 2ml Up Fail 8.24 L Q3 Pass 44.26 - Pass 39.63 - F 
2 Spurt 635 cm/s 2ml Down Fail 7.63 R Q2 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 F 
3 Spurt 635 cm/s 2ml Right Pass 17.13 - Pass 46.31 - Pass 40.13 - F 
4 Spurt 635 cm/s 2ml Left Pass 12.35 - Pass 36.13 - Pass 23.49 - F 
1 Spray 500 cm/s 1ml Up Fail 13.25 R Q2 Pass 31.03 - Pass 38.47 - F 
2 Spray 500 cm/s 1ml Down Fail 15.97 R Q4 Pass 25.53 - Pass 48.67 - F 
3 Spray 500 cm/s 1ml Right Pass 13.99 - Pass 40.67 - Pass 45.9 - F 
4 Spray 500 cm/s 1ml Left Pass 12.46 - Pass 39.16 - Pass 43.15 - F 
1 Spurt 635 cm/s 2ml Up Pass 4.95 - Pass 47.86 - Pass 41.7 - F 
2 Spurt 635 cm/s 2ml Down Fail 9.05 R Q4 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 F 
3 Spurt 635 cm/s 2ml Right Pass 16.11 - Pass 41.17 - Pass 39.42 - F 
4 Spurt 635 cm/s 2ml Left Pass 19.23 - Pass 38.55 - Pass 31.48 - F 
1 Spray 500 cm/s 1ml Up Pass 10.9 - Pass 35.24 - Pass 48.03 - F 
2 Spray 500 cm/s 1ml Down Fail 24.49 R Q2 Pass 40.14 - Pass 61.25 - F 
3 Spray 500 cm/s 1ml Right Pass 10.17 - Pass 42.37 - Pass 45.78 - F 
4 Spray 500 cm/s 1ml Left Pass 11.98 - Pass 45.61 - Pass 44.78 - F 
1 Spurt 635 cm/s 2ml Up Fail 12.92 L Q4 Pass 43.64 - Pass 33.76 - F 
2 Spurt 635 cm/s 2ml Down Fail 17.35 L Q3 Fail Ran Thru Q3/Q4 Fail Ran Thru Q1,Q2,Q3,Q4 F 
3 Spurt 635 cm/s 2ml Right Pass 14.58 - Pass 39.44 - Pass 37.47 - F 
4 Spurt 635 cm/s 2ml Left Pass 16.73 - Pass 45.61 - Pass 41.24 - F 
1 Spray 500 cm/s 1ml Up Fail 13.98 L Q4 Pass 37.74 - Pass 46.99 - F 
2 Spray 500 cm/s 1ml Down Fail 23.93 L Q4 Pass 47.02 - Pass 59.95 - F 
3 Spray 500 cm/s 1ml Right Pass 14.72 - Pass 42.51 - Pass 45.64 - F 
4 Spray 500 cm/s 1ml Left Pass 12.23 - Pass 46.78 - Pass 47.26 - F 
1 Spurt 635 cm/s 2ml Up Fail 4.94 R Q4 Pass 40.7 - Pass 39.47 - F 
2 Spurt 635 cm/s 2ml Down Fail 24.64 L Q2 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 F 
3 Spurt 635 cm/s 2ml Right Pass 15.33 - Pass 41.49 - Pass 40.73 - F 
4 Spurt 635 cm/s 2ml Left Pass 8.74 - Pass 39.56 - Pass 36.62 - F 
1 Spray 500 cm/s 1ml Up Fail 14.3 R Q3 Pass 32.84 - Pass 42.2 - F 
2 Spray 500 cm/s 1ml Down Pass 5.76 - Pass 58.67 - Pass 71.1 - F 
3 Spray 500 cm/s 1ml Right Pass 19.43 - Pass 35.7 - Pass 43.15 - F 
4 Spray 500 cm/s 1ml Left Pass 10.56 - Pass 32.13 - Pass 36.84 - F 
1 Spurt 635 cm/s 2ml Up Fail 11.19 R Q4 Pass 1.09 - Fail Ran Thru Q1/Q4 G 
2 Spurt 635 cm/s 2ml Down Fail 19.22 R Q4 Fail Ran Thru Q2/Q3 Pass 5.46 - G 
3 Spurt 635 cm/s 2ml Right Pass 14.63 - Pass 42.94 - Pass 51.36 - G 
4 Spurt 635 cm/s 2ml Left Pass 23.12 - Pass 45.08 - Pass 50.02 - G 
1 Spray 500 cm/s 1ml Up Fail 10.86 R Q3 Pass 36.87 - Pass 53.33 - G 
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2 Spray 500 cm/s 1ml Down Pass 4.82 - Pass 31.63 - Pass 53.17 - G 
3 Spray 500 cm/s 1ml Right Fail 20.82 L Q4 Pass 40.63 - Pass 40.21 - G 
4 Spray 500 cm/s 1ml Left Fail 14.51 R Q3 Pass 35.46 - Pass 36.55 - G 
1 Spurt 635 cm/s 2ml Up Fail 3.34 L Q3 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 G 
2 Spurt 635 cm/s 2ml Down Fail 6.61 L Q3 Fail Ran Thru Q1/Q4 Pass 9.91 - G 
3 Spurt 635 cm/s 2ml Right Pass 18.42 - Pass 47.02 - Pass 46.85 - G 
4 Spurt 635 cm/s 2ml Left Pass 20 - Pass 47.16 - Pass 51.44 - G 
1 Spray 500 cm/s 1ml Up Fail 14.44 R Q4 Pass 41.42 - Pass 56.61 - G 
2 Spray 500 cm/s 1ml Down Fail 16.56 R Q2 Pass 37.56 - Pass 61.07 - G 
3 Spray 500 cm/s 1ml Right Fail 24.52 L Q1 Pass 35.81 - Pass 34.89 - G 
4 Spray 500 cm/s 1ml Left Fail 8.38 R Q3 Pass 28.35 - Pass 37.76 - G 
1 Spurt 635 cm/s 2ml Up Fail 1.07 L Q3 Pass 1.01 - Pass 34.6 - G 
2 Spurt 635 cm/s 2ml Down Fail 20.72 R Q2 Fail 5.33 Q2 Pass 25.32 - G 
3 Spurt 635 cm/s 2ml Right Pass 13.03 - Pass 45.28 - Pass 31.22 - G 
4 Spurt 635 cm/s 2ml Left Pass 26.96 - Pass 46.36 - Pass 57.62 - G 
1 Spray 500 cm/s 1ml Up Fail 3.12 L Q3 Pass 35.8 - Pass 55.39 - G 
2 Spray 500 cm/s 1ml Down Pass 3.68 - Pass 43.91 - Pass 64.05 - G 
3 Spray 500 cm/s 1ml Right Fail 15.98 L Q4 Pass 31.64 - Pass 34.42 - G 
4 Spray 500 cm/s 1ml Left Fail 14.52 R Q3 Pass 31.2 - Pass 41.15 - G 
1 Spurt 635 cm/s 2ml Up Fail 0.66 L Q4 Pass On Line Q1/Q2 Pass 27.6 - G 
2 Spurt 635 cm/s 2ml Down Fail 16.33 L Q2 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3 G 
3 Spurt 635 cm/s 2ml Right Pass 10.02 - Pass 48.2 - Pass 49.98 - G 
4 Spurt 635 cm/s 2ml Left Pass 13.5 - Pass 46.4 - Pass 41.96 - G 
1 Spray 500 cm/s 1ml Up Fail 1.49 L Q4 Pass 34.49 - Pass 51.35 - G 
2 Spray 500 cm/s 1ml Down Pass 3.06 - Pass 39.05 - Pass 58.56 - G 
3 Spray 500 cm/s 1ml Right Pass 0.081 - Pass 38.62 - Pass 38.83 - G 
4 Spray 500 cm/s 1ml Left Fail 16.27 R Q3 Pass 25.34 - Pass 37.13 - G 
1 Spurt 635 cm/s 2ml Up Fail 2.86 L Q3 Pass 1.54 - Pass 31.31 - G 
2 Spurt 635 cm/s 2ml Down Fail 11.64 L Q1 Fail 5.64 Q1 Pass 15.83 - G 
3 Spurt 635 cm/s 2ml Right Pass 12.06 - Pass 47.72 - Pass 39.25 - G 
4 Spurt 635 cm/s 2ml Left Pass 11.86 - Pass 49.92 - Pass 40.91 - G 
1 Spray 500 cm/s 1ml Up Fail 6.24 R Q4 Pass 31.12 - Pass 52.83 - G 
2 Spray 500 cm/s 1ml Down Pass 2.03 - Pass 41.03 - Pass 59.87 - G 
3 Spray 500 cm/s 1ml Right Fail 14.48 L Q4 Pass 29.76 - Pass 36.26 - G 
4 Spray 500 cm/s 1ml Left Fail 16.97 R Q3 Pass 34.72 - Pass 37.23 - G 
1 Spurt 635 cm/s 2ml Up Fail 1.29 R Q2 Pass 1.98 - Pass 23.31 - G 
2 Spurt 635 cm/s 2ml Down Fail 9.76 R Q1 Fail Ran Thru Q1/Q2/Q3 Pass 5.09 - G 
3 Spurt 635 cm/s 2ml Right Pass 14.32 - Pass 47.19 - Pass 34.46 - G 
4 Spurt 635 cm/s 2ml Left Pass 17.7 - Pass 49.4 - Pass 53.92 - G 
1 Spray 500 cm/s 1ml Up Fail 12.44 L Q4 Pass 35.25 - Pass 54.78 - G 
2 Spray 500 cm/s 1ml Down Fail 16.83 L Q4 Pass 31.06 - Pass 51.1 - G 
3 Spray 500 cm/s 1ml Right Fail 17.69 L Q4 Pass 35.38 - Pass 34.55 - G 
4 Spray 500 cm/s 1ml Left Fail 13.5 R Q3 Pass 31.27 - Pass 32.45 - G 
1 Spurt 635 cm/s 2ml Up Fail 3.86 L Q3 Pass 1.81 - Pass 27.45 - G 
2 Spurt 635 cm/s 2ml Down Fail 13.42 R Q4 Fail 6.94 Q2 Pass 24.37 - G 
3 Spurt 635 cm/s 2ml Right Pass 12.36 - Pass 43.69 - Pass 50.64 - G 
4 Spurt 635 cm/s 2ml Left Pass 22.12 - Pass 44.8 - Pass 49.48 - G 
1 Spray 500 cm/s 1ml Up Fail 5.44 R Q4 Pass 31.42 - Pass 51.9 - G 
2 Spray 500 cm/s 1ml Down Pass 3.01 - Pass 46.27 - Pass 65.81 - G 
3 Spray 500 cm/s 1ml Right Fail 14.61 L Q4 Pass 33.51 - Pass 32.78 - G 
4 Spray 500 cm/s 1ml Left Fail 16.01 R Q3 Pass 33.98 - Pass 31.47 - G 
1 Spurt 635 cm/s 2ml Up Fail 1.98 R Q2 Pass 0.55 - Pass 21.76 - G 
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2 Spurt 635 cm/s 2ml Down Fail 7.69 L Q3 Fail Ran Thru Q1/Q4 Fail Ran Thru Q1/Q4 G 
3 Spurt 635 cm/s 2ml Right Pass 11.2 - Pass 49.23 - Pass 47.68 - G 
4 Spurt 635 cm/s 2ml Left Pass 12.25 - Pass 45.62 - Pass 40.39 - G 
1 Spray 500 cm/s 1ml Up Fail 12.33 L Q3 Pass 33.09 - Pass 53.8 - G 
2 Spray 500 cm/s 1ml Down Fail 2.44 L Q4 Pass 18.6 - Pass 44.38 - G 
3 Spray 500 cm/s 1ml Right Fail 14.82 L Q4 Pass 33.4 - Pass 34.92 - G 
4 Spray 500 cm/s 1ml Left Fail 12.87 R Q3 Pass 28.91 - Pass 32.55 - G 
1 Spurt 635 cm/s 2ml Up Fail 0.77 R Q1 Fail Ran Thru Q1/Q4 Pass 14.2 - G 
2 Spurt 635 cm/s 2ml Down Fail 12.53 L Q3 Fail Ran Thru Q4 Fail Q1/Q2/Q3 - G 
3 Spurt 635 cm/s 2ml Right Pass 12.67 - Pass 54.45 - Pass 48.11 - G 
4 Spurt 635 cm/s 2ml Left Pass 15.86 - Pass 59.26 - Pass 44.98 - G 
1 Spray 500 cm/s 1ml Up Fail 9.68 R Q4 Pass 35.68 - Pass 51.23 - G 
2 Spray 500 cm/s 1ml Down Pass 3.11 - Pass 37.56 - Pass 55.41 - G 
3 Spray 500 cm/s 1ml Right Fail 14.52 L Q4 Pass 30.64 - Pass 38.56 - G 
4 Spray 500 cm/s 1ml Left Fail 15.69 R Q3 Pass 32.33 - Pass 40.21 - G 
1 Spurt 635 cm/s 2ml Up Fail 12.27 L Q2 Pass 2.36 - Pass 16.13 - G 
2 Spurt 635 cm/s 2ml Down Fail 4.27 R Q4 Fail 4.27 Q1 Pass 24.55 - G 
3 Spurt 635 cm/s 2ml Right Pass 10.72 - Pass 51.26 - Pass 45.62 - G 
4 Spurt 635 cm/s 2ml Left Pass 8.56 - Pass 47.26 ` Pass 41.23 - G 
1 Spray 500 cm/s 1ml Up Fail 11.22 L Q3 Pass 33.25 - Pass 50.36 - G 
2 Spray 500 cm/s 1ml Down Pass 2.75 - Pass 36.12 - Pass 49.51 - G 
3 Spray 500 cm/s 1ml Right Fail 12.23 L Q4 Pass 30.23 - Pass 33.26 - G 
4 Spray 500 cm/s 1ml Left Fail 14.78 R Q3 Pass 31.74 - Pass 34.51 - G 
1 Spurt 635 cm/s 2ml Up Fail 14.45 L Q3 Pass 3.01 - Pass 33.09 - H 
2 Spurt 635 cm/s 2ml Down Pass 0.91 - Pass 44.73 - Pass 66.37 - H 
3 Spurt 635 cm/s 2ml Right Pass 15.23 - Pass 45.38 - Pass 35.42 - H 
4 Spurt 635 cm/s 2ml Left Pass 16.48 - Pass 44.72 - Pass 33.64 - H 
1 Spray 500 cm/s 1ml Up Fail 7.03 L Q2 Pass 34.28 - Pass 58.75 - H 
2 Spray 500 cm/s 1ml Down Pass 5.78 - Pass 44.97 - Pass 76.8 - H 
3 Spray 500 cm/s 1ml Right Pass 9.54 - Pass 48.39 - Pass 33.47 - H 
4 Spray 500 cm/s 1ml Left Pass 10.62 - Pass 45.98 - Pass 29.17 - H 
1 Spurt 635 cm/s 2ml Up Pass 12.97 - Pass 2.95 - Pass 31.32 - H 
2 Spurt 635 cm/s 2ml Down Fail 17.76 R Q1 Pass 2.26 - Fail Ran Thru Q2/Q3 H 
3 Spurt 635 cm/s 2ml Right Pass 12.02 - Pass 45.52 - Pass 36.63 - H 
4 Spurt 635 cm/s 2ml Left Pass 15.22 - Pass 44.54 - Pass 39.52 - H 
1 Spray 500 cm/s 1ml Up Fail 4.55 R Q4 Pass 44.7 - Pass 67.76 - H 
2 Spray 500 cm/s 1ml Down Pass 6.53 - Pass 48.76 - Pass 69.43 - H 
3 Spray 500 cm/s 1ml Right Pass 13.96 - Pass 50.1 - Pass 32.81 - H 
4 Spray 500 cm/s 1ml Left Pass 10.52 - Pass 39.03 - Pass 21.28 - H 
1 Spurt 635 cm/s 2ml Up Fail 9.22 L Q2 Pass 6.8 - Pass 36.73 - H 
2 Spurt 635 cm/s 2ml Down Fail 4.53 R Q2 Pass 35.05 - Pass 59.81 - H 
3 Spurt 635 cm/s 2ml Right Pass 16.04 - Pass 53.63 - Pass 39.48 - H 
4 Spurt 635 cm/s 2ml Left Pass 15.27 - Pass 48.52 - Pass 38.39 - H 
1 Spray 500 cm/s 1ml Up Fail 15.26 L Q2 Pass 36.46 - Pass 60.74 - H 
2 Spray 500 cm/s 1ml Down Pass 7.01 - Pass 56.56 - Pass 82.25 - H 
3 Spray 500 cm/s 1ml Right Pass 15.48 - Pass 53.85 - Pass 40.23 - H 
4 Spray 500 cm/s 1ml Left Pass 6.76 - Pass 37.79 - Pass 22.29 - H 
1 Spurt 635 cm/s 2ml Up Pass 9.45 - Pass 7.26 - Pass 35.79 - H 
2 Spurt 635 cm/s 2ml Down Fail 13.88 R Q4 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3 H 
3 Spurt 635 cm/s 2ml Right Pass 8.82 - Pass 54.96 - Pass 41.88 - H 
4 Spurt 635 cm/s 2ml Left Pass 12.54 - Pass 52.49 - Pass 53.23 - H 
1 Spray 500 cm/s 1ml Up Fail 9.6 L Q2 Pass 39.85 - Pass 60.2 - H 
2 Spray 500 cm/s 1ml Down Pass 5.03 - Pass 47.3 - Pass 70.37 - H 
3 Spray 500 cm/s 1ml Right Pass 8.11 - Pass 50.64 - Pass 38.77 - H 
4 Spray 500 cm/s 1ml Left Pass 9.43 - Pass 39.72 - Pass 23.62 - H 
1 Spurt 635 cm/s 2ml Up Pass 4.5 - Pass 8.56 - Pass 36.59 - H 
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2 Spurt 635 cm/s 2ml Down Fail 2.45 L Q4 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 H 
3 Spurt 635 cm/s 2ml Right Pass 9.58 - Pass 50.23 - Pass 42.21 - H 
4 Spurt 635 cm/s 2ml Left Pass 11.21 - Pass 48.27 - Pass 40.54 - H 
1 Spray 500 cm/s 1ml Up Fail 5.96 R Q3 Pass 31.24 - Pass 56.15 - H 
2 Spray 500 cm/s 1ml Down Pass 6.04 - Pass 56.17 - Pass 79.7 - H 
3 Spray 500 cm/s 1ml Right Pass 10.13 - Pass 45.19 - Pass 31.1 - H 
4 Spray 500 cm/s 1ml Left Pass 8.69 - Pass 38.56 - Pass 23.37 - H 
1 Spurt 635 cm/s 2ml Up Fail 14.71 R Q1 Pass 45.65 - Pass 67.83 - H 
2 Spurt 635 cm/s 2ml Down Fail 15.25 L Q4 Fail Ran Thru Q1/Q4 Fail Q2/Q3 
 
H 
3 Spurt 635 cm/s 2ml Right Pass 11.37 - Pass 54.36 - Pass 42.61 - H 
4 Spurt 635 cm/s 2ml Left Pass 7.25 - Pass 47.46 - Pass 44 - H 
1 Spray 500 cm/s 1ml Up Fail 7.91 L Q2 Pass 33.38 - Pass 56.97 - H 
2 Spray 500 cm/s 1ml Down Pass 5.13 - Pass 41.79 - Pass 60.91 - H 
3 Spray 500 cm/s 1ml Right Pass 14.39 - Pass 51.03 - Pass 38.56 - H 
4 Spray 500 cm/s 1ml Left Pass 5.64 - Pass 34.34 - Pass 27.18 - H 
1 Spurt 635 cm/s 2ml Up Fail 5.31 R Q1 Pass 2.54 - Pass 31.72 - H 
2 Spurt 635 cm/s 2ml Down Fail 11.13 L Q4 Fail Ran Thru Q1/Q4 Fail Ran Thru Q1/Q4 H 
3 Spurt 635 cm/s 2ml Right Pass 5.16 - Pass 47.14 - Pass 41.13 - H 
4 Spurt 635 cm/s 2ml Left Pass 20.58 - Pass 48.24 - Pass 46.94 - H 
1 Spray 500 cm/s 1ml Up Fail 8.45 L Q4 Pass 28.69 - Pass 58.5 - H 
2 Spray 500 cm/s 1ml Down Pass 5.27 - Pass 51.83 - Pass 73.93 - H 
3 Spray 500 cm/s 1ml Right Pass 14.09 - Pass 39.21 - Pass 31.52 - H 
4 Spray 500 cm/s 1ml Left Pass 2.59 - Pass 45.4 - Pass 31.47 - H 
1 Spurt 635 cm/s 2ml Up Pass 8.66 - Pass 3.26 - Pass 30.19 - H 
2 Spurt 635 cm/s 2ml Down Pass 1.91 - Fail Ran Thu Q1/Q4 Pass 11.18 - H 
3 Spurt 635 cm/s 2ml Right Pass 19.47 - Pass 35.23 - Pass 48.92 - H 
4 Spurt 635 cm/s 2ml Left Pass 19.83 - Pass 47.48 - Pass 44.59 - H 
1 Spray 500 cm/s 1ml Up Pass 6.37 - Pass 45.27 - Pass 66.03 - H 
2 Spray 500 cm/s 1ml Down Pass 9.45 - Pass 52.21 - Pass 72.05 - H 
3 Spray 500 cm/s 1ml Right Pass 8.38 - Pass 50.64 - Pass 37.85 - H 
4 Spray 500 cm/s 1ml Left Pass 11.21 - Pass 41.63 - Pass 23.52 - H 
1 Spurt 635 cm/s 2ml Up Fail 12.75 L Q2 Pass 65.63 - Pass 97.7 - H 
2 Spurt 635 cm/s 2ml Down Fail 14.32 L Q2 Fail Ran Thru Q1/Q4 Fail Ran Thur Q1/Q4 H 
3 Spurt 635 cm/s 2ml Right Pass 12.46 - Pass 58.46 - Pass 25.91 - H 
4 Spurt 635 cm/s 2ml Left Pass 8.26 - Pass 43.69 - Pass 49.38 - H 
1 Spray 500 cm/s 1ml Up Fail 14.95 R Q1 Pass 50.2 - Pass 69.44 - H 
2 Spray 500 cm/s 1ml Down Pass 6.68 - Pass 57.64 - Pass 79.43 - H 
3 Spray 500 cm/s 1ml Right Pass 8.42 - Pass 51.94 - Pass 40.3 - H 
4 Spray 500 cm/s 1ml Left Pass 7.78 - Pass 35.42 - Pass 32.84 - H 
1 Spurt 635 cm/s 2ml Up Fail 15.23 L Q2 Pass 8 - Pass 35.94 - H 
2 Spurt 635 cm/s 2ml Down Fail 21.6 R Q4 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3 H 
3 Spurt 635 cm/s 2ml Right Pass 13.52 - Pass 54.63 - Pass 29.24 - H 
4 Spurt 635 cm/s 2ml Left Pass 5.26 - Pass 48.59 - Pass 45.01 - H 
1 Spray 500 cm/s 1ml Up Fail 2.28 L Q2 Pass 37.93 - Pass 63.29 - H 
2 Spray 500 cm/s 1ml Down Pass 6.93 - Pass 59.09 - Pass 82.28 - H 
3 Spray 500 cm/s 1ml Right Pass 11.11 - Pass 50.26 - Pass 38.37 - H 
4 Spray 500 cm/s 1ml Left Pass 7.67 - Pass 44.9 - Pass 29.96 - H 
1 Spurt 635 cm/s 2ml Up Fail 19.02 L Q4 Pass 39.57 - Pass 61.21 - I 
2 Spurt 635 cm/s 2ml Down Fail 19.51 R Q4 Pass 2.75 - Pass 3.26 - I 
3 Spurt 635 cm/s 2ml Right Pass 19.59 - Pass 39.55 - Pass 29.07 - I 
4 Spurt 635 cm/s 2ml Left Pass 15.69 - Pass 56.74 - Pass 31.52 - I 
1 Spray 500 cm/s 1ml Up Fail 6.91 L Q1 Pass 31.2 - Pass 61.46 - I 
2 Spray 500 cm/s 1ml Down Pass 3.84 - Pass 34.74 - Pass 59.91 - I 
3 Spray 500 cm/s 1ml Right Fail 18.24 L Q4 Pass 33.98 - Pass 49.41 - I 
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4 Spray 500 cm/s 1ml Left Pass 1.43 - Pass 35.38 - Pass 39.97 - I 
1 Spurt 635 cm/s 2ml Up Fail 11.95 L Q1 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 I 
2 Spurt 635 cm/s 2ml Down Fail 14.73 R Q4 Pass 2.15 - Pass 4.67 - I 
3 Spurt 635 cm/s 2ml Right Pass 13.27 - Pass 40.46 - Pass 30.6 - I 
4 Spurt 635 cm/s 2ml Left Pass 18.37 - Pass 51.49 - Pass 49.08 - I 
1 Spray 500 cm/s 1ml Up Fail 5.67 L Q4 Pass 32.77 - Pass 62.06 - I 
2 Spray 500 cm/s 1ml Down Pass 3.33 - Pass 34.73 - Pass 57.07 - I 
3 Spray 500 cm/s 1ml Right Pass 2.95 - Pass 34.3 - Pass 45.09 - I 
4 Spray 500 cm/s 1ml Left Pass 2.95 - Pass 34.38 - Pass 34.93 - I 
1 Spurt 635 cm/s 2ml Up Fail 15.61 R Q1 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3 I 
2 Spurt 635 cm/s 2ml Down Fail 11.37 L q3 Fail Ran Thru Q4 Fail Ran Thru Q2/Q3 I 
3 Spurt 635 cm/s 2ml Right Pass 14.02 - Pass 48.97 - Pass 25.89 - I 
4 Spurt 635 cm/s 2ml Left Pass 14.14 - Pass 47.12 - Pass 37.21 - I 
1 Spray 500 cm/s 1ml Up Fail 3.24 R Q4 Pass 37.89 - Pass 57.56 - I 
2 Spray 500 cm/s 1ml Down Pass 4.59 - Pass 33.83 - Pass 58.71 - I 
3 Spray 500 cm/s 1ml Right Fail 22.98 L Q4 Pass 42.81 - Pass 40.65 - I 
4 Spray 500 cm/s 1ml Left Fail 21.36 R Q3 Pass 34.76 - Pass 40.95 - I 
1 Spurt 635 cm/s 2ml Up Fail 19.77 L Q2 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 I 
2 Spurt 635 cm/s 2ml Down Fail 16.47 R Q3 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3 I 
3 Spurt 635 cm/s 2ml Right Pass 12.98 - Pass 41.46 - Pass 45.08 - I 
4 Spurt 635 cm/s 2ml Left Pass 24.78 - Pass 41.12 - Pass 37.58 - I 
1 Spray 500 cm/s 1ml Up Fail 17.02 R Q1 Pass 33.66 - Pass 54.69 - I 
2 Spray 500 cm/s 1ml Down Pass 4.02 - Pass 37.21 - Pass 62.57 - I 
3 Spray 500 cm/s 1ml Right Pass 2.33 - Pass 34.49 - Pass 30.21 - I 
4 Spray 500 cm/s 1ml Left Pass 2.51 - Pass 35.38 - Pass 44.6 - I 
1 Spurt 635 cm/s 2ml Up Fail 15.34 R Q4 Fail Ran Thru Q1 Fail Ran Thru Q1/Q4 I 
2 Spurt 635 cm/s 2ml Down Fail 15.71 R Q4 Fail Ran Thru Q3/Q4 Fail Ran Thru Q2/Q3 I 
3 Spurt 635 cm/s 2ml Right Pass 11.97 - Pass 49.09 - Pass 38.49 - I 
4 Spurt 635 cm/s 2ml Left Pass 15.9 - Pass 50.52 - Pass 37.47 - I 
1 Spray 500 cm/s 1ml Up Fail 18.46 R Q4 Pass 38.47 - Pass 59.52 - I 
2 Spray 500 cm/s 1ml Down Pass 2.25 - Pass 31.69 - Pass 55.65 - I 
3 Spray 500 cm/s 1ml Right Pass 7.55 - Pass 50.37 - Pass 44.24 - I 
4 Spray 500 cm/s 1ml Left Pass 2.74 - Pass 38.57 - Pass 42.01 - I 
1 Spurt 635 cm/s 2ml Up Fail 17.39 L Q3 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3 I 
2 Spurt 635 cm/s 2ml Down Fail 7.09 R Q4 Fail Ran Thru Q3 Fail Ran Thru Q1/Q4 I 
3 Spurt 635 cm/s 2ml Right Pass 22.25 - Pass 40.72 - Pass 26.62 - I 
4 Spurt 635 cm/s 2ml Left Pass 18.56 - Pass 34.12 - Pass 31.56 - I 
1 Spray 500 cm/s 1ml Up Fail 3.35 R Q4 Pass 38.66 - Pass 59.47 - I 
2 Spray 500 cm/s 1ml Down Pass 1.88 - Pass 33.68 - Pass 55.43 - I 
3 Spray 500 cm/s 1ml Right Pass 3.21 - Pass 36.45 - Pass 49.12 - I 
4 Spray 500 cm/s 1ml Left Pass 2.74 - Pass 40.23 - Pass 51.02 - I 
1 Spurt 635 cm/s 2ml Up Fail 16.03 R Q4 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 I 
2 Spurt 635 cm/s 2ml Down Fail 8.64 L Q3 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 I 
3 Spurt 635 cm/s 2ml Right Pass 16.1 - Pass 55.16 - Pass 41.28 - I 
4 Spurt 635 cm/s 2ml Left Pass 12.31 - Pass 51.26 - Pass 35.78 - I 
1 Spray 500 cm/s 1ml Up Fail 9.24 L Q4 Pass 34.68 - Pass 55.26 - I 
2 Spray 500 cm/s 1ml Down Pass 0.68 - Pass 30.48 - Pass 51.03 - I 
3 Spray 500 cm/s 1ml Right Pass 1.56 - Pass 31.21 - Pass 48.75 - I 
4 Spray 500 cm/s 1ml Left Fail 19.23 R Q3 Pass 33.61 - Pass 47.89 - I 
1 Spurt 635 cm/s 2ml Up Fail 5.23 L Q3 Pass 3.42 - Fail Ran Thru Q1/Q4 I 
2 Spurt 635 cm/s 2ml Down Fail 14.69 L Q4 Pass 2.51 - Pass 1.54 - I 
3 Spurt 635 cm/s 2ml Right Pass 20.19 - Pass 37.45 - Pass 29.7 - I 
4 Spurt 635 cm/s 2ml Left Pass 16.87 - Pass 52.36 - Pass 31.25 - I 
1 Spray 500 cm/s 1ml Up Fail 20.48 R Q1 Pass 36.43 - Pass 56.96 - I 
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2 Spray 500 cm/s 1ml Down Pass 1.45 - Pass 36.47 - Pass 57.05 - I 
3 Spray 500 cm/s 1ml Right Pass 3.65 - Pass 35.26 - Pass 54.23 - I 
4 Spray 500 cm/s 1ml Left Pass 3.12 - Pass 33.59 - Pass 51.24 - I 
1 Spurt 635 cm/s 2ml Up Fail 14.25 R Q4 Fail Ran Thru Q2/Q3 Fail Ran Thru Q2/Q3 I 
2 Spurt 635 cm/s 2ml Down Fail 12.1 L Q3 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 I 
3 Spurt 635 cm/s 2ml Right Pass 12.27 - Pass 41.64 - Pass 31.06 - I 
4 Spurt 635 cm/s 2ml Left Pass 17.48 - Pass 50.49 - Pass 49.28 - I 
1 Spray 500 cm/s 1ml Up Fail 22.31 L Q1 Pass 38.04 - Pass 61.37 - I 
2 Spray 500 cm/s 1ml Down Pass 1.72 - Pass 26.83 - Pass 52.74 - I 
3 Spray 500 cm/s 1ml Right Fail 20.26 L Q4 Pass 19.54 - Pass 48.51 - I 
4 Spray 500 cm/s 1ml Left Fail 17.54 R Q3 Pass 29.65 - Pass 49.21 - I 
1 Spurt 635 cm/s 2ml Up Fail 12.01 L Q2 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 I 
2 Spurt 635 cm/s 2ml Down Fail 13.4 L Q3 Fail Ran Thru Q1/Q2/Q3/Q4 Fail Ran Thru Q1/Q2/Q3/Q4 I 
3 Spurt 635 cm/s 2ml Right Pass 12.28 - Pass 41.46 - Pass 46.08 - I 
4 Spurt 635 cm/s 2ml Left Pass 18.32 - Pass 40.21 - Pass 35.48 - I 
1 Spray 500 cm/s 1ml Up Fail 8.69 L Q4 Pass 35.98 - Pass 55.53 - I 
2 Spray 500 cm/s 1ml Down Pass 3.34 - Pass 34.11 - Pass 55.11 - I 
3 Spray 500 cm/s 1ml Right Pass 4.51 - Pass 33.67 - Pass 48.56 - I 
4 Spray 500 cm/s 1ml Left Pass 1.98 - Pass 30.48 - Pass 45.22 - I 
1 Spurt 635 cm/s 2ml Up Fail 6 L Q2 Pass 3.56 - Pass 6.46 - J 
2 Spurt 635 cm/s 2ml Down Fail 7.5 R Q4 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 J 
3 Spurt 635 cm/s 2ml Right Pass 15.5 - Pass 38.56 - Pass 32.35 - J 
4 Spurt 635 cm/s 2ml Left Pass 26.08 - Pass 59.23 - Pass 57.84 - J 
1 Spray 500 cm/s 1ml Up Fail 14.62 L Q4 Pass 36.3 - Pass 47.6 - J 
2 Spray 500 cm/s 1ml Down Fail 2.52 L Q4 Pass 34.24 - Pass 51.02 - J 
3 Spray 500 cm/s 1ml Right Fail 15.24 L Q1 Pass 36.64 - Pass 36.33 - J 
4 Spray 500 cm/s 1ml Left Fail 16.31 R Q3 Pass 27.33 - Pass 34.13 - J 
1 Spurt 635 cm/s 2ml Up Fail 9 L Q1 Pass 2.75 - Pass 3.25 - J 
2 Spurt 635 cm/s 2ml Down Fail 16.5 L Q1 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 J 
3 Spurt 635 cm/s 2ml Right Pass 23.75 - Pass 45.49 - Pass 35.38 - J 
4 Spurt 635 cm/s 2ml Left Pass 25.89 - Pass 60.82 - Pass 61.41 - J 
1 Spray 500 cm/s 1ml Up Fail 4.22 R Q3 Pass 38.09 - Pass 53.89 - J 
2 Spray 500 cm/s 1ml Down Fail 0.5 L Q2 Pass 19.79 - Pass 41.87 - J 
3 Spray 500 cm/s 1ml Right Pass 4.33 - Pass 35.07 - Pass 38.34 - J 
4 Spray 500 cm/s 1ml Left Fail 22.34 R Q2 Pass 38.56 - Pass 30.8 - J 
1 Spurt 635 cm/s 2ml Up Fail 4.29 R Q4 Pass 56.47 - Pass 33.78 - J 
2 Spurt 635 cm/s 2ml Down Fail 24 L Q1 Fail Ran Thru Q4 Fail Ran Thru Q1/Q4 J 
3 Spurt 635 cm/s 2ml Right Pass 14.56 - Pass 36.32 - Pass 28.89 - J 
4 Spurt 635 cm/s 2ml Left Pass 23.6 - Pass 55.45 - Pass 47.65 - J 
1 Spray 500 cm/s 1ml Up Fail 11 R Q3 Pass 37.5 - Pass 58.74 - J 
2 Spray 500 cm/s 1ml Down Fail 0.25 L Q1 Pass 18.68 - Pass 48.08 - J 
3 Spray 500 cm/s 1ml Right Fail 17.03 L Q1 Pass 36.27 - Pass 36.54 - J 
4 Spray 500 cm/s 1ml Left Fail 22.86 R Q2 Pass 31.07 - Pass 33.62 - J 
1 Spurt 635 cm/s 2ml Up Fail 7.5 R Q4 Pass 27.94 - Pass 31.53 - J 
2 Spurt 635 cm/s 2ml Down Fail 22.75 R Q4 Fail ran thru Q3 Fail ran thru Q2/Q3 J 
3 Spurt 635 cm/s 2ml Right Pass 23.06 - Pass 44.93 - Pass 32.87 - J 
4 Spurt 635 cm/s 2ml Left Pass 22.22 - Pass 52.83 - Pass 50.12 - J 
1 Spray 500 cm/s 1ml Up Fail 8 L Q1 Pass 28.54 - Pass 48.77 - J 
2 Spray 500 cm/s 1ml Down Fail 0.46 R Q4 Pass 13.25 - Pass 39.48 - J 
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3 Spray 500 cm/s 1ml Right Fail 16.43 L Q1 Pass 36.63 - Pass 37.25 - J 
4 Spray 500 cm/s 1ml Left Fail 24.79 R Q1 Pass 26.47 - Pass 31.12 - J 
1 Spurt 635 cm/s 2ml Up Fail 2.43 R Q1 Pass 19.87 - Pass 34.84 - J 
2 Spurt 635 cm/s 2ml Down Fail 16.46 L Q3 Fail ran thur Q4 Fail ran thru Q1/Q4 J 
3 Spurt 635 cm/s 2ml Right Pass 22 - Pass 52.37 - Pass 45.67 - J 
4 Spurt 635 cm/s 2ml Left Pass 18.17 - Pass 56.51 - Pass 47.2 - J 
1 Spray 500 cm/s 1ml Up Fail 0.33 L Q1 Pass 14.53 - Pass 41.42 - J 
2 Spray 500 cm/s 1ml Down Fail 14.78 R Q3 Pass 30.88 - Pass 45.58 - J 
3 Spray 500 cm/s 1ml Right Fail 23 L Q4 Pass 38.92 - Pass 37.04 - J 
4 Spray 500 cm/s 1ml Left Fail 15.64 R Q3 Pass 22.79 - Pass 33.78 - J 
1 Spurt 635 cm/s 2ml Up Fail 2.58 L Q1 Pass 2 - Fail ran thru Q1/Q4 J 
2 Spurt 635 cm/s 2ml Down Fail 3.28 L Q1 fail ran thru Q3 Fail ran thru Q2/Q3 J 
3 Spurt 635 cm/s 2ml Right Pass 25.14 - Pass 52.47 - Pass 44.56 - J 
4 Spurt 635 cm/s 2ml Left Pass 14.4 - Pass 52.74 - Pass 41.31 - J 
1 Spray 500 cm/s 1ml Up Fail 5.23 R Q2 Pass 37.05 - Pass 49.48 - J 
2 Spray 500 cm/s 1ml Down Fail 1.2 R Q4 Pass 7.45 - Pass 29.2 - J 
3 Spray 500 cm/s 1ml Right Pass 3.4 - Pass 29.02 - Pass 31.11 - J 
4 Spray 500 cm/s 1ml Left Fail 23.3 R Q3 Pass 34.97 - Pass 36.01 - J 
1 Spurt 635 cm/s 2ml Up Fail 1.33 L Q2 Pass 3.64 - Fail ran thru Q1/Q4 J 
2 Spurt 635 cm/s 2ml Down Fail 11.13 L Q2 Fail ran thru Q4 Fail ran thru Q1/Q4 J 
3 Spurt 635 cm/s 2ml Right Pass 19.76 - Pass 58.07 - Pass 43.47 - J 
4 Spurt 635 cm/s 2ml Left Pass 24.46 - Pass 36.96 - Pass 53.26 - J 
1 Spray 500 cm/s 1ml Up Fail 10.18 R Q3 Pass 33.65 - Pass 50.99 - J 
2 Spray 500 cm/s 1ml Down Fail 1.87 L Q3 Pass 22.02 - Pass 43.96 - J 
3 Spray 500 cm/s 1ml Right Fail 24.31 L Q4 Pass 29.85 - Pass 35.19 - J 
4 Spray 500 cm/s 1ml Left Fail 16.88 R Q1 Pass 27.88 - Pass 33.92 - J 
1 Spurt 635 cm/s 2ml Up Fail 11.18 R Q1 Pass 14 - Pass 28.71 - J 
2 Spurt 635 cm/s 2ml Down Fail 17.6 L Q2 Fail Ran Thru Q4 Fail ran thru Q1/Q4 J 
3 Spurt 635 cm/s 2ml Right Pass 19.01 - Pass 45.56 - Pass 28.09 - J 
4 Spurt 635 cm/s 2ml Left Pass 25.78 - Pass 40.53 - Pass 26.34 - J 
1 Spray 500 cm/s 1ml Up Fail 17.81 L Q1 Pass 40.36 - Pass 50.81 - J 
2 Spray 500 cm/s 1ml Down Fail 0.91 R Q3 Pass 28.74 - Pass 45.82 - J 
3 Spray 500 cm/s 1ml Right Fail 1.15 L Q4 Pass 36.45 - Pass 39.24 - J 
4 Spray 500 cm/s 1ml Left Fail 18.52 R Q4 Pass 34.37 - Pass 35.36 - J 
1 Spurt 635 cm/s 2ml Up Fail 10.32 L Q2 Pass 20.29 - Pass 39.87 - J 
2 Spurt 635 cm/s 2ml Down Fail 2.87 L Q2 Fail Ran Thru Q3 Fail Ran thru Q2/Q3 J 
3 Spurt 635 cm/s 2ml Right Pass 15.11 - Pass 41.9 - Pass 29.02 - J 
4 Spurt 635 cm/s 2ml Left Pass 17.09 - Pass 40.01 - Pass 30.7 - J 
1 Spray 500 cm/s 1ml Up Fail 17.18 R Q2 Pass 37.69 - Pass 50.84 - J 
2 Spray 500 cm/s 1ml Down Fail 1.17 R Q3 Pass 17.06 - Pass 46.92 - J 
3 Spray 500 cm/s 1ml Right Fail 21.25 L Q3 Pass 33.45 - Pass 35.28 - J 
4 Spray 500 cm/s 1ml Left Fail 7.08 R Q4 Pass 30.36 - Pass 34.24 - J 
1 Spurt 635 cm/s 2ml Up Fail 4.47 L Q2 Fail Ran Thru Q3 Fail Ran Thru Q2/Q3 J 
2 Spurt 635 cm/s 2ml Down Fail 12.59 L Q3 Pass 1.75 - Fail Ran Thru Q1/Q4 J 
3 Spurt 635 cm/s 2ml Right Pass 14.41 - Pass 42.83 - Pass 33.39 - J 
4 Spurt 635 cm/s 2ml Left Pass 14.52 - Pass 43.08 - Pass 32.25 - J 
1 Spray 500 cm/s 1ml Up Fail 21.51 L Q1 Pass 29.13 - Pass 49.26 - J 
2 Spray 500 cm/s 1ml Down Fail 3.2 L Q1 Pass 22.95 - Pass 44.24 - J 
3 Spray 500 cm/s 1ml Right Fail 19.02 L Q4 Pass 34.32 - Pass 37.47 - J 
4 Spray 500 cm/s 1ml Left Fail 15.93 R Q2 Pass 25.72 - Pass 33.1 - J 
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The SAS System 
 
The LOGISTIC Procedure 
Model Information 
Data Set WORK.A 
Response Variable eyespf 
Number of Response Levels 2 
Model binary logit 
Optimization Technique Fisher's scoring 
 
Number of Observations Read 800 
Number of Observations Used 800 
 
Response Profile 
Ordered 
Value 
eyespf Total 
Frequency 
1 0 563 
2 1 237 
 
Probability modeled is eyespf=0. 
 
Class Level Information 
Class Value Design Variables 
position1 1 1 0 0             
  2 0 1 0             
  3 0 0 1             
  4 -1 -1 -1             
type1 Spray 1                 
  Spurt -1                 
Ensemble A 1 0 0 0 0 0 0 0 0 
  B 0 1 0 0 0 0 0 0 0 
  C 0 0 1 0 0 0 0 0 0 
  D 0 0 0 1 0 0 0 0 0 
  E 0 0 0 0 1 0 0 0 0 
  F 0 0 0 0 0 1 0 0 0 
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Class Level Information 
Class Value Design Variables 
  G 0 0 0 0 0 0 1 0 0 
  H 0 0 0 0 0 0 0 1 0 
  I 0 0 0 0 0 0 0 0 1 
  J -1 -1 -1 -1 -1 -1 -1 -1 -1 
 
Model Convergence Status 
Quasi-complete separation of data points detected. 
 
Warning: The maximum likelihood estimate may not exist. 
 
Warning: The LOGISTIC procedure continues in spite of the above warning. Results shown are based 
on the last maximum likelihood iteration. Validity of the model fit is questionable. 
Model Fit Statistics 
Criterion Intercept Only Intercept and 
Covariates 
AIC 974.245 524.657 
SC 978.930 590.241 
-2 Log L 972.245 496.657 
 
Testing Global Null Hypothesis: BETA=0 
Test Chi-Square DF Pr > ChiSq 
Likelihood Ratio 475.5886 13 <.0001 
Score 361.8529 13 <.0001 
Wald 157.3174 13 <.0001 
 
Type 3 Analysis of Effects 
Effect DF Wald 
Chi-Square 
Pr > ChiSq 
position1 3 122.5091 <.0001 
type1 1 0.3130 0.5758 
Ensemble 9 128.1231 <.0001 
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Analysis of Maximum Likelihood Estimates 
Parameter   DF Estimate Standard 
Error 
Wald 
Chi-Square 
Pr > ChiSq 
Intercept   1 3.0071 21.7286 0.0192 0.8899 
position1 1 1 -2.1815 0.2230 95.7103 <.0001 
position1 2 1 -1.3424 0.2066 42.2004 <.0001 
position1 3 1 1.8694 0.2547 53.8631 <.0001 
type1 Spray 1 0.0627 0.1120 0.3130 0.5758 
Ensemble A 1 -0.0517 21.7311 0.0000 0.9981 
Ensemble B 1 0.2385 21.7315 0.0001 0.9912 
Ensemble C 1 13.3205 195.6 0.0046 0.9457 
Ensemble D 1 -1.3241 21.7302 0.0037 0.9514 
Ensemble E 1 2.5303 21.7476 0.0135 0.9074 
Ensemble F 1 -1.7854 21.7302 0.0068 0.9345 
Ensemble G 1 -4.1692 21.7309 0.0368 0.8479 
Ensemble H 1 -1.4167 21.7302 0.0043 0.9480 
Ensemble I 1 -2.6410 21.7303 0.0148 0.9033 
 
Odds Ratio Estimates 
Effect Point Estimate 95% Wald 
Confidence Limits 
position1 1 vs 4 0.022 0.010 0.048 
position1 2 vs 4 0.050 0.023 0.106 
position1 3 vs 4 1.240 0.590 2.606 
type1 Spray vs Spurt 1.134 0.731 1.758 
Ensemble A vs J 104.534 35.706 306.037 
Ensemble B vs J 139.734 45.680 427.444 
Ensemble C vs J >999.999 <0.001 >999.999 
Ensemble D vs J 29.287 11.091 77.334 
Ensemble E vs J >999.999 161.369 >999.999 
Ensemble F vs J 18.464 7.135 47.783 
Ensemble G vs J 1.702 0.743 3.901 
Ensemble H vs J 26.695 10.153 70.188 
183  
Odds Ratio Estimates 
Effect Point Estimate 95% Wald 
Confidence Limits 
Ensemble I vs J 7.848 3.164 19.462 
 
Association of Predicted Probabilities and 
Observed Responses 
Percent Concordant 92.3 Somers' D 0.848 
Percent Discordant 7.5 Gamma 0.850 
Percent Tied 0.2 Tau-a 0.354 
Pairs 133431 c 0.924 
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The SAS System 
 
The LOGISTIC Procedure 
Model Information 
Data Set WORK.A 
Response Variable nosepf 
Number of Response Levels 2 
Model binary logit 
Optimization Technique Fisher's scoring 
 
Number of Observations Read 800 
Number of Observations Used 800 
 
Response Profile 
Ordered 
Value 
nosepf Total 
Frequency 
1 0 737 
2 1 63 
 
Probability modeled is nosepf=0. 
 
Class Level Information 
Class Value Design Variables 
position1 1 1 0 0             
  2 0 1 0             
  3 0 0 1             
  4 -1 -1 -1             
type1 Spray 1                 
  Spurt -1                 
Ensemble A 1 0 0 0 0 0 0 0 0 
  B 0 1 0 0 0 0 0 0 0 
  C 0 0 1 0 0 0 0 0 0 
  D 0 0 0 1 0 0 0 0 0 
  E 0 0 0 0 1 0 0 0 0 
  F 0 0 0 0 0 1 0 0 0 
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Class Level Information 
Class Value Design Variables 
  G 0 0 0 0 0 0 1 0 0 
  H 0 0 0 0 0 0 0 1 0 
  I 0 0 0 0 0 0 0 0 1 
  J -1 -1 -1 -1 -1 -1 -1 -1 -1 
 
Model Convergence Status 
Quasi-complete separation of data points detected. 
 
Warning: The maximum likelihood estimate may not exist. 
 
Warning: The LOGISTIC procedure continues in spite of the above warning. Results shown are based 
on the last maximum likelihood iteration. Validity of the model fit is questionable. 
Model Fit Statistics 
Criterion Intercept Only Intercept and 
Covariates 
AIC 443.129 133.337 
SC 447.814 198.922 
-2 Log L 441.129 105.337 
 
Testing Global Null Hypothesis: BETA=0 
Test Chi-Square DF Pr > ChiSq 
Likelihood Ratio 335.7918 13 <.0001 
Score 241.2354 13 <.0001 
Wald 41.0603 13 <.0001 
 
Type 3 Analysis of Effects 
Effect DF Wald 
Chi-Square 
Pr > ChiSq 
position1 3 36.6243 <.0001 
type1 1 0.0203 0.8868 
Ensemble 9 23.4097 0.0053 
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Analysis of Maximum Likelihood Estimates 
Parameter   DF Estimate Standard 
Error 
Wald 
Chi-Square 
Pr > ChiSq 
Intercept   1 20.6033 96.9257 0.0452 0.8317 
position1 1 1 -5.6956 64.6752 0.0078 0.9298 
position1 2 1 -9.5151 64.6761 0.0216 0.8830 
position1 3 1 7.6053 144.6 0.0028 0.9581 
type1 Spray 1 8.0958 56.8641 0.0203 0.8868 
Ensemble A 1 -4.0433 44.4794 0.0083 0.9276 
Ensemble B 1 10.4283 233.9 0.0020 0.9644 
Ensemble C 1 10.4283 233.9 0.0020 0.9644 
Ensemble D 1 -1.5728 44.4816 0.0013 0.9718 
Ensemble E 1 10.4283 233.9 0.0020 0.9644 
Ensemble F 1 -4.4617 44.4796 0.0101 0.9201 
Ensemble G 1 -5.7610 44.4803 0.0168 0.8969 
Ensemble H 1 -3.6525 44.4792 0.0067 0.9346 
Ensemble I 1 -6.8914 44.4808 0.0240 0.8769 
 
Odds Ratio Estimates 
Effect Point Estimate 95% Wald 
Confidence Limits 
position1 1 vs 4 <0.001 <0.001 >999.999 
position1 2 vs 4 <0.001 <0.001 >999.999 
position1 3 vs 4 1.000 <0.001 >999.999 
type1 Spray vs Spurt >999.999 <0.001 >999.999 
Ensemble A vs J 2.360 0.376 14.830 
Ensemble B vs J >999.999 <0.001 >999.999 
Ensemble C vs J >999.999 <0.001 >999.999 
Ensemble D vs J 27.921 3.415 228.254 
Ensemble E vs J >999.999 <0.001 >999.999 
Ensemble F vs J 1.553 0.245 9.836 
Ensemble G vs J 0.424 0.067 2.662 
Ensemble H vs J 3.489 0.559 21.792 
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Odds Ratio Estimates 
Effect Point Estimate 95% Wald 
Confidence Limits 
Ensemble I vs J 0.137 0.022 0.869 
 
Association of Predicted Probabilities and 
Observed Responses 
Percent Concordant 99.0 Somers' D 0.982 
Percent Discordant 0.8 Gamma 0.985 
Percent Tied 0.3 Tau-a 0.143 
Pairs 46431 c 0.991 
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The SAS System 
 
The LOGISTIC Procedure 
Model Information 
Data Set WORK.A 
Response Variable mouthpf 
Number of Response Levels 2 
Model binary logit 
Optimization Technique Fisher's scoring 
 
Number of Observations Read 800 
Number of Observations Used 800 
 
Response Profile 
Ordered 
Value 
mouthpf Total 
Frequency 
1 0 741 
2 1 59 
 
Probability modeled is mouthpf=0. 
 
Class Level Information 
Class Value Design Variables 
position1 1 1 0 0             
  2 0 1 0             
  3 0 0 1             
  4 -1 -1 -1             
type1 Spray 1                 
  Spurt -1                 
Ensemble A 1 0 0 0 0 0 0 0 0 
  B 0 1 0 0 0 0 0 0 0 
  C 0 0 1 0 0 0 0 0 0 
  D 0 0 0 1 0 0 0 0 0 
  E 0 0 0 0 1 0 0 0 0 
  F 0 0 0 0 0 1 0 0 0 
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Class Level Information 
Class Value Design Variables 
  G 0 0 0 0 0 0 1 0 0 
  H 0 0 0 0 0 0 0 1 0 
  I 0 0 0 0 0 0 0 0 1 
  J -1 -1 -1 -1 -1 -1 -1 -1 -1 
 
Model Convergence Status 
Quasi-complete separation of data points detected. 
 
Warning: The maximum likelihood estimate may not exist. 
 
Warning: The LOGISTIC procedure continues in spite of the above warning. Results shown are based 
on the last maximum likelihood iteration. Validity of the model fit is questionable. 
Model Fit Statistics 
Criterion Intercept Only Intercept and 
Covariates 
AIC 423.172 147.969 
SC 427.857 213.554 
-2 Log L 421.172 119.969 
 
Testing Global Null Hypothesis: BETA=0 
Test Chi-Square DF Pr > ChiSq 
Likelihood Ratio 301.2031 13 <.0001 
Score 215.7963 13 <.0001 
Wald 34.0715 13 0.0012 
 
Type 3 Analysis of Effects 
Effect DF Wald 
Chi-Square 
Pr > ChiSq 
position1 3 26.2271 <.0001 
type1 1 0.0173 0.8954 
Ensemble 9 26.6381 0.0016 
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Analysis of Maximum Likelihood Estimates 
Parameter   DF Estimate Standard 
Error 
Wald 
Chi-Square 
Pr > ChiSq 
Intercept   1 20.4299 100.6 0.0413 0.8390 
position1 1 1 -6.1559 65.4768 0.0088 0.9251 
position1 2 1 -9.0621 65.4775 0.0192 0.8899 
position1 3 1 7.6090 146.4 0.0027 0.9586 
type1 Spray 1 7.9343 60.3654 0.0173 0.8954 
Ensemble A 1 -3.5928 46.7437 0.0059 0.9387 
Ensemble B 1 10.1180 245.9 0.0017 0.9672 
Ensemble C 1 10.1180 245.9 0.0017 0.9672 
Ensemble D 1 -1.9675 46.7463 0.0018 0.9664 
Ensemble E 1 10.1180 245.9 0.0017 0.9672 
Ensemble F 1 -4.8867 46.7438 0.0109 0.9167 
Ensemble G 1 -3.2577 46.7439 0.0049 0.9444 
Ensemble H 1 -3.9170 46.7437 0.0070 0.9332 
Ensemble I 1 -6.8762 46.7454 0.0216 0.8831 
 
Odds Ratio Estimates 
Effect Point Estimate 95% Wald 
Confidence Limits 
position1 1 vs 4 <0.001 <0.001 >999.999 
position1 2 vs 4 <0.001 <0.001 >999.999 
position1 3 vs 4 1.000 <0.001 >999.999 
type1 Spray vs Spurt >999.999 <0.001 >999.999 
Ensemble A vs J 9.617 1.750 52.837 
Ensemble B vs J >999.999 <0.001 >999.999 
Ensemble C vs J >999.999 <0.001 >999.999 
Ensemble D vs J 48.857 6.373 374.556 
Ensemble E vs J >999.999 <0.001 >999.999 
Ensemble F vs J 2.637 0.531 13.102 
Ensemble G vs J 13.446 2.359 76.620 
Ensemble H vs J 6.955 1.303 37.122 
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Odds Ratio Estimates 
Effect Point Estimate 95% Wald 
Confidence Limits 
Ensemble I vs J 0.361 0.069 1.875 
 
Association of Predicted Probabilities and 
Observed Responses 
Percent Concordant 98.7 Somers' D 0.976 
Percent Discordant 1.0 Gamma 0.980 
Percent Tied 0.3 Tau-a 0.134 
Pairs 43719 c 0.988 
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CURRICULUM VITAE 
 
Jeremy R. Gouzd 
 Laboratory Technician Level II 
NIOSH 
Evaluation and Testing Branch 
Phone: 304.285.6031 
Email: Ltv5@cdc.gov 
 JGouzd2@gmail.com  
 
Education: 
B.S. - Mechanical Engineering, Fairmont State University, 11/2013, High 
Honors Scholar graduate 
 
M.S. – Education-Professional Studies, Fairmont State University, 5/2015 
 
Certifications: 
 
IS-00100.b – Introduction to Incident Command System ICS-100 
IS-00200.b – Single Resources and Initial Action Incident, ICS-200 
IS-00700.b – National Incident Management System (NIMS), ICS-700 
IS-00800.b – National Response Framework, ICS-800 
AWR-130 - Incident Response to Terrorist Bombing - Awareness  
 
 
 
Work Experience: 
Laboratory Technician Level II at NIOSH in the Evaluation and Testing Branch 
 
Major project responsibilities and leadership roles: 
 
• Conduct Laboratory Experiments Related To Analytical Research For 
Stockpile Investigation And Research. I use industry-accepted standards to 
test and evaluate a variety of personal protective equipment (PPE) such as 
respirators and isolation gowns worn by healthcare workers. Duties include 
ensuring the equipment meets manufacturer specifications to successfully 
perform testing. Operate TSI 8130 Filter Testers for Salt (NaCl) to 
determination of particulate Filter Efficiency Level for N95, N99, N100 
Filters against solid particles. Including the determination of Inhalation 
Resistance Test, Exhalation Resistance Test, and Exhalation Valve Leakage 
Test.  
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• Work With Senior Project Officers To Implement Complex Sampling 
Plans. Operate And Maintain All Industrial Equipment For Field Readiness 
for preparation of field samples from occupationally-exposed workers. Field 
samples include fire fighter turnout gear and respirators that were involved in 
a fatality and evaluated as part of NIOSH’s Fire Fighter Fatality Investigation 
Prevention Program (FFFIPP). The equipment must be prepped and ready at 
all times to prepare for turnout gear and respirator investigations, which are 
often high-profile and confidential. Regularly follow a chain of custody with 
evidence and all paperwork in a sensitive manner. All chain of custody 
evidence must be thoroughly documented upon arrival, signed in and out of 
the evidence cage, and documentation of its departure. Photo and written 
documentation is recorded as the package arrives, during the opening of 
package, and very specific details of the PPE as the visual inspection is 
completed. Respond to Requests for Information from senior project officers 
for the PPE evaluation results from the NIOSH FFFIPP. Designed and built 
new test equipment that allows more efficient and accurate tests to be 
conducted. Gained competency of laboratory equipment and standard test 
procedures used for investigations in the FFFIPP including Air Flow test, 
Rated service time test, positive pressure test, static pressure test, Gas flow 
test, Remaining service life indicator test (mechanical and electronic), and 
Exhalation resistance test.  
 
• Calibrate Wide-Range Of Industrial Equipment To Ensure Valid 
Measurement Of Data. Calibrate and maintain equipment prior to use of all 
test devices used for these bench tests. I Follow Property Procedures To 
Track Laboratory Equipment by keeping detailed logs for each laboratory 
device and coordinate with manufacturers when calibration is needed by 
obtaining quotes, preparing appropriate forms, and shipping the equipment. 
Set up numerous quotes and estimates for purchasing of equipment and 
testing devices, which involves keeping track of laboratory equipment and its 
statuses. 
 
• Conduct Laboratory Experiments Related To Analytical Research. I use 
industry-accepted standards to test and evaluate a variety of personal 
protective equipment (PPE) such as respirators and isolation gowns worn by 
healthcare workers. Duties include ensuring the equipment meets 
manufacturer specifications to successfully perform testing. Gained 
competency in the PPE testing equipment such as Frazier Differential 
Pressure Air Permeability Tester, Instron Tensile Tester. I have also gained 
knowledge and experience related to testing according to industry standards 
for various types of respirators for penetration by synthetic blood according, 
including calibration of instrument and conditioning of samples.   
 
• Follow Established Decontamination Procedures Of Field Samples. As 
part of the FFFIPP program, I must maintain good safety hygiene practices 
and follow decontamination and clean up guidelines after testing. I ensure 
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appropriate PPE and sufficient ventilation is always used during the visual 
inspection and testing of PPE. I use procedures of maintaining a clean 
decontamination process with contaminated units. Having the knowledge of 
correct PPE is vital in testing contaminated field samples. 
 
• Document And Prepare Analyses And Reports Of Study Findings And 
Test Results. Documenting fire fighter PPE investigations includes taking 
detailed records on appropriate data sheets, in putting the records into the 
electronic reports, and taking photographs. After the testing and evaluations 
are complete, I use the analyses and reports of the findings from the bench 
tests results and prepare a final report. These reports contain detailed 
information on the PPE investigations, equipment used, and the findings. I 
enter the reports into the computer and file the hard copies in appropriate 
locations. 
 
 
